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Impact Of Adverse Childhood Experiences On Behavioral And Neural Markers Of
Executive Function In Menopausal Women
Abstract
Many healthy women with no history of cognitive dysfunction experience subjective executive difficulties
during menopause. Indicators of risk for executive function difficulties at menopause are lacking, as is a
mechanistic understanding of how loss of estradiol unmasks this vulnerability. We hypothesized that
adverse childhood experiences (ACE) increase the risk of executive dysfunction during menopause via
alterations in monoaminergic neurotransmission. To test this hypothesis, we evaluated the effect of ACE
on subjective and objective measures of executive function as well as executive activation, functional
connectivity, and neurochemistry. We used tryptophan depletion (TD) and lisdexamfetamine (LDX) to
probe serotonergic and catecholaminergic function, respectively. High ACE women endorsed greater
symptoms of executive dysfunction and performed worse on tasks probing sustained attention and
working memory. These negative ACE effects were partially mediated by anxiety and depressive
symptoms. ACE moderated the impact of TD on DLPFC activation in hypogonadal women such that TD
increased activation in high ACE participants but decreased activation in low ACE participants.
Importantly, treatment with estradiol attenuated the effects of both ACE and TD. ACE similarly moderated
the impact of TD on within-network connectivity. While ACE was associated with lower within-network
connectivity regardless of depletion condition, TD increased connectivity in the high ACE group but had no
effect on connectivity in the low ACE group. ACE also moderated response to LDX. In the high ACE group,
LDX (vs placebo) increased activation in the insula and reduced symptoms related to difficulty with
organization and activation for work. In contrast, response to LDX was not significantly different from
placebo in the low ACE group.
These results have several clinical and mechanistic implications. First, they highlight that addressing
concurrent mood changes is a critical step in treating menopause-induced executive difficulties. Second,
this work suggests that early life adversity has latent impacts on serotonergic circuits underlying
executive function that are unmasked by loss of estradiol during menopause. Third, they indicate that
early adversity may have lasting effects on catecholaminergic neurotransmission and may moderate
response to stimulant medications. Together, they emphasize the importance of considering ACE when
treating executive difficulties with pharmacologic agents during menopause.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Neuroscience

First Advisor
C. Neill Epperson

Keywords
Childhood adversity, Cognition, Executive function, fMRI, Menopause

Subject Categories
Neuroscience and Neurobiology
This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/2580

IMPACT OF ADVERSE CHILDHOOD EXPERIENCES ON BEHAVIORAL AND
NEURAL MARKERS OF EXECUTIVE FUNCTION IN MENOPAUSAL WOMEN
Sheila Shanmugan
A DISSERTATION
in
Neuroscience
Presented to the Faculties of the University of Pennsylvania
in
Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2017

Supervisor of Dissertation
______________________
C. Neill Epperson, MD
Professor of Psychiatry and Obstetrics and Gynecology

Graduate Group Chairperson
______________________
Joshua Gold, PhD
Professor of Neuroscience

Dissertation Committee
James Loughead, PhD, Associate Professor of Psychiatry
Theodore Satterthwaite, MD, MA, Assistant Professor of Psychiatry
Yvette Sheline, MD, McLure Professor of Psychiatry, Radiology, Neurology
Mary Sammel, ScD, Professor of Biostatistics, Obstetrics and Gynecology

IMPACT OF ADVERSE CHILDHOOD EXPERIENCES ON BEHAVIORAL AND
NEURAL MARKERS OF EXECUTIVE FUNCTION IN MENOPAUSAL WOMEN
COPYRIGHT
2017
Sheila Shanmugan

This work is licensed under the
Creative Commons AttributionNonCommercial-ShareAlike 3.0
License
To view a copy of this license, visit

https://creativecommons.org/licenses/by-nc-sa/3.0/us/

ACKNOWLEDGMENT

I am incredibly grateful to my mentor, Neill Epperson, whose creativity and love for
research inspired me to embark on a career as a physician-scientist. Since joining her
lab, I have had the opportunity to benefit from her wisdom, insights, and genuine
warmth. She has consistently challenged me to be the best scientist I can be, while
nurturing my intellectual and personal growth. I hope one day to mentor a student with
the same enthusiasm and selflessness with which she has mentored me. I have
enormous gratitude for members of my thesis committee, including Ted Satterthwaite,
for teaching me how to teach myself and being there when I failed; James Loughead, for
his patient instruction in the concepts behind fMRI and for reminding me not to take
things too seriously; Mary Sammel, for teaching me everything that I know about
statistics; and Yvette Sheline, for her insightful comments and constructive feedback. I
would also like to thank Wen Cao for teaching me the granular details of fMRI analysis
and always answering my questions, no matter the time or day.

iii

ABSTRACT
IMPACT OF ADVERSE CHILDHOOD EXPERIENCES ON BEHAVIORAL AND
NEURAL MARKERS OF EXECUTIVE FUNCTION IN MENOPAUSAL WOMEN
Sheila Shanmugan
Dr. C. Neill Epperson

Many healthy women with no history of cognitive dysfunction experience subjective
executive difficulties during menopause. Indicators of risk for executive function
difficulties at menopause are lacking, as is a mechanistic understanding of how loss of
estradiol unmasks this vulnerability. We hypothesized that adverse childhood
experiences (ACE) increase the risk of executive dysfunction during menopause via
alterations in monoaminergic neurotransmission. To test this hypothesis, we evaluated
the effect of ACE on subjective and objective measures of executive function as well as
executive activation, functional connectivity, and neurochemistry. We used tryptophan
depletion (TD) and lisdexamfetamine (LDX) to probe serotonergic and catecholaminergic
function, respectively. High ACE women endorsed greater symptoms of executive
dysfunction and performed worse on tasks probing sustained attention and working
memory. These negative ACE effects were partially mediated by anxiety and depressive
symptoms. ACE moderated the impact of TD on DLPFC activation in hypogonadal
women such that TD increased activation in high ACE participants but decreased
activation in low ACE participants. Importantly, treatment with estradiol attenuated the
effects of both ACE and TD. ACE similarly moderated the impact of TD on withinnetwork connectivity. While ACE was associated with lower within-network connectivity
regardless of depletion condition, TD increased connectivity in the high ACE group but
iv

had no effect on connectivity in the low ACE group. ACE also moderated response to
LDX. In the high ACE group, LDX (vs placebo) increased activation in the insula and
reduced symptoms related to difficulty with organization and activation for work. In
contrast, response to LDX was not significantly different from placebo in the low ACE
group.
These results have several clinical and mechanistic implications. First, they
highlight that addressing concurrent mood changes is a critical step in treating
menopause-induced executive difficulties. Second, this work suggests that early life
adversity has latent impacts on serotonergic circuits underlying executive function that
are unmasked by loss of estradiol during menopause. Third, they indicate that early
adversity may have lasting effects on catecholaminergic neurotransmission and may
moderate response to stimulant medications. Together, they emphasize the importance
of considering ACE when treating executive difficulties with pharmacologic agents during
menopause.
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CHAPTER 1

General Introduction: Could Early
Life Adversity Increase Risk for
Executive Dysfunction during
Menopause?

1

The Clinical Problem
The menopause transition is marked initially by fluctuating levels of ovarian
hormones and ends with an overall dearth of estrogen in the postmenopausal period
(Burger et al., 2007; Henderson and Popat, 2011; Shanmugan and Epperson, 2014).
During this transition, many women report experiencing a decline in cognitive function
(Greendale et al., 2009; Mitchell and Woods, 2011), specifically in areas of memory and
attention (Halbreich et al., 1995; Weber and Mapstone, 2009; Schaafsma et al., 2010;
Mitchell and Woods, 2011). Recent reports have suggested that healthy women with no
history of cognitive dysfunction experience increased difficulty with everyday tasks
requiring executive processes such as working memory, focus, attention, organization,
and planning (Epperson et al., 2011; Shanmugan and Epperson, 2014; Epperson et al.,
2015; Shanmugan et al., 2017). Evidence as to whether this midlife onset in cognitive
decline can be attributed to the menopause transition is suggestive but not conclusive
(Henderson and Popat, 2011). This variability in results across studies has traditionally
been attributed to lack of consistency in the stages of menopause examined, covariates
considered, and the use of cognitive measures with varying degrees of ecological
validity (Luetters et al., 2007). A more recent hypothesis is that individual biological and
environmental differences contribute to risk vs resilience for executive dysfunction with
waning estradiol (Shanmugan and Epperson, 2014). In particular, there is preliminary
evidence that adverse childhood experiences (ACE) including abuse, neglect, and
household dysfunction may confer a vulnerability for executive difficulties that is revealed
by loss of estradiol during menopause (Shanmugan and Epperson, 2014). This
hypothesis is based on the negative impacts of ACE on executive functions and
cognitive aging as well as the converging effects of estradiol and early life stress on
monoaminergic function in the prefrontal cortex (PFC).
2

The Prefrontal Cortex: Location and Function
Before discussing the effects of estradiol and early life adversity on the PFC at
the neurotransmitter level, it is important to review the anatomical and working nature of
the PFC. The PFC is located at the anterior of the frontal lobes of the brain and includes
Brodmann’s areas 8, 9, 10, 11, 44, 45, 46, and 47 (Shanmugan and Epperson, 2014).
The PFC is important for executive processes such as inhibiting distracting information
and stimuli, planning, evaluating consequences when making decisions, and working
memory. Working memory is often defined as the ability to keep desired or target
information ‘‘online’’ and accessible as well as the ability to manipulate this information
while being presented with new information that could serve as a distraction. Several
clinical neuroimaging studies and preclinical studies in rodents and nonhuman primates
have established the importance of the PFC in such behaviors. Rodents and monkeys
with PFC lesions exhibit impaired performance on tasks requiring working memory
(Butters and Pandya, 1969; Brito and Brito, 1990; Carlson et al., 1997; Chafee and
Goldman-Rakic, 1998; Funahashi and Inoue, 2000; Lauwereyns et al., 2001; Chang et
al., 2002; Baeg et al., 2003), reversal learning and flexibility (Rolls et al., 1996; Meunier
et al., 1997; Dias and Aggleton, 2000; Chudasama and Robbins, 2003; Kim and
Ragozzino, 2005; Floresco and Ghods-Sharifi, 2007; Rygula et al., 2010), and decisionmaking (Mobini et al., 2002; Floresco and Ghods-Sharifi, 2007; Kim et al., 2008;
Churchwell et al., 2009; Hauber and Sommer, 2009; Endepols et al., 2010; O'Neill and
Schultz, 2010). In healthy human subjects, performing tasks requiring these processes,
particularly working memory, increases blood oxygen level dependent (BOLD) signal in
the PFC (Barch et al., 1997; Braver et al., 1997; D'Esposito et al., 1998; Callicott et al.,
1999; Clark et al., 2000; Diwadkar et al., 2000; Owen et al., 2005). The results of this
research suggest that certain portions of the PFC are important for particular executive
3

functions. For example, the dorsal and lateral portions of the PFC are key in the
regulation of attention, whereas the ventral and medial portions are important for
emotional regulation (Arnsten, 2009). Optimal executive functioning and PFC regulation
of subcortical brain structures are dependent upon prefrontal concentrations of
monoamines, specifically dopamine (Arnsten, 2011), norepinephrine (Arnsten, 2011),
and serotonin (5-HT) (Boulougouris and Tsaltas, 2008; Shanmugan and Epperson,
2014).
As suggested by Arnsten and colleagues, dopamine and norepinephrine exhibit
an inverted U-shaped dose–response curve on PFC regulation of behavior (Arnsten,
2009, 2011). When present at ideal levels, norepinephrine maintains network
connectivity through the stimulation of postsynaptic α2A-receptors and dopamine inhibits
inappropriate attention to stimuli through stimulation of D1 receptors (Arnsten, 2009,
2011). Insufficient stimulation of these receptors at lower concentrations can lead to
symptoms of executive dysfunction such as fatigue, distractibility, and impulsivity while
the excessive D1 stimulation and inappropriate norepinephrine α1 and β1 stimulation
that occur at higher neurotransmitter concentrations mimic symptoms of excessive
stress such as mental inflexibility (Arnsten, 2009; Shanmugan and Epperson, 2014)
While serotonin also contributes to PFC modulation of executive function
(Boulougouris and Tsaltas, 2008), its mechanisms of action are less well understood.
Serotonin has a predominantly inhibitory effect on glutamatergic activity in the PFC (Puig
and Gulledge, 2011). This inhibitory effect is driven by the 5-HT1A receptor, which
reduces action potential generation at the cell body and axon of glutamatergic pyramidal
neurons (Puig and Gulledge, 2011). The 5-TH1A receptor also acts as a presynaptic
autoreceptor on projections from the dorsal raphe, inhibiting further release of serotonin
(Li et al., 1999). Stimulation of the 5-TH1A receptor has been associated with improved
4

attentional control and decreased impulsivity (Carli et al., 2006; Puig and Gulledge,
2011). Serotonin also binds to 5-HT2A receptors on the apical dendrites of pyramidal
neurons, which increases membrane excitability and excitatory post-synaptic potentials
(Puig and Gulledge, 2011). Simulation of these 5-HT2A receptors has been associated
with worse cognitive flexibility (Carli et al., 2006), reversal learning (Boulougouris et al.,
2008; Boulougouris and Tsaltas, 2008), and impulsivity (Carli et al., 2006; Puig and
Gulledge, 2011). These seemingly paradoxical effects result in serotonin inhibiting the
activity of individual neurons while increasing the coherence of networks of neurons in
the PFC (Puig and Gulledge, 2011).
Evidence supporting the withdrawal of estrogen modulation of these prefrontal
monoaminergic systems as one mechanism leading to decline in executive functions will
be discussed further below.

Estradiol’s effect on executive function
Subjective cognitive complaints, particularly in areas of memory and attention,
are commonly reported by women transitioning through menopause (Halbreich et al.,
1995; Weber and Mapstone, 2009; Schaafsma et al., 2010; Epperson et al., 2011;
Mitchell and Woods, 2011; Epperson et al., 2015; Shanmugan et al., 2017). Mitchell and
Woods (Mitchell and Woods, 2011) found that 60% of their sample of menopausal
women reported experiencing increasing memory problems while 79% of menopausal
women in another sample reported experiencing memory loss (Weber and Mapstone,
2009). Rodent and non-human primate studies have suggested that this midlife cognitive
decline can be attributed to the loss of estradiol experienced during the menopause
transition. Estrogen, alone or in combination with progesterone, has been shown to be
successful in correcting ovariectomy induced impairments in spatial working memory
5

and recognition memory consolidation, pre-clinical proxies for executive function (Rapp
et al., 2003; Inagaki et al., 2010). In a delayed response test of spatial working memory,
estrogen replacement reversed cognitive impairments associated with cognitive aging in
intact aged female rhesus monkeys, while ovariectomy worsened the same symptoms
(Rapp et al., 2003; Shanmugan and Epperson, 2014). Enhanced performance on
working memory tasks in ovariectomized nonhuman primates receiving estradiol is
thought to be in part due to estradiol-induced increases in dendritic spine density and the
number of smaller, more motile dendritic spines thought to be important for synaptic
plasticity (Rapp et al., 2003; Hao et al., 2007).

ACE effects on executive function
Unlike other cognitive domains, the executive system undergoes a protracted
period of development that extends into young adulthood, making it particularly
susceptible to the effects of early life adversity (Pechtel and Pizzagalli, 2011). The high
density of glucocorticoid receptors and dopaminergic inputs make the PFC especially
vulnerable (Brake et al., 2000; Pechtel and Pizzagalli, 2011). Inhibitory control and
cognitive flexibility develop more slowly in preschool-aged children with less access to
learning resources (Clark et al., 2013; Shanmugan and Satterthwaite, 2016).
Impairments in inhibitory control (Navalta et al., 2006; Mueller et al., 2010) and PFC
hyperactivation (Mueller et al., 2010) have also been observed in adolescents with high
levels of early life stress (Mueller et al., 2010) as well as adult women with a history of
sexual abuse (Navalta et al., 2006; Pechtel and Pizzagalli, 2011). A longitudinal
neuroimaging study found an interactive effect of socioeconomic status and sex on both
behavior and brain function, but no effect of socioeconomic status or sex alone
(Spielberg et al., 2015; Shanmugan and Satterthwaite, 2016), highlighting the relevance
6

of considering interactions between early adversity and estradiol on neural function. This
study suggested that inhibitory processing in the DLPFC is less efficient in females of
lower socioeconomic status than those of higher socioeconomic status (Spielberg et al.,
2015). The negative effects of early life stress on executive function last into adulthood.
In healthy adults, early trauma has been associated with poorer working memory
performance (Philip et al., 2016), executive system hyperactivation during a working
memory task (Philip et al., 2016), and decreased functional connectivity within networks
at rest (Philip et al., 2013). Findings from rodent studies have suggested that the impact
of early life stress on later cognitive functions may become particularly acute during
middle-age (Brunson et al., 2005). Significant adversity during childhood has similarly
been associated with sub-optimal cognitive aging in human participants (Kremen et al.,
2012; Zhang et al., 2016). Together, these studies suggest that early life adversity alters
the developmental trajectory of executive functions, which may result in heightened
vulnerability to executive dysfunction with loss of estradiol. Reviewing the mechanisms
by which estradiol and ACE impact monoaminergic systems is necessary to understand
why the effects of ACE may be particularly acute during the menopause transition.

Estradiol effects on prefrontal catecholamine systems
Estradiol modulates PFC concentrations of dopamine and norepinephrine,
catecholamines crucial for executive functioning (Arnsten, 2011). Previous studies have
demonstrated that treatment with 17b-estradiol both improves memory consolidation and
regulates dopaminergic and noradrenergic neurotransmission in the rodent PFC. In
rodents, estradiol treatment improves memory consolidation and raises concentrations
of

3-Methoxy-4-hydroxyphenylglycol

(metabolite

of

norepinephrine)

and

3,4-

Dihydroxyphenylacetic acid (metabolite of dopamine) in the PFC (Inagaki et al., 2010).
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Estrogen benzoate or ERb agonist-induced elevations in prefrontal dopamine and
norepinephrine metabolites are accompanied by improvements in recognition memory in
ovariectomized rats (Jacome et al., 2010). However, treatment with significantly higher
or lower doses of estradiol does not improve memory consolidation in ovariectomized
rats despite increases in neurotransmitter levels observed at higher doses, indicating
that estrogen’s effects on cognition are dose dependent (Inagaki et al., 2010).
Estrogen also modulates these catecholaminergic systems through enzymatic
regulation of transmitter metabolism. In female rats, OVX or treatment with tamoxifen, an
estrogen antagonist, has been shown to elevate PFC protein expression and enzyme
activity of catechol-o-methyl transferase (COMT), an enzyme involved in dopamine and
norepinephrine metabolism (Schendzielorz et al., 2011). Jacobs and D’Esposito (2011)
showed that the relationship between BOLD signal in the medial frontal gyrus (MFG)
during performance of a working memory task (N-back task) and estradiol levels are
dependent on catecholaminergic tone, as determined by COMT Val158Met genotype
and enzyme activity. In this study, premenopausal women with the genotype Val/Val had
greater COMT enzyme activity, and therefore metabolized dopamine more quickly,
compared to women who were homozygous for the Met allele. Performance on the Nback task as well as MFG activation exhibited an inverted U-shaped curve dependent on
both genotype and estradiol level. Women who were homozygous for the Val allele
showed better working memory performance and increased MFG activation when
estradiol levels were high compared with when estradiol levels were low, presumably
because the increase in estradiol increased dopamine to optimum levels. The opposite
was true of women with the genotype Met/Met. In their case, the increase in estradiol
resulted in overly heightened PFC dopamine levels, pushing them to the right side of the
inverted U-shaped curve and impairing executive functioning (Jacobs and D'Esposito,
8

2011). This literature suggests withdrawal of estrogen modulation of prefrontal
catecholamine systems during menopause may be one mechanism leading to decline in
executive functions (Shanmugan and Epperson, 2014).

ACE effects on prefrontal catecholamine systems
Maternal deprivation and separation paradigms have been used to model early
life stress in rodents. In these rodent models of early life stress, adversity results in an
increase in PFC dopamine turnover (Matthews et al., 2001; Rentesi et al., 2013) and
may lower dopamine levels in comparison to controls (Rentesi et al., 2013). Rodents
exposed to early life stress are more sensitive to the effects of d-amphetamine
(Zimmerberg and Shartrand, 1992; Rentesi et al., 2013), a stimulant that increases
concentrations of dopamine and norepinephrine, as well as apomorphine (Daskalakis et
al., 2012; Rentesi et al., 2013), a dopamine agonist. Early stress also decreases
dopamine D2 receptor expression in the PFC (Rentesi et al., 2013). Similarly, in
nonhuman primates, early and life-long stress in the form of social subordination results
in decreased D2 receptor function accompanying stressed behaviors in female monkeys
(Shively, 1998).
Evidence from human participants suggests the consequences of these changes
in neurotransmission manifest early in life. A large longitudinal study recently found that
a child’s executive functioning is determined by the interaction between genotype for
COMT and history of early life adversity (Blair et al., 2015). This study found that
between the ages of 3 and 5, the presence of early life adversity was associated with
poorer executive function. Additionally, there was a COMT genotype x early life adversity
interaction on the trajectory of executive functioning development during this time. In
children with low levels of adversity, Val/Val children initially performed better on
9

executive functioning tasks, but children with a Met allele improved faster. In contrast,
children with a Met allele and high levels of adversity demonstrated the slowest
executive development, resulting in the lowest performance levels at 5 years of age
among the four groups (Val/Val low adversity = Val-Met/Met-Met low adversity > Val/Val
high adversity > Val-Met/Met-Met high adversity) (Blair et al., 2015).
These studies demonstrate that estradiol and early life adversity act on common
molecular targets involved in catecholamine function and suggest that exposure to high
levels of early life adversity may result in heightened vulnerability to loss of estradiol
modulation of catecholamine function.

Estradiol effects on serotonin
Rodent and non-human primate studies have demonstrated that estradiol has
profound impacts on serotonin function at the gene, enzyme, and receptor level. (Amin
et al., 2005). Estradiol treatment increases serotonin concentration (Inagaki et al., 2010),
synthesis (Cone et al., 1981), release (Cone et al., 1981) and turnover (Di Paolo et al.,
1983), increases gene expression of tryptophan hydroxylase (the rate limiting enzyme in
serotonin synthesis) (Pecins-Thompson et al., 1998), increases serotonin transporter
binding (Fink et al., 1999), and increases serotonin receptor 2A mRNA and binding (Cyr
et al., 1998; Fink et al., 1999; Amin et al., 2005). Using the tryptophan depletion (TD)
paradigm, Epperson et al. (2012) provided novel evidence for estrogen by serotonin
interactions during working memory in menopausal women. In this study, the TD
paradigm was used to lower central serotonin levels in healthy menopausal women
before and after treatment with transdermal estradiol. During the 2-back task, TD was
associated with a decrease in BOLD signal in the right and left DLPFC and middle
frontal/cingulate gyrus prior to estradiol treatment. This attenuation in BOLD was
10

prevented by estradiol treatment, suggesting that estradiol’s effects on brain activation
during working memory are in part via estradiol’s effects on serotonergic function
(Epperson et al., 2012; Shanmugan and Epperson, 2014).

ACE effects on serotonin
Preclinical studies have shown that early life adversity exerts lasting effects on
the serotonin system (Comasco et al., 2013; van der Doelen et al., 2014a; van der
Doelen et al., 2014b; van der Doelen et al., 2015), suggesting the interaction between
these factors may further exacerbate executive difficulties during hypogonadism. In
rodent models of early life stress, maternal deprivation results in a decrease in serotonin
levels in the PFC (Matthews et al., 2001; Rentesi et al., 2013) as well as an increase in
serotonin turnover (Masis-Calvo et al., 2013; Rentesi et al., 2013; Wong et al., 2015).
Early life adversity also decreases tryptophan hydroxylase type 2, the rate-limiting
enzyme in serotonin synthesis (Bethea et al., 2008) and increases monoamine oxidaseA (Wong et al., 2015), an enzyme involved in serotonin metabolism. Early life stress also
attenuates 5-HT1A receptor function (Wong et al., 2015) and decreases 5-HT2A
receptor expression (Rentesi et al., 2013) in the prefrontal cortex of adult rats.
Furthermore, low serotonin levels have been shown to exacerbate the negative effects
of early life stress on impulsivity in adult mice (Sachs et al., 2013). This literature
indicates that estradiol and early life stress act on common serotonergic targets at the
molecular level and suggests that one mechanism by which early life adversity increases
risk for executive dysfunction during menopause may be via decreased serotonin
concentration and receptor function.

Overview of original research chapters
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The overarching purpose of this dissertation is to determine whether early life
adversity is a risk factor for executive function difficulties during menopause and to
examine the impact of ACE on monoaminergic function during this hormonal transition.
To answer this question, we use behavioral and neuroimaging data from 3 separate
samples of menopausal women with high and low levels of early life adversity.
First, we sought to determine whether ACE confers a risk for executive
dysfunction during menopause. In chapter 2, we use behavioral data from a large
sample of women who underwent surgical menopause to establish the impact of ACE on
subjective and objective measures of executive function. We demonstrate that ACE is
associated with greater symptoms of executive dysfunction as well as poorer task
performance. Importantly, we show that these effects of ACE are partially mediated by
anxiety and depression symptoms.
The strong associations between ACE and mood symptoms in chapter 2
suggested to us that ACE is likely associated with suboptimal serotonergic function.
Given the previous work from our lab demonstrating the importance of intact
serotonergic function to working memory function during menopause (Epperson et al.,
2012) as well as the converging effects of estradiol and early life stress on common
serotonergic targets at the molecular level, we hypothesized that one mechanism by
which ACE exerts a negative impact on executive function during periods of low estradiol
may be via effects on serotonin.
To test this hypothesis, we used functional magnetic resonance imaging and
tryptophan depletion (TD), a paradigm used to lower central serotonin levels. We
hypothesized that ACE would be associated with executive hyperactivation and that TD
would exacerbate differences between ACE groups. However, given that previous
studies have shown that TD may improve sustained attention and response inhibition
12

(Schmitt et al., 2000; Booij et al., 2005; Scholes et al., 2007), our competing hypothesis
was that TD would attenuate differences in ACE groups. The common theme underlying
both of these hypotheses is that, because early adversity negatively impacts multiple
aspects of serotonergic function, the serotonin system of high ACE individuals would be
more “vulnerable” to experimental manipulations affecting serotonin, resulting in
differential response to TD.
In chapter 3, we present data consistent with our competing hypothesis. We
show that in the absence of exogenous estradiol, TD increases DLPFC activation in high
ACE subjects but decreases DLPFC activation in low ACE subjects. Importantly,
treatment with estradiol attenuates the effects of both ACE and TD. Given that the TD x
ACE interaction on BOLD signal, while consistent with our competing hypothesis, was
not as initially predicated, we chose to further probe this finding by examining whether
ACE and TD would show similar effects on a different neural marker of executive
function: functional connectivity.
In chapter 4, we residualize task effects to obtain an approximate resting state
timeseries. Using this pseudo-resting state, we examine the impact of ACE and TD on
within-network connectivity, a measure shown to underlie executive functions across the
lifespan (Betzel et al., 2014; Chan et al., 2014; Tsvetanov et al., 2016). We predicted
that ACE would be associated with lower within-network connectivity. We also initially
predicted that TD would further lower connectivity in women with high levels of early
adversity but have no effect in in women with low levels of early adversity. However,
given the results of chapter 3, we strongly considered the competing hypothesis that TD
would attenuate differences between ACE groups by selectively increasing connectivity
in the high ACE group. This was in fact what we found. We demonstrate that ACE is
associated with lower within-network connectivity regardless of depletion condition. We
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also show that TD increases connectivity in the high ACE group but has no effect on
connectivity in the low ACE group.
We first examined whether serotonergic differences contribute to ACE effects on
executive function because results of chapter 2 indicated that ACE likely alters
serotonergic function and because previous work from our lab (Epperson et al., 2012)
indicated that the serotonin system may be vulnerable to additional insults during
periods of low estradiol. However, as reviewed earlier in the introduction, ACE likely
affects

executive

function

via

multiple

mechanisms

involving

monoamine

neurotransmission.
Therefore, we next examined the impact of ACE on dopaminergic and
noradrenergic function in menopausal women with subjective cognitive complaints.
Because rodent studies have demonstrated that early life stress may increase sensitivity
to amphetamine, we chose to use a stimulant medication as our pharmacological probe.
We specifically selected lisdexamfetamine (LDX), because this medication successfully
improves subjective measures of executive function in menopausal women with selfreported new-onset executive difficulties (Epperson et al., 2015).
Previous studies have shown that stimulant medications increase activation in
executive regions, including the insula (Rubia et al., 2014) and DLPFC (Wong and
Stevens, 2012) in subjects with attention deficit hyperactivity disorder (ADHD).
Stimulants have also been shown to decrease glutamate levels in the PFC of children
with ADHD (Wiguna et al., 2012). However, no brain imaging studies examining the
effect of LDX on brain activation or neurochemistry have been performed. Therefore,
before examining whether ACE alters response to this drug, we first characterize the
impact of LDX on executive activation and neurochemistry in chapter 5. Results from
chapter 5 demonstrate that LDX improves subjective symptoms of executive
14

dysfunction, increases insula activation, and decreases DLPFC glutamate. In chapter 6,
we examine whether ACE moderates the impact of LDX on these outcomes and
demonstrate that ACE is a moderator of both behavioral and brain response to LDX.
In summary, this body of work seeks to address why many healthy women with
no history of cognitive dysfunction experience executive difficulties during the
menopause transition. Indicators of risk for executive function difficulties at menopause
are currently lacking, as is an understanding of the mechanisms contributing to this
vulnerability with diminishing estradiol. Therefore, in the following chapters I will examine
early life adversity as a risk factor for this decline and explore potential mechanisms by
which early adversity confers this vulnerability to executive dysfunction with loss of
estradiol.
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Abstract
Objective: Many women who undergo risk reduction salpingo-oophorectomy (RRSO) to
reduce risk of breast and ovarian cancers experience onset of executive dysfunction.
Adverse childhood experiences (ACE) may be one factor contributing to risk vs
resilience for executive dysfunction after oophorectomy. Here the authors examined the
effect of ACE on subjective and objective measures of executive function in women who
underwent RRSO. The authors hypothesized that ACE would be associated with poorer
executive function and that these effects would be mediated by mood symptoms.
Method: The authors studied 552 women who completed cognitive testing after RRSO at
up to two time points (857 sessions total). Cognitive tasks included the Continuous
Performance Task and letter n-back task to probe sustained attention and working
memory, respectively. The ACE questionnaire was used to assess early life adversity.
ACE effects on task performance and subjective symptoms of executive dysfunction
were examined using generalized estimating equations. Mood (anxiety/depressive)
symptoms were evaluated as a mediator of ACE effects on these outcomes.
Results: ACE was associated with more symptoms of executive dysfunction and worse
performance on both cognitive tasks. Mood symptoms were a partial mediator of ACE
effects on sustained attention and subjective report of executive dysfunction.
Conclusions: These data suggest that early life adversity is associated with increased
risk of executive dysfunction after RRSO and that the negative effects of early adversity
on executive function are in part mediated by mood symptoms, highlighting the
importance of assessing anxiety and depressive symptoms in women who have
undergone RRSO.

26

Introduction
Women with mutations in breast cancer type 1 or 2 susceptibility genes (BRCA1
and BRCA2) are at increased risk for developing breast and ovarian cancers (Finch et
al., 2012). Risk reduction salpingo-oophorectomy (RRSO) by 35 – 40 years of age is the
standard of care (Muto, 2015) and up to 90% of BRCA carriers undergo RRSO (Finch et
al., 2012). While this procedure reduces the risk of ovarian cancer by 85-95% and the
risk of breast cancers by 53-68% (Guidozzi, 2016), there are several consequences of
being hypogonadal at such an early age.
Given that ovarian hormones such as estradiol and progesterone have numerous
neuromodulatory and neuroprotective effects (Shanmugan and Epperson, 2014), recent
studies have examined RRSO as a potential risk for central nervous system (CNS)
impairment and overall decline in quality of life. For example, large cohort studies have
shown that women who undergo oophorectomy before natural menopause are at
increased risk of dementia (Rocca et al., 2007) and cognitive dysfunction during and
after the seventh decade of life (Rocca et al., 2007; Ryan et al., 2014). More specifically,
the largest declines in cognitive performance following oophorectomy occur in executive
functioning domains (Kurita et al., 2016). This post-oophorectomy onset of executive
difficulties may be a result of reduced estradiol modulation of brain regions such as the
prefrontal cortex (PFC) that are critical to proper executive processes such as working
memory, organization, focus, and sustained attention (Epperson et al., 2011;
Shanmugan and Epperson, 2014; Epperson et al., 2015; Shanmugan et al., 2017).
Executive functioning capacity depends on the neurochemical environment in the
PFC. Optimal executive function is maintained by a balance of factors in this region
including dopamine, norepinephrine, and glutamate concentration and receptor function
(Arnsten and Jin, 2014) as well as hormonal status (Jacobs and D'Esposito, 2011;
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Shanmugan and Epperson, 2014). However, previous research has shown that
significant adverse childhood experiences (ACE) not only alter the developmental
trajectory of the executive system (Shanmugan and Satterthwaite, 2016) but also have
lasting impacts on dopaminergic (Kasanova et al., 2016), noradrenergic (Zitnik et al.,
2016), and glutamatergic (Llorente et al., 2012) function, which may leave the individual
vulnerable to cognitive changes during periods of low estradiol such as after RRSO
(Shanmugan and Epperson, 2014).
Together, these studies suggest that premature, abrupt loss of estradiol with
RRSO induces executive function difficulties in many, but not all, hypogonadal women
and that ACE may be one factor contributing to risk vs resilience for executive
dysfunction after oophorectomy. However, no studies examining the effect of ACE on
executive function after RRSO have been performed. Early life adversity has also been
shown to increase risk for mood disorders during natural menopause (Epperson et al., In
Press), and mood symptoms have been independently associated with executive
dysfunction (Shanmugan et al., 2016). As such, it is not clear to what extent ACE effects
on mood symptoms drive ACE effects on executive function in hypogonadal women.
Here we examined the effect of ACE on subjective and objective measures of
executive function while rigorously controlling for multiple possible confounding variables
in 552 women who underwent RRSO. We hypothesized that high levels of early life
adversity would be associated with greater self-reported symptoms of executive
dysfunction as well as poorer performance on neuropsychological tasks probing
executive function. Furthermore, we hypothesized that these ACE effects on executive
function would be partially mediated by ACE effects on mood symptoms.

Method
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Participants
Subjects were recruited through mailings from the Cancer Risk Evaluation
Program at the University of Pennsylvania, through local advertising, and through an
advocacy group for women with genetic risk for breast and ovarian cancer (FORCE;
Facing Our Risk of Cancer Empowered). Women over the age of 30 at high risk for
breast or ovarian cancer who had undergone RRSO were eligible to participate.
Exclusion criteria included inability to provide informed consent.
Subjects completed online surveys through Qualtrics. These surveys assessed
mood, subjective and objective cognition, menopausal symptoms and related quality of
life measures, early life adversity, and medication use. Subjects were asked to repeat
the survey after 1 year. In this report, we consider the sample of subjects from this
cohort that completed one or more outcomes of interest at least once.

Assessment of subjective executive function
Subjective symptoms of executive dysfunction were evaluated using a modified
version of the 40-item Brown Attention Deficit Disorder Scale (BADDS), a validated
subjective measure of executive function (Sandra Kooij et al., 2008) that assesses the
frequency and severity of five domains of executive dysfunction: (1) organization and
activating for work, (2) sustaining attention and concentration, (3) sustaining alertness,
effort, and processing speed, (4) managing affective interference, and (5) using working
memory and accessing recall. The original version of the BADDS was adapted for online
use. Each item is rated on a scale from 0 to 3. Higher scores are indicative of more
dysfunction. Total BADDS score served as the primary measure of subjective executive
function, while BADDS subscales were secondary outcome measures.

29

Assessment of objective executive function
As part of a comprehensive computerized cognitive battery, (Gur et al., 2010)
subjects completed two neuropsychological tasks probing executive domains. In this
report, we specifically focused on measures related to executive functions given the
converging evidence for the effects of estradiol and early life stress on this domain
(Shanmugan and Epperson, 2014; Shanmugan and Satterthwaite, 2016). The Penn
Continuous Performance Task (CPT) number and letter version (Kurtz et al., 2001) was
used to assess sustained attention. During the task, subjects were instructed to respond
when the image seen was a complete letter or number. The primary measure of
sustained attention was d’, a signal detection metric that limits the influence of response
bias.
A letter version of the n-back task (Ragland et al., 2002) was used to probe
working memory function across four conditions that placed varying demands on
working memory load: 0-back, 1-back, 2-back and 3-back. Stimuli were 4-letter nonwords without vowels. In the 0-back condition, participants responded with a button
press to a pre-specified target 4-letter stimulus, while subjects responded to a stimulus
“n” number of stimuli before it in all other conditions. Because the 3-back condition
places the greatest demands on working memory load, 3-back d’ served as the primary
measure of working memory.

Assessment of early life adversity
The Adverse Childhood Experiences (ACE) Questionnaire (Felitti et al., 1998)
was used to assess history of child abuse, childhood neglect, and household
dysfunction. The ACE questionnaire has been widely used to assess the association
between early life stress and health-related outcomes in adult life (Felitti et al., 1998).
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Using the ACE questionnaire allowed us to consider the effects of overall early life
adversity as a predictor of cognitive dysfunction rather than examining the
consequences of a particular trauma or stressor.

The number of exposures was

summed to create the ACE score (range: 0–10). Based on evidence from prior studies
indicating increased risk of depressive disorders in later life in subjects with 2 or more
ACEs (Chapman et al., 2004; Epperson et al., In Press), we considered subjects with an
ACE score ≥ 2 “high ACE” and subjects with an ACE score of < 2 “low ACE”.

Assessment of mood symptoms
Presence of depressive and anxiety symptoms was assessed using the 14-item
Hospital Anxiety and Depression Scale. This scale contains a 7-item depression
subscale that assesses changes in mood, loss of interest, and psychomotor slowing and
a 7-item anxiety subscale that assesses mental agitation and psychological distress.
Each item is rated on a scale of 0 to 3. In line with prior studies of executive functions
that have represented anxiety and depressive symptoms as a composite “mood” score
(Shanmugan et al., 2016), total scores on the depression and anxiety subscales were
summed to create a composite measure of mood symptoms.

Statistical analyses
Generalized estimating equations implemented using the geepack package
(HÃ¸jsgaard et al., 2006) in R (R Core Team, 2015) were employed to evaluate the
effect of ACE on executive outcomes. This method accommodates multiple survey
assessments per woman, and adjusts for non-independence of these repeated
measures. Age, time since oophorectomy, and age at oophorectomy were assessed as
possible covariates. However, at baseline, age was highly correlated with both age at
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oophorectomy (r=0.85, p<0.0001) and time since oophorectomy (r=0.49, p<0.0001). To
fully account for the effects of age on cognitive outcomes, generalized estimating
equations with cognitive measures as the outcomes and age as the predictor were used
to obtain age-residualized scores for the BADDS, CPT, and n-back outcomes.
Subsequent analyses were performed on these residuals rather than raw values. Time
without hormones (a summary of time since oophorectomy and duration of hormone
therapy use, if any), education level, and history of chemotherapy use were included as
covariates in all models. Significance was defined as p<=0.05.
Mediation models were used to examine whether ACE confers a risk for
executive dysfunction after RRSO via increased mood symptoms. The three primary
outcome measures served as the dependent variable in 3 separate analyses. Total ACE
served as the independent variable, while the composite mood score served as the
mediator. The indirect effect was estimated using the Product of Coefficients approach
followed by significance testing using a bootstrap resampling approach implemented
with the boot package (Canty and Ripley, 2016) using ordinary nonparametric
bootstrapping and 2,000 iterations.
Psychotropic medication use served as an additional covariate in supplemental
analyses of primary outcome variables. Supplementary analyses also examined the
effects of ACE in the subset of women who had undergone oophorectomy prior to age
47.4, 2 standard deviations (1 SD=2.26 years) below the average age (51.9 years) of
post-menopause onset (Freeman et al., 2012). To evaluate whether timing of adversity
was driving results, we also separately examined the effects of pre-pubertal ACE and
post-pubertal ACE on primary outcome measures. Puberty was defined as 2 years prior
to menstrual cycle onset.

32

Results
Participants
Eight hundred subjects completed cognitive testing at baseline and were eligible
for inclusion in this report. Of these 800 subjects, 453 repeated cognitive testing after 1
year, yielding a total of 1,253 sessions that were eligible for inclusion. Sessions included
in analyses must have completed at least one outcome of interest (n=1,058). Sessions
missing information regarding age at testing (n=16), hormone therapy use (n=165), ACE
(n=12), education level (n=8), and mood symptoms (n=30) were excluded. As part of
data quality assurance, subjects who performed below chance (<50% true positives) on
the CPT were excluded from analyses of the CPT (n=20). Similarly, subjects who
performed below chance (<5 true positive responses) on the 0-back control condition
were excluded from analyses of the n-back (n=13). The final sample included in
analyses was 552 subjects (Table 2-1; Figure 2-1). Complete data for at least one
outcome measure and all primary covariates were obtained on 494 subjects at baseline
and 363 subjects at the 1-year follow-up session, yielding a total of 857 sessions
included in analyses.

ACE effects on executive function
ACE was associated with higher total BADDS score (β= 7.1, p=0.0005) (Figure
2-2a) as well as each BADDS subscale (organization/activation for work, β=1.7, p=
0.002; attention/concentration, β=1.8, p=0.001; alertness/effort/processing speed, β=1.4,
p=0.004; managing affective interference, β=1.3, p=0.0007; working memory/accessing
recall, β=0.8 p=0.03) (Figure 2-2b). The high ace group also performed worse on both
the n-back (β=-0.17, p=0.007) (Figure 2-3a) and CPT (β=-0.1, p=0.03) (Figure 2-3b) in
comparison to the low ACE group. Chemotherapy use also had a negative impact on
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sustained attention (β=-0.17, p=0.006). Time in a hypogonadal state was not significantly
associated with any outcome measure.

Mood symptoms mediate ACE effects on executive function
We conducted mediation analyses to determine whether ACE effects on
executive function are mediated by ACE effects on mood symptoms. Mood symptoms
partially mediated the relationship between ACE and total BADDS score (Figure 2-4a).
After accounting for the effects of previous chemotherapy use, education, and length of
time hypogonadal, ACE was significantly associated with mood symptoms (β=2.1,
p=0.0003) and mood symptoms were significantly associated with age-residualized total
BADDS scores (β=2.1, p<0.0001). ACE continued to be associated with total BADDS
scores when mood symptoms were included as a covariate (β=2.8, p=0.08). Mood
symptoms mediated 62.8% (95% CI: 42.3% - 100%) of ACE effect on total BADDS
score.
Mood symptoms partially mediated ACE effects on sustained attention (Figure 24b). ACE was significantly associated with higher mood symptoms (β=2.1, p=0.0002)
and mood symptoms were significantly negatively associated with age-residualized CPT
d’ (β=-0.01, p=0.001). ACE continued to be associated with CPT d’ when mood
symptoms were included as a covariate (β=-0.09, p=0.08). Mood symptoms mediated
21.3% (95% CI: 9.3% - 100%) of ACE effects on CPT d’.
In contrast to the role of mood symptoms as a mediator of ACE effects on
subjective executive function and sustained attention, mood symptoms did not mediate a
significant proportion of the relationship between ACE and working memory performance
(95% CI: -1.4% – 50%) (Figure 2-4c). However, ACE effects on n-back d’ remained
significant when mood symptoms were included as a covariate (β=-0.16, p=0.01).
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Supplementary analyses
ACE effects on subjective executive function (β=6.1, p=0.002), sustained
attention (β=-0.11, p=0.03), and working memory (β=-0.16, p=0.01) were similar when
controlling for use of psychoactive medications. Results were also similar in the subset
of women who underwent oophorectomy before age 47.4 (total BADDS, n=353, β =8.4,
p=0.0008; CPT d’, n=350, β = -0.12, p=0.06; n-back d’, n=382, β = -0.16, p=0.06). While
pre-pubertal ACE was associated with significantly more subjective executive difficulties
(β=5.6, p=0.03), post-pubertal ace was not. In contrast, post-pubertal ACE was
associated with worse sustained attention (β=-0.24, p=0.006), while pre-pubertal ACE
was not. Pre-pubertal ACE (β=-0.13, p=0.08) and post-pubertal ACE (β=-0.22, p=0.07)
were both associated with poorer working memory.

Discussion
In this large study of cognitive function in women who underwent RRSO, we
examined associations between early life adversity and subjective and objective
measures of executive function. To account for the fact that early adversity is associated
with increased risk of mood disorders with loss of estradiol, we conducted mediation
analyses to determine the extent to which ACE effects on executive function result from
concurrent mood changes. Women with high levels of early life adversity reported more
symptoms of dysfunction across executive domains. High ACE women also performed
worse on executive tasks probing sustained attention and working memory. While mood
symptoms partially mediated ACE effects on sustained attention and subjective report of
executive dysfunction, the associations between ACE and poorer subjective and
objective measures of executive function remained present after accounting for the
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effects of anxiety and depression symptoms. Taken together, these data emphasize that
early life adversity is associated with increased risk of executive dysfunction after RRSO.

Evidence for ACE effects on executive function
As predicted, we found that ACE was associated with greater subjective report of
executive dysfunction as well as poorer performance on neuropsychological tasks of
executive function. Several studies have demonstrated early life adversity is associated
with poorer executive function during childhood and adolescence (Hostinar et al., 2012;
Loman et al., 2013; Heyman and Hauser-Cram, 2015) and that this negative effect
persists into adulthood (Philip et al., 2016). For example, a study of 90 young children
found that early psychosocial deprivation was associated with lower composite scores of
executive function after controlling for IQ (Hostinar et al., 2012). Such deprivation has
been associated with slower neural responses and attentional processing in older
children (Loman et al., 2013). Similarly, early life stress has been associated with poorer
working memory performance and aberrant activation in associated brain regions in
healthy adults (Philip et al., 2016). This literature suggests early life adversity likely alters
the developmental trajectory of the executive system (Shanmugan and Satterthwaite,
2016).
Animal models suggest the mechanisms underlying the detrimental effects of
early adversity on executive function development are likely multifold. For example, early
life stress in mice has been shown to induce alterations in PFC dendritic architecture
(Yang et al., 2015). Early adversity also alters dopaminergic (Kasanova et al., 2016),
noradrenergic (Zitnik et al., 2016), serotonergic (Matsuzaki et al., 2009), and
glutamatergic (Llorente et al., 2012) function in the PFC. Importantly, estradiol supports
the normal development and maintenance of each of the above neurotransmitter
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systems (Shanmugan and Epperson, 2014). Additionally, the effects of early adversity
and estradiol converge on common molecular targets at the synaptic level (Shively et al.,
2003; Amin et al., 2005; Matsuzaki et al., 2009; Michopoulos et al., 2014; Shanmugan
and Epperson, 2014). Together, this literature suggests abrupt loss of estradiol
regulation of these neurotransmitter systems after RRSO is likely a key mechanism
underlying the observed differences in executive function between high and low ACE
groups (Shanmugan and Epperson, 2014).

Evidence for mood as a mediator of ACE effects on executive function
ACE effects on subjective report of executive dysfunction and ACE effects on
sustained attention performance after RRSO were partially mediated by anxiety and
depressive symptoms. Many healthy women experience onset of executive function
difficulties during menopause concurrent with loss of estradiol (Epperson et al., 2011;
Epperson et al., 2015; Shanmugan et al., 2017). During this hormonal transition, women
with no history of depression are also at increased risk of new onset depressive
symptoms (Freeman et al., 2014). Early life adversity has been suggested as a risk
factor for both executive function difficulties (Shanmugan and Epperson, 2014) as well
as mood changes (Epperson et al., In Press) during periods of waning estradiol. Mood
symptoms are also associated with executive system dysfunction (Shanmugan et al.,
2016), highlighting the importance of jointly considering the role of early adversity and
mood changes on executive functions after RRSO. Notably, the mediating effect of
mood and timing of pre- vs post-pubertal adversity varied across domains, suggesting
future studies of ACE effects on executive function would benefit from further
dissociation between sustained attention, working memory, and subjective report of

37

executive dysfunction symptoms as well as timing of adversity onset in relation to
puberty.
Our results highlight that addressing concurrent mood changes is a critical step
in treating either natural or surgical menopause-induced executive difficulties.
Importantly, we found that ACE effects were mediated by anxiety and depressive
symptoms, which may or may not translate to a full diagnosis of generalized anxiety
disorder, major depressive disorder, or other mood disorder. The mediating effect of
mood was significant even though the average anxiety and depression subscale scores
in this sample (Table 1) were below those corresponding to full categorical diagnoses of
anxiety (8+) or depressive disorders (8+) (Bjelland et al., 2002), further emphasizing the
importance of screening for sub-threshold mood symptoms in this population. However,
mood was a partial, not full, mediator of ACE effects on BADDS and CPT performance.
Additionally, mood did not mediate ACE effects on working memory. Furthermore, ACE
effects on working memory remained significant when accounting for the effects of mood
symptoms, age, chemotherapy use, time since oophorectomy, hormone therapy use,
and education. Together, these data suggest that mood symptoms are only one
component of the mechanism underlying new onset cognitive dysfunction with loss of
estradiol and that at least a portion of ACE-associated risk for executive difficulties is
independent of the association between ACE and anxiety and depressive symptoms.
Further research is necessary to determine these mood-independent mechanisms, but
dopaminergic (Shanmugan et al., 2017), glutamatergic (Shanmugan et al., 2017), and
serotonergic (Shanmugan and Epperson, 2014) pathways likely play a role.
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Limitations
While this study had a large sample size and controlled for multiple possible
confounds, certain limitations should be acknowledged. First, subjects completed
cognitive testing in an uncontrolled environment, potentially reducing validity of these
neuropsychological tests. However, excluding subjects who performed below chance on
control conditions allowed us to limit this effect. Additionally, such a study design
enabled us to examine the effects of early adversity on cognition post-RRSO at a scale
that would have been much less feasible with in-office visits. Second, while a previous
study (Ryan et al., 2014) found effects of age at oophorectomy on cognitive outcomes,
we did not find a similar effect of time without hormones. This difference may be due to
differences in the predictive variable examined as well as the fact that that study was
conducted in a much older population (age at baseline > 65). Third, all subjects in this
study were surveyed after undergoing RRSO. As such, while results demonstrate that
ACE is associated with worse executive function after RRSO, it is not clear whether ACE
has similar effects prior to RRSO. Longitudinal studies testing subjects before and after
RRSO would be necessary to determine whether the impacts of RRSO and ACE on
executive function are synergistic or additive.

Conclusions
In summary, these data provide novel evidence regarding the impact of early life
adversity on executive function after RRSO. These results emphasize that the negative
effects of early adversity on executive function are at least in part mediated by ACE
effects on mood, underscoring the importance of assessing anxiety and depressive
symptoms in women who have undergone RRSO. These results suggest that the
neurotransmitter systems underlying these processes, including serotonin, glutamate,
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and dopamine, may be important targets of interventions that seek to improve executive
function in this population. Further research utilizing longitudinal study designs and multimodal neuroimaging would be helpful in elucidating ACE x RRSO effects on
glutamatergic and monoaminergic function.
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Table 2-1. Participant Characteristics

n
Age (years)
Age at oophorectomy (years)
Time since oophorectomy (months)
Time without hormones (months)
History of cancer
Previous hormone therapy use
Current hormone therapy use
Previous chemotherapy use
Education
Graduate school
College
Some College
High school
Some high school
8th grade or less
Race
Caucasian
African American
Asian
Hispanic
Other

Low ACE
High ACE
Mean (SD) or number
350
202
47.2 (7.2)
48.1 (7.9)
43.4 (6.0)
43.9 (7.3)
45.6 (46.2)
49.3 (48.3)
30.8 (41.3)
33.3 (43.0)
156
101
150
80
98
52
94
65
155
155
34
3
1
2

94
68
32
8
0
0

326
2
3
8
6

181
4
0
6
3

10

8

11.3 (6.7)
5.5 (3.8)
5.7 (3.6)

13.5 (7.1)
6.7 (4.0)
6.9 (3.4)

4
98
9
13
3
43
32

4
62
12
7
2
30
16

Unknown or preferred not to disclose
Mood symptoms
HADS total score
HADS depression subscale score
HADS anxiety subscale score
Current psychoactive medication indication or
class
Attention deficit disorder
Depression
Anxiety
Neurological conditions
Narcotics
SERM antagonist/Aromatase inhibitor
Tamoxifen/SERM
Mean ACE
Abuse
Emotional abuse
Physical abuse
Sexual abuse
Neglect
Emotional neglect
Physical neglect
Household dysfunction
Parents divorced/separated
Witnessed domestic violence
Drug abuse in household
Mental illness in household
Incarceration of family member

0.32 (0.47)

3.4 (1.6)

6
4
25

119
78
51

11
1

102
25

37
2
10
7
2

107
26
93
93
13

ACE=Adverse Childhood Experiences; HADS=Hospital Anxiety
SERM=Selective Estrogen Receptor Modulator
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Depression

Scale;

Figures

Figure 2-1. Consort diagram. Eight hundred subjects completed cognitive testing at
baseline and 453 subjects repeated cognitive testing after 1 year, yielding a total of
1,253 sessions that were eligible for inclusion. Sessions included in analyses must have
completed at least one outcome of interest (n=1,058). Sessions missing information
regarding age at testing (n=16), hormone therapy use (n=165), ACE (n=12), education
level (n=8), and mood symptoms (n=30) were excluded. Subjects who performed below
chance (<50% true positives) on the CPT were excluded from analyses of the CPT
(n=20). Similarly, subjects who performed below chance (<5 true positive responses) on
the 0-back control condition were excluded from analyses of the n-back (n=13).
Complete data for at least one outcome measure and all primary covariates were
obtained on 494 subjects at baseline and 363 subjects at the 1-year follow-up session,
yielding a total of 552 subjects and 857 sessions included in analyses. ACE=adverse
childhood experiences
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Figure 2-2. ACE effects on subjective symptoms of executive dysfunction. ACE
was associated with higher total BADDS score (β= 7.1, p=0.0005) (a) as well as each
BADDS

subscale

(b)

(organization/activation

for

work,

β=1.7,

p=

0.002;

attention/concentration, β=1.8, p=0.001; alertness/effort/processing speed, β=1.4,
p=0.004; managing affective interference, β=1.3, p=0.0007; working memory/accessing
recall, β=0.8 p=0.03). Bars represent means. BADDS=Brown Attention Deficit Disorder
Scale. ACE=adverse childhood experiences
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Figure 2-3. ACE effects on sustained attention and working memory. When
controlling for age, time without hormones, chemotherapy use, and education level, ACE
was associated with worse performance worse on both the CPT (β=-0.1, p=0.03) (a) and
n-back (β=-0.17, p=0.007) (b). Bars represent means. CPT=continuous performance
task. ACE=adverse childhood experiences.
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Figure 2-4. Mood symptoms mediate ACE effects on executive function. a) Mood
symptoms partially mediated the relationship between ACE and total BADDS score.
ACE was significantly associated with total BADDS scores (β=7.2, r2=0.03, p=0.0005).
ACE was significantly associated with mood symptoms (β=2.1, p=0.0003), mood
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symptoms were significantly associated with age-residualized total BADDS scores
(β=2.1, p<0.0001), and ACE was associated with BADDS scores when mood symptoms
were included as a covariate (β=2.8, r2=0.41, p=0.08). Mood symptoms mediated 62.8%
(95% CI: 42.3% - 100%) of ACE effect on total BADDS score. b) Mood symptoms
partially mediated ACE effects on sustained attention. ACE was significantly associated
with CPT performance (β=-0.1, r2=0.02, p=0.03). ACE was associated with greater mood
symptoms (β=2.1, p=0.0002), mood symptoms were negatively associated with ageresidualized CPT d’ (β=-0.01, p=0.001), and ACE was associated with CPT d’ when
mood symptoms were included as a covariate (β=-0.09, r2=0.04, p=0.08). Mood
symptoms mediated 21.3% (95% CI: 9.3% - 100%) of ACE effects on CPT d’. c) ACE
was significantly associated with working memory performance (β=-0.17, r2=0.02,
p=0.007). Mood symptoms did not mediate a significant proportion of the relationship
between ACE and working memory performance (95% CI: -1.4% – 50%). However,
ACE effects on n-back d’ remained significant when mood symptoms were included as a
covariate (β=-0.16, r2=0.02, p=0.01). BADDS=Brown Attention Deficit Disorder Scale.
CPT=continuous performance task. ACE=adverse childhood experiences
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Abstract
Many healthy women with no history of cognitive dysfunction experience subjective
executive difficulties during menopause. Preclinical literature suggests latent effects of
early life adversity on serotonin function may play a role in this phenomenon. However,
evidence in human participants regarding the mechanisms by which loss of estradiol
contributes to this vulnerability is lacking. Here we examined the impact of tryptophan
depletion (TD) and adverse childhood experiences (ACE) on brain activation during a
working memory task in menopausal women. We hypothesized that an interactive effect
between ACE and TD would be observed when women were hypogonadal, and that
treatment with estradiol would attenuate this effect. Thirty-three women underwent
functional imaging at four time points (123 total scans) in this double-blind, placebo
controlled, crossover study. The effects of TD, ACE, and TD x ACE were evaluated
using a voxelwise, mixed-effects, 2 x 2 ANOVA. In the absence of exogenous estradiol,
a TD by ACE interaction was observed on BOLD signal in the right DLPFC such that TD
increased activation in high ACE subjects but decreased activation in low ACE subjects.
While a similar interaction was observed with placebo treatment, treatment with estradiol
attenuated the effects of ACE and TD such that no between or within group differences
were observed. Together, these results suggest that early life adversity may have a
lasting impact on serotonergic circuits underlying executive function that are unmasked
by loss of estradiol during menopause.
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Introduction
During menopause, many healthy women experience new onset subjective
difficulties with executive processes involving sustained attention, motivation for work,
organization and working memory (Epperson et al., 2015; Shanmugan et al., 2017).
Onset of these executive difficulties coincides with waning estradiol levels and may be a
result of reduced estradiol modulation of the prefrontal cortex (PFC) (Shanmugan and
Epperson, 2014). We previously showed that estradiol modulation of serotonergic
function in the dorsolateral PFC (DLPFC) may be particularly important in maintaining
intact working memory processes in menopausal women (Epperson et al., 2012). Early
life experiences may also shape an individual’s executive function during this hormonal
transition (Shanmugan and Epperson, 2014). Significant adversity during childhood
alters executive system development (Bruce et al., 2013; Shanmugan and Satterthwaite,
2016), resulting in poor working memory and executive system hyper-activation into
adulthood (Majer et al., 2010; Bruce et al., 2013; Philip et al., 2016) as well as suboptimal cognitive aging (Barnes et al., 2012). Moreover, adverse childhood experiences
(ACE) have lasting impacts on serotonergic function (Comasco et al., 2013; van der
Doelen et al., 2015), which may leave individuals vulnerable to cognitive changes during
periods of low estradiol such as during menopause (Epperson et al., 2011; Shanmugan
and Epperson, 2014; Epperson et al., 2015; Shanmugan et al., 2017).
Non-human primate studies indicate effects of early life stress and estradiol
converge on key aspects of serotonergic function. Specifically, reduction in tryptophan
hydroxylase type 2 (TPH2) gene expression resulting from social subordination stress in
ovariectomized macaques is ameliorated by treatment with estradiol (Bethea et al.,
2008). In non-stressed, ovariectomized rats and macaques, chronic estradiol treatment
not only increases serotonin synthesis via TPH2, but also enhances serotonin release
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and turnover, increases serotonin transporter binding, and increases serotonin receptor
2A mRNA and binding (Amin et al., 2005). Together, this preclinical literature suggests
early life stress and estradiol act on common serotonergic targets at the molecular level.
However, what roles early adversity and the interaction between early adversity and
serotonin function play in conferring vulnerability to executive dysfunction during
menopause is unknown. Human participants studies examining ACE effects on
serotonergic function during conditions of low and high estradiol are needed to
determine whether early adversity increases risk for executive dysfunction during
menopause via effects on serotonin.
We used tryptophan depletion (TD) and a double-blind, placebo-controlled,
cross-over design in 33 healthy menopausal women with high and low levels of early life
adversity. We hypothesized that ACE would be associated with aberrant activation in the
DLPFC. Additionally, we predicted TD would differentially impact DLPFC activation in
high vs low ACE hypogonadal women. Moreover, we hypothesized that estradiol
treatment would attenuate ACE and TD effects.

Methods and Materials
Participants were healthy women ages 48-60 with no psychiatric diagnoses and
within 10 years of their last menstrual period. Participants were right-handed and had a
FSH > 30 IU/ml, a normal mammogram within the last year, and a clear urine toxicology.
Exclusion criteria included use of hormone therapy within the last year, contraindications
to hormone therapy, IQ < 95, Mini Mental Status Exam Score < 25, lifetime history of
psychotic or bipolar disorder, other psychiatric or substance use disorder in the last year,
Hamilton depression score > 14, psychotropic medication use within the last month,
metallic implant, and claustrophobia. This study was approved by the Institutional
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Review Board at the University of Pennsylvania. All participants provided written
informed consent.
Study design
Participants underwent 4 test days in this double-blind, placebo-controlled, crossover study (Figure 3-1a). During test days 1 and 2 (phase 1), participants underwent 2
imaging sessions: active TD or sham TD. The order of condition was counterbalanced
and double-blind. After phase 1, participants were randomized to 17β-estradiol (Vivelle
Dot® 0.100 mg/d) or placebo patch treatment for 10 weeks. After completing ~8 weeks
of estradiol or placebo, participants underwent active TD and sham TD (phase 2).
On test days, participants ingested capsules containing either amino acids
without tryptophan (active TD) or microcellulose (sham TD). Blood was taken for free
tryptophan analysis (Figure 3-1b) and mood ratings were completed prior to
consumption of capsules and approximately 6 hours later, after which participants
underwent neuroimaging. Subjects with percent change in tryptophan approximately >3
SD from the average for the assigned depletion status were excluded to ensure that
tryptophan levels were consistent with the assigned condition.

Assessment of early life adversity
The Adverse Childhood Experiences Questionnaire (Felitti et al., 1998) was used
to assess history of emotional, physical, or sexual abuse, childhood neglect, and
household dysfunction. The ACE questionnaire assesses the number of exposures
rather than severity (Teicher and Parigger, 2015) and has been used extensively to
assess the association between early adversity and later life health outcomes (Felitti et
al., 1998). Number of exposures was summed to create the ACE score (range: 0–10).
Subjects with an ACE score ≥ 2 were considered “high ACE” while subjects with ACE
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score of < 2 were considered “low ACE”. A threshold of 2 was used to define the high
ACE group based on studies of depression prevalence in later life that demonstrate
increased susceptibility at this level of exposure (Chapman et al., 2004; Epperson et al.,
In Press).

Assessment of mood
Mood was measured as a possible confound using the Profile of Mood States.
Total score and “Depression-Dejection” sub-score assessed changes in overall mood
and depressive symptoms, respectively. Difference in mood score (AM-PM) served as
the outcome in regression models used to assess the effects of TD and ACE on mood.

Task paradigm
A letter n-back task was used to probe executive system function during fMRI.
The task included four conditions: 0-back, 1-back, 2-back and 3-back. Stimuli were 4letter non-words without vowels presented for 500 ms, followed by an interstimulus
interval of 2500 ms. In the 0-back condition, participants responded to a target stimulus.
In all other conditions, participants responded to a stimulus “n” number of stimuli before
it. Each condition consisted of 3 20-trial blocks (60s; 1:2 target-foil ratio). Visual
instructions (9s) preceded each block. Baseline rest periods occurred at the beginning
(72s), middle (24s), and end (24s) of acquisition. Task duration was 924s. Equivalent nback tasks with unique stimuli were used for each session and version order was
counter-balanced. Performance measures of interest were overall true positive count,
false positive count, and median true positive response time.

Image acquisition and processing
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Imaging data were acquired on 3T Siemens Trio scanner. A magnetizationprepared, rapid acquisition gradient echo T1-weighted image (TR=1810 ms, TE=3.51
ms, FOV=180 x 241mm, matrix=192 x 256, 160 slices, effective voxel resolution of 0.94
x 0.94 x 1 mm) was acquired to aid spatial normalization to standard space. Functional
images were acquired using a whole-brain, single-shot gradient-echo echoplanar
sequence with the following parameters: TR/TE=3000/32 ms, FOV=192 × 192mm,
matrix=64 x 64, slice thickness/gap=3/0 mm, 46 slices, effective voxel resolution of 3 x 3
x 3 mm.
BOLD time series data were skull stripped with BET (Smith, 2002), despiked with
AFNI’s 3dDespike (Cox, 1996), motion-corrected with MCFLIRT (Jenkinson et al., 2002),
high pass filtered (120s), spatially smoothed (6mm FWHM), and mean-based intensity
normalized. Subject-level timeseries analyses were carried out using FILM (FMRIB's
Improved Linear Model) with local autocorrelation correction (Woolrich et al., 2001;
Woolrich et al., 2009). The four condition blocks (0-back, 1-back, 2-back, and 3-back)
and their temporal derivatives were modeled using a canonical (double-gamma)
hemodynamic response function with standard plus extended motion parameters
included as nuisance covariates. The rest condition (fixation point) served as the
unmodeled baseline. Functional and anatomical volumes were co-registered using
boundary-based registration (Greve and Fischl, 2009). The anatomical image was
normalized to the MNI 152 T1 1mm template using diffeomorphic SyN registration in
ANTs (Klein et al., 2009; Avants et al., 2011). Co-registration, normalization, and downsampling to 3 mm3 were concatenated so only one interpolation was performed. Images
were assessed for excessive motion (mean relative displacement > 0.5 mm) and low
temporal signal-to-noise ratio (tSNR < 2 SD).
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Group-level analyses
Analyses of imaging data were completed using voxelwise linear mixed-effects
models with FSL’s FLAME1 procedure. A two-way, whole-brain, voxel-wise, mixedeffects ANOVA was used to determine the effects of TD, ACE, and TD x ACE on brain
activation during phase 1. The primary analysis focused on the parametric contrast; 0-,
1-, 2-, and 3-back were weighted -3, -1, 1, and 3 to model a linear increase in activity
across conditions. The parametric contrast is most sensitive to linear effects in signal
associated with increasing working memory load and may not capture non-linear effects.
Therefore, we also examined the 3-back > 0-back contrast. As prior imaging studies
found effects of early life stress at 0-back > baseline (Philip et al., 2016), we also
examined this contrast. To adequately control for Type I error (Eklund et al., 2016) and
limit the probability of Type 2 error, we implemented stringent cluster correction
procedures using 10,000 Monte-Carlo simulations executed with AFNI’s 3dClustSim
program (Cox, 1996).

Parameters selected include voxel height threshold of z>3.1,

cluster probability of p<0.05, non-Gaussian (long-tailed) filtering, padded simulated
volumes to account for edge effect artifacts, 1-sided thresholding, and first-nearest
neighbor clustering (clustering of above threshold voxels if faces touch). Smoothness
was estimated with AFNI’s 3dFWHMx program using residuals of the group level
analysis and spatial autocorrelation computed as a function of the radius using a mixed
Gaussian plus mono-exponential model (Eklund et al., 2016). Mean percent signal
change from significant voxels was extracted for further statistical testing and
visualization. Signal was also extracted from the 1-back>0-back and 2-back>0-back
contrasts to investigate effects of TD and ACE at varying levels of working memory load
(Figure 3-S1). To examine whether estradiol attenuated the impact of ACE and TD on
BOLD, signal from significant phase 1 voxels was extracted from phase 2 scans.
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Statistical analyses
Linear mixed-effects models implemented using the nlme package (Pinheiro et
al., 2016) in R (R Core Team, 2015) were employed to evaluate the effect of TD, ACE
and their interaction on mood, behavior, and BOLD signal during phase 1 as well as the
4-way interaction between ACE group x TD status x estradiol/placebo group x study
phase. All models accounted for repeated measures and controlled for age, estradiol
level, and time since last menstrual period. Hypotheses regarding the impact of TD and
ACE status under estradiol and placebo conditions on significant phase 1 outcome
measures were then tested using this modeling framework. Test day was included as an
additional covariate in secondary analyses of significant behavioral findings to account
for practice effects. Difference in percent errors between 3-back and 0-back was
included as a covariate in supplementary analyses to account for differences in task
performance between back levels that may be reflected in the 3-back > 0-back BOLD
contrast. The square root of the coefficient of determination from a linear mixed-effects
model was used to estimate the partial correlation between BOLD signal within the
DLPFC and behavior while accounting for repeated measures. Spearman’s rank
correlation was used to examine the relationship between ACE as a continuous variable
and BOLD signal during sham depletion. Statistical tests were two-sided with p<=0.05
considered significant.

Results
Participants
Sixty participants completed screening and were enrolled in this study. Two
participants self-withdrew before the first test day and 3 were lost to follow-up. Six
participants did not complete the first test day due to inability to complete the depletion
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procedure (n=1), claustrophobia (n=4), and lack of space (n=1) inside the MRI scanner.
All study procedures were otherwise well tolerated with no serious or unintended
adverse events. Three participants self-withdrew prior to the second test day, and one
subject was withdrawn due to artifacts produced by dental fillings. Per a priori exclusion
criteria, participants were excluded from phase 1 analyses for excessive motion (n=0),
having a percent change in tryptophan level approximately greater than 3 SD from the
average for the assigned depletion status (n=3), or missing data regarding ACE (n=3),
imaging (n=1), or tryptophan levels (n=4). The subject with the lowest tSNR (< 2 SD)
was flagged for further inspection; independent component analysis confirmed lack of nback network activation and the subject was excluded.
The final sample included in phase 1 analyses consisted of 19 low ACE and 14
high ACE participants (Table 3-1, Table 3-S1). One of these participants was lost to
follow-up prior to randomization. Only subjects included in phase 1 analyses were
considered for inclusion in analyses of phase 2. Sessions during phase 2 that had
percent change in tryptophan level approximately 3 SD from the average for each
condition (n=2), did not complete imaging (n=1), or had missing tryptophan levels (n=4)
were excluded from analyses of phase 2. The final sample included in phase 2 analyses
consisted of 10 low ACE participants (19 sessions) and 11 high ACE participants (19
sessions) randomized to estradiol and 8 low ACE participants (13 sessions) and 3 high
ACE participants (6 sessions) randomized to placebo.

Behavioral results
Active TD significantly decreased free tryptophan concentration in comparison to
sham TD (p<0.0001; Figure 3-1b). There was not a significant difference in percent
change in tryptophan levels between ACE groups. As expected, increasing working
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memory load was associated with fewer correct responses to targets and greater false
positive responses to foils (Figure 3-1c). During phase 1 (pre-randomization), active TD
increased true positive responses (p=0.03) in comparison to sham depletion, though had
no effect on false positive responses or reaction time. This main effect of TD on true
positive count remained significant (p=0.04) when accounting for non-significant practice
effects, though was not present in the smaller subgroups randomized to estradiol or
placebo. High ACE was associated with slower true positive reaction time in comparison
to low ACE during phase 1 (p=0.1), but not in the smaller subgroups of phase 2. There
was no effect of TD x ACE on behavior during either phase of the study. Similarly, there
was no significant effect of ACE or TD on overall mood or depressive symptoms.

Imaging results: phase 1
As expected, the parametric (Figure 3-S2) and 3-back > 0-back (Figure 3-1d)
contrasts robustly recruited the executive network (Owen et al., 2005; Loughead et al.,
2009; Loughead et al., 2010; Satterthwaite et al., 2013; Shanmugan et al., 2016). Lower
activation during 3-back relative to 0-back in regions associated with the default mode
network were also robust. No effects of TD or ACE on the parametric or 0-back contrasts
survived correction, and subsequent analyses focused on the 3-back > 0-back contrast.
A whole-brain analysis demonstrated that TD differentially altered right DLPFC activation
in high and low ACE groups (Figure 3-2a; MNI coordinates: x=45, y=21, z=48;
volume=108 mm3; peak z=3.94). BOLD signal in this region significantly correlated with
true positive responses across all subjects (r=0.34, p=0.007) (Figure 3-2b). During
sham depletion, BOLD signal in this region was significantly correlated with total ACE
score (r=0.41, p=0.02; Figure 3-2c). When controlling for the effects of age, estradiol
level, and time since last menstrual period, the interaction between ACE and TD
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remained significant (p=0.0001). Post-hoc comparisons revealed the following effects:
higher BOLD signal in low ACE participants on active TD compared to sham TD
(p=0.03), lower BOLD signal in high ACE participants on active TD compared to sham
TD (p=0.0003), and higher BOLD in high ACE participants compared to low ACE
participants during sham TD (p=0.007). During active TD, there was no difference
between ACE groups. This interactive effect of TD and ACE on DLPFC BOLD remained
significant when true positive count was included as an additional covariate (p=0.0002).
Similarly, this interaction remained significant (p=0.0002) when controlling for the
difference in percent errors between 3-back and 0-back. Post-hoc comparisons revealed
the following effects: higher BOLD signal in low ACE participants on active TD compared
to sham TD (p=0.03), lower BOLD signal in high ACE participants on active TD
compared to sham TD (p=0.0007), and higher BOLD in high ACE participants compared
to low ACE participants during sham TD (p=0.005). There was no difference between
ACE groups during active TD.

Imaging results: phase 2
Within the right DLPFC cluster from phase 1, a 4-way interaction between ACE
group x TD status x estradiol/placebo group x study phase was detected (p=0.03). A
comparable interactive effect to that observed in phase 1 between ACE and TD on
BOLD was present in the participants randomized to placebo (Figure 3-3b; p=0.07). As
in phase 1, lower BOLD signal was observed in high ACE participants on active TD
compared to sham TD (p=0.08) and higher BOLD was observed in high ACE
participants compared to low ACE participants during sham TD (p=0.04). However, in
participants randomized to estradiol, there was no effect of ACE or TD on BOLD (Figure

62

3-3c). In these participants, estradiol attenuated differences between high and low ACE
groups during sham TD as well as BOLD response to active TD in the high ACE group.
Results were similar when controlling for differences in percent errors between 3back and 0-back. The 4-way interaction between ACE group x TD status x
estradiol/placebo group x study phase remained significant (p=0.03). An ACE x TD
interaction was observed in participants randomized to placebo (p=0.09); lower BOLD
signal was observed in high ACE participants on active TD compared to sham TD
(p=0.1) and higher BOLD was observed in high ACE participants compared to low ACE
participants during sham TD (p=0.04). No effect of ACE or TD was observed in
participants randomized to estradiol.

Discussion
This double-blind, placebo-controlled, cross-over study examined whether TD
differentially impacted brain activation in high vs low ACE hypogonadal women in the
presence and absence of exogenous estradiol. In the absence of exogenous estradiol,
TD increased right DLPFC BOLD signal and improved working memory performance in
women who experienced low levels of early life adversity. In contrast, TD decreased
right DLPFC activation without worsening performance in high ACE women. However,
treatment with estradiol attenuated the effects of ACE and TD such that no between or
within group differences were observed. Together, these results suggest that ACE has
lasting impacts on serotonergic circuits supporting executive function that are unmasked
by loss of estradiol during menopause.
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Evidence for TD x ACE effects on executive function
As expected, we found main effects of ACE and TD as well as an ACE by TD
interaction on DLPFC activation in hypogonadal women. The DLPFC is part of the
frontoparietal network responsible for goal-directed executive functions (Cortese et al.,
2012) and dysfunction of this region contributes to executive deficits across multiple
psychiatric disorders (Shanmugan et al., 2016). During sham depletion, the high ACE
group exhibited significantly greater activation in this region and a trend for slower
reaction time than the low ACE group This finding suggests early adversity is associated
with inefficient hyperactivation of the DLPFC in hypogonadal menopausal women. Our
findings are globally convergent with the only other study that used a whole-brain
approach to examine early adversity effects on brain activation during the n-back in
healthy adults, which found that early adversity was associated with hyperactivation of
several brain regions (Philip et al., 2016). While that study found effects of early life
adversity during 0-back, differences in results between our study and theirs are likely
due to differences in correction methods employed and instruments used to assess early
adversity.
While the high ACE group demonstrated inefficient hyperactivation of the DLPFC
during sham TD, this ACE effect was not present during active TD. That TD ameliorates
this ACE-associated inefficiency in DLPFC activation suggests that serotonergic
differences likely contribute to baseline differences in BOLD between ACE groups
observed during the sham condition. This finding is in agreement with two other n-back
studies demonstrating TD-induced decreases in DLPFC activation in the absence of
performance changes (Allen et al., 2006; Epperson et al., 2012). In contrast, TD
increased activation and task performance in the low ACE group. Similar TD-induced
improvements in performance (Schmitt et al., 2000; Booij et al., 2005; Scholes et al.,
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2007) have been reported during tasks requiring focused attention and response
inhibition (Mendelsohn et al., 2009). These studies may not be directly relevant to our
results as they examined executive domains other than working memory. The
combination of group differences observed during sham depletion and the differential
direction of response to active depletion highlight that the effects of ACE should be
accounted for in future neuroimaging studies utilizing neurotransmitter manipulations.
Failure to account for this moderating effect is likely a major factor contributing to the
inconclusive supporting literature regarding TD’s effects on executive function.
In combination, these results suggest that ACE has lasting impacts on serotonin
function and that hypogonadal middle-aged women with high and low levels of early
adversity respond differently to experimental manipulations of the serotonergic system.
As early adversity negatively impacts serotonin synthesis (Shively et al., 2003),
metabolism (Wong et al., 2015), and signaling (Murrough et al., 2011), the mechanism
contributing to differential TD response in low and high ACE participants is likely
multifold. A human participants study found that low socioeconomic status is associated
with lower serotonergic activity (Matthews et al, 2000), suggesting differences in
baseline serotonin concentration may play a role. Animal studies demonstrating that
early life stress lowers TPH2 expression (Shively et al., 2003) and increases monoamine
oxidase-A (Wong et al., 2015) support this hypothesis. However, early adversity also
reduces 5-HT1B expression (Murrough et al., 2011) and attenuates 5-HT1A function
(Matsuzaki et al., 2009). This suggests alterations in feedback inhibition or receptor
sensitivity may also contribute to differences in BOLD response to TD between high and
low ACE individuals.
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Evidence for estradiol modulation of TD x ACE effects on executive function
As predicted, treatment with estradiol attenuated ACE and TD effects on BOLD
signal in the DLPFC. In contrast to the ACE by TD interaction seen in the absence of
exogenous estradiol during phase 1 and participants randomized to placebo, no
between or within group differences were observed in participants randomized to
estradiol. This finding is in agreement with our previous study demonstrating that
estradiol prevented TD-induced alterations in brain activation (Epperson et al., 2012).
These data support the hypothesis that early adversity has long-term effects on
serotonergic circuits involved in working memory that are revealed by loss of estradiol
during menopause. Given that TD results in decreased serotonin synthesis, and the
animal literature demonstrating effects of early adversity and estradiol on TPH2 gene
expression (Shively et al., 2003), one likely mechanism by which ACE is exerting these
latent effects on working memory may be via TPH2. However, the converging effects of
early trauma (Matsuzaki et al., 2009) and estradiol (Michopoulos et al., 2014) on 5-HT1A
make the presynaptic autoreceptor another promising alternative.

Limitations
While this study leveraged a unique study design with several levels of rigorous
controls, certain limitations merit discussion. First, given the association between ACE
and many adverse health-related outcomes (Felitti et al., 1998), the resilient sample of
highly educated, physically and psychologically healthy hypogonadal women studied
here reduces generalizability to the typical menopausal population, particularly those
with substantial early life stress. However, using this sample allowed us to examine the
effects of early life adversity on serotonin system function while limiting the potentially
confounding impacts of comorbid psychiatric symptomatology and psychotropic
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medication use. Second, no parametric effects of ACE or TD survived correction, and
results are based on a post-hoc analysis of the 3-back > 0-back contrast. However,
results using this contrast indicate ACE and TD effects are present when high demands
are placed on working memory. Third, the sample size of 33 is relatively small. It is
possible that lack of ACE and TD effects in the estradiol group could be driven by
diminished power in the sub-sample of phase 1 participants. However, these findings are
unlikely due to lack of power given the significant 4-way interaction as well as the ACE
and ACE x TD effects observed in the smaller sub-sample randomized to placebo.
Additionally, the double-blind, placebo-controlled, cross-over study design using
repeated-measures allowed for decreased variance in estimates of treatment effects and
increased power to detect between group differences using > 100 fMRI scans, a
comparatively large data set for an imaging study employing a pharmacologic
manipulation in a healthy population. Furthermore, the stringent Type 1 error correction
method applied to our whole brain analysis highlights the robust nature of these findings.

Conclusions
In summary, these data imply that early life adversity exerts enduring effects on
serotonergic circuits underlying executive processes that are unmasked by loss of
estradiol during menopause. To confirm this effect of menopause, a longitudinal study of
women pre- to postmenopause would be ideal. Our results emphasize serotonin’s role in
executive function and highlight that the moderating effects of early adversity must be
accounted for when manipulating serotonin levels. Further, they provide preliminary
mechanistic evidence as to why some, but not all, women experience executive
difficulties during menopause and that brain responses to estradiol vary. Further
research in a larger sample would be helpful in elucidating the impact of timing of early
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life adversity on serotonin system function across brain networks, whether sexdifferences exist with regard to TD x ACE interactions, and finally whether early life
adversity alters the risk-benefit profile of peri- and postmenopausal estrogen treatment.
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Table 3-1. Participant characteristics at admission

Low ACE

High ACE

Mean (SD) or number (%)
n

19

14

Age (years)

55.4 (3.6)

54.8 (2.9)

Months since last menstrual period

52.9 (33.4)

62.5 (32.1)

Follicle-stimulating hormone (IU/L)

93.4 (35.6)

75.7 (42.8)

Estradiol (pg/mL)

26.5 (18.8)

24.1 (10.5)

11 (58)

2 (14)

Some Graduate

1 (5)

3 (21)

College

4 (21)

4 (29)

Some College

2 (11)

5 (36)

High School

1 (5)

0 (0)

Caucasian

16 (84)

9 (64)

African American

2 (11)

4 (29)

Asian

1 (5)

1 (7)

Full time

14 (64)

9 (64)

Part time

1 (12)

4 (29)

Retired

2 (11)

0 (0)

Unknown or preferred not to disclose

0 (0)

1 (7)

Education
Graduate

Race

Employment
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Figure Legends

Figure 3-1. Study design, tryptophan levels, working memory performance,
contrast of interest. a. This study used a double-blind, placebo-controlled, cross-over
design. Each participant underwent 4 test days. During test days 1 and 2 (phase 1),
each participant underwent 2 imaging sessions: active TD or sham TD. The order of
condition (active TD vs sham TD) was counterbalanced and double-blind. After
completing phase 1, participants were randomized to 17β-estradiol 0.100 mg/d or lookalike placebo patch treatment for a total of 10 weeks. Randomization was assigned by
the research pharmacist and was blocked and stratified with a block size of 3 to maintain
a 2:1 ratio of estrogen to placebo within each stratum. Randomization allocation
sequence was generated using a random sequence generator in Excel. Lot and
expiration information were withheld by investigational drug services to conceal
70

sequence and randomization status. After completion of approximately 8 weeks of
estradiol treatment or placebo treatment, each participant again underwent active TD
and sham TD on two separate test days (phase 2). On test days, participants presented
to the Penn Center for Women’s Behavioral Wellness (PCWBW) at 7:30 am after an
overnight fast and ingested 70 capsules containing either 31.5g of amino acids without
tryptophan (active TD) or 31.5g of microcellulose (sham TD). The active capsules
consisted of L-isoleucine 4.2g, L-leucine 6.6g, L-lysine 4.8g, L-methionine 1.5g, Lphenylalanine 6.6g, L-threonine 3.0g and L-valine 4.8g. Enrollement and post-test day
follow-up (24 hours for placebo, 3 weeks for estradiol) was conducted by research
coordinators at PCWBW. b. Blood was taken for free tryptophan analysis prior to
consumption of the study capsules (morning) and approximately 6 hours later
(afternoon). The effect of active vs sham depletion was assessed using a linear mixed
model with percent change in free tryptophan concentration as the outcome. Active TD
resulted in a significant decrease in tryptophan level in comparison to sham TD
(p<0.0001). There was not a significant difference in percent change in tryptophan levels
between ACE groups. Bars represent means and error bars represent standard error. c.
Increased working memory load was associated with fewer correct responses to targets
and more false positive responses to foils d. The Bonferonni corrected group mean of
the 3-back > 0- back contrast across the 123 scans included in analyses activated
executive regions and de-activated default mode network regions.
displayed using caret. TD=tryptophan depletion.
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Images were

Figure 3-2. Phase 1 imaging results. a. A whole-brain mixed-effects 2 x 2 ANOVA
demonstrated that TD differentially altered right DLPFC activation in high and low ACE
groups (MNI coordinates: x=45, y=21, z=48; volume=108 mm3; peak z=3.94). b. BOLD
signal in this region significantly correlated with true positive responses across all
subjects (r=0.34, p=0.007). This relationship remained significant when excluding the
two sessions with the lowest BOLD signal (r=0.30, p=0.02). c. During sham depletion,
BOLD signal in this region was significantly correlated with total ACE score (r=0.41,
p=0.02) d. Signal from the region displayed in Figure 2a was extracted for visualization.
In the low ACE group, active TD increased BOLD relative to sham TD (β=0.20, 95% CI: 0.16 – 0.21, p=0.03). In the high ACE group, active TD decreased activation relative to
sham TD (β=-0.43, 95% CI: -0.65 – -0.22, p=0.0003). During sham depletion, high ACE
was associated with greater activation relative to low ACE (β=0.49, 95% CI: 0.15 – 0.82,
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p=0.007). During active TD, there was no difference between ACE groups. Bars
represent means and error bars represent standard error. TD=tryptophan depletion.
ACE=adverse childhood experiences. *p<0.1, **p<0.05, ***p<0.01, ****p<0.001
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Figure 3-3. Phase 2 imaging results. a. TD and ACE exerted an interactive effect on
right DLPFC BOLD during phase one. This panel is identical to Figure 2c. b. Within this
cluster, a 4-way interaction between ACE group x TD status x estradiol/placebo group x
study phase was detected (β=1.1, 95% CI: 0.12 – 2.1, p=0.03). A comparable interactive
effect to that observed in phase 1 between ACE and TD on BOLD was present in the
participants randomized to placebo. Active TD decreased activation in the high ACE
group in comparison to sham TD (β=-0.62, 95% CI: -1.4 – 0.12, p=0.08) and high ACE
was associated with increased activation in comparison to low ACE during sham TD
(β=0.59, 95% CI: 0.12 – 1.1, p=0.04). c. Estradiol attenuated differences between high
and low ACE groups during sham TD as well as BOLD response to active TD in the high
ACE group. There was no effect of ACE or TD on BOLD after estradiol treatment. Bars
represent means and error bars represent standard error. TD=tryptophan depletion.
ACE=adverse childhood experiences. *p<0.1, **p<0.05, ***p<0.01, ****p<0.001
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Table 3-S1. Occurrence of Individual ACEs in Study Sample

Low ACE

High ACE

0.32 ± 0.48

3.79 ± 1.25

Emotional abuse

0

8

Physical abuse

0

5

Sexual abuse

1

5

Emotional neglect

0

8

Physical neglect

0

0

Parents divorced/separated

2

7

Witnessed domestic violence

0

8

Drug abuse in household

2

6

Mental illness in household

1

7

Incarceration of family member

0

0

Mean ACE
Abuse

Neglect

Household dysfunction
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Figure 3-S1. TD and ACE effects on DLPFC activation across n-back levels. a. A
whole-brain mixed-effects 2 x 2 ANOVA demonstrated that TD differentially altered right
DLPFC activation in high and low ACE groups (MNI coordinates: x=45, y=21, z=48;
volume=108 mm3; peak z=3.94). This panel is identical to Figure 2a. b. Signal from the
region depicted in part a was extracted from the 1-back > 0-back, 2-back > 0-back, and
3-back > 0-back contrasts to investigate the effects of TD and ACE across varying levels
of working memory load.
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Figure 3-S2. Mean parametric contrast. The Bonferonni corrected group mean of the
parametric contrast across the 123 scans included in analyses activated executive
regions. Decreasing activation with increasing working memory load was observed in
default mode network regions.
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Abstract
During the menopause transition, women are at increased risk of subjective
symptoms of executive dysfunction. Evidence from animal and human participant
studies suggests adverse childhood experiences (ACE) may be a risk factor for
executive complaints during this hormonal transition. Preclinical literature indicates early
life adversity effects on serotonin function may play a role in this increased susceptibility.
However, the mechanisms underlying this increase in vulnerability in human participants
remain relatively unknown. Here we examined the impact of ACE and tryptophan
depletion (TD) on functional network connectivity in discovery and replication datasets.
We hypothesized that ACE would be associated with decreased within-network
connectivity. We predicted that TD would further lower connectivity in women with high
levels of early adversity, but have no effect in in women with low levels of early
adversity. Forty women underwent two functional imaging sequences at two time points
(141 total scans) in a double-blind, placebo controlled, crossover study. The effects of
ACE and TD were evaluated using generalized estimating equations (GEE). As
predicted, ACE was associated with lower within-network connectivity. While TD had no
effect on connectivity in the low ACE group, TD increased connectivity in the high ACE
group. The robust main effect of ACE remained significant in the replication dataset,
though the ACE x TD interaction did not. Together, these results suggest that early life
adversity has lasting impacts on large-scale functional networks underlying executive
function. Alterations in functional network connectivity may be one mechanism by which
early life adversity increases the risk of cognitive disorders during menopause.
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1. Introduction
The menopause transition is associated with increased susceptibility to
subjective symptoms of cognitive dysfunction (Shanmugan and Epperson, 2014).
Several reports have suggested that healthy women with no history of cognitive
dysfunction experience increased difficulty with everyday tasks requiring executive
processes such as working memory, focus, attention, organization, and planning
(Epperson et al., 2015; Shanmugan and Epperson, 2014; Shanmugan et al., 2017).
There is preliminary evidence for adverse childhood experiences (ACE) such as abuse,
neglect, and household dysfunction as a risk factor for executive dysfunction during this
hormonal transition (Shanmugan and Epperson, 2014).
Significant adversity during childhood alters normal trajectories of brain
maturation (Bruce et al., 2013; Hanson et al., 2015; Shanmugan and Satterthwaite,
2016) resulting in heightened vulnerability to executive dysfunction (Philip et al., 2016) in
adult life. Neuroimaging studies have demonstrated that early adversity alters activation
in brain regions subserving executive processes. In healthy adults, early trauma has
been associated with executive system hyperactivation during working memory (Philip et
al., 2016). In healthy menopausal women, estradiol treatment attenuates this ACEassociated executive hyperactivation (Shanmugan et al., 2016), suggesting the effects of
ACE may be magnified when women are hypogonadal.
While these studies demonstrate that ACE has effects on activation in particular
brain regions, the impact of ACE on functional network architecture is less clear. There
is growing evidence that the functional connectivity between brain regions as part of
larger cognitive systems is critical to maintaining intact executive function (reviewed by
Vaidya and Gordon, 2013). A recent large neuroimaging study in healthy adults ages
18-88 demonstrated that the degree of connectivity between and within large-scale brain
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networks becomes increasingly important to maintaining cognitive performance as we
age (Tsvetanov et al., 2016). Additionally, altered neural connectivity has been
suggested as a potential marker of menopausal women who may be at risk of late-life
cognitive dysfunction (Vega et al., 2016). As such, understanding whether early
adversity alters connectivity among these functional networks is particularly relevant in
this middle-aged population.
During development, networks supporting cognitive processes segregate: brain
regions become more connected with regions of the same network (increased withinnetwork connectivity) and less connected with regions of other networks (decreased
between-network connectivity) (Dosenbach et al., 2010; Fair et al., 2007a; Power et al.,
2010; Satterthwaite and Baker, 2015; Shanmugan and Satterthwaite, 2016). Adversityinduced disruptions in this trajectory of network segregation have been observed as
early as preschool (Demir-Lira et al., 2016) and last into adulthood (Philip et al., 2013).
In healthy adults, early life trauma is associated with decreased connectivity between
regions within the same network as well as increased connectivity between regions in
different networks (Philip et al., 2013). Such patterns of dysconnectivity are associated
with poorer working memory across the lifespan (Tsvetanov et al., 2016).
Together these studies suggest that early life adversity may confer a risk for
executive dysfunction during menopause by altering connectivity between and within
neural networks. However, the effects of ACE on functional network connectivity during
this hormonal transition have not been studied. Converging evidence from animal and
human studies suggests one mechanism by which ACE may alter brain function during
periods of low estradiol may be via effects on serotonin. In non-human primates, both
ovariectomy and social subordination stress are associated with reductions in tryptophan
hydroxylase type 2 (TPH2) gene expression (Shively et al., 2003) and 5-HT1A binding
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potential (Michopoulos et al., 2014). Similarly, lowering central serotonin levels
differentially impacts prefrontal cortex activation in menopausal women with high and
low levels of early life adversity (Shanmugan et al., 2016). However, whether ACE and
sertononin exhibit a similar interactive effect on functional networks is not known.
Accordingly, we tested the hypothesis that ACE adversely impacts functional
network connectivity during menopause via alterations in serotonin function. Forty
healthy menopausal women with high and low levels of early life adversity underwent
tryptophan depletion (TD) and performed two cognitive tasks during functional magnetic
resonance imaging. Task effects were regressed to obtain discovery and replication
timeseries approximate to the resting state (Fair et al., 2007b). The impact of ACE, TD,
and the interaction between ACE and TD on within-network connectivity were examined
in both datasets. We predicted that within-network connectivity would be lower in the
high ACE group compared to the low ACE group during both active TD and sham TD.
We also predicted that TD would further lower this measure in the high ACE group, but
have no effect on connectivity in the low ACE group.

2. Methods
2.1. Participants
Participants were healthy menopausal women ages 48-60 with no current
psychiatric diagnoses and within 10 years of their last menstrual period. Participants
were right-handed and had a FSH > 30 IU/ml, a normal mammogram and pap smear
within the last year, and a clear urine toxicology. Exclusion criteria included use of
estrogen or hormone therapy within the last year, contraindications to hormone therapy,
IQ less than 95, Mini Mental Status Exam Score less than 25, lifetime history of DSM-V
psychotic or bipolar disorder, other psychiatric or substance use disorder in the last year,
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Hamilton depression score > 14, psychotropic medication use within the last month,
metallic implants, and claustrophobia. The sample considered here constitutes a
superset of participants previously included in a report focusing on the impact of early
adversity on prefrontal cortex activation during working memory (Shanmugan et al.,
2016).

2.2 Study design
This study used a double-blind, placebo-controlled, cross-over design. Each
participant underwent 2 imaging sessions: active TD or sham TD. The order of condition
(active TD vs sham TD) was counterbalanced and double-blind. On each test day,
participants presented after an overnight fast and ingested 70 capsules containing either
31.5g of amino acids without tryptophan (active TD) or 31.5g of microcellulose (sham
TD). The active capsules consisted of L-isoleucine 4.2g, L-leucine 6.6g, L-lysine 4.8g, Lmethionine 1.5g, L-phenylalanine 6.6g, L-threonine 3.0g and L-valine 4.8g. Blood was
taken for free tryptophan analysis and mood ratings were completed prior to
consumption of the capsules and approximately 6 hours later, after which participants
underwent cognitive testing and neuroimaging.

2.3 Assessment of early life adversity
The Adverse Childhood Experiences (ACE) Questionnaire (Felitti et al., 1998)
was used to assess history of emotional, physical, or sexual abuse, childhood neglect,
and household dysfunction. The ACE questionnaire assesses the number of exposure
categories and has been used extensively to assess the association between early life
adversity and later life health-related outcomes. The number of exposures was summed
to create the ACE score (range: 0–10). Participants with an ACE score greater than or
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equal to 2 were considered “high ACE” while participants with ACE score of less than 2
were considered “low ACE”. A threshold of 2 was used to define the high ACE group
based on studies of depression prevalence in later life that demonstrate increased
susceptibility at this level of exposure (Chapman et al., 2004; Epperson et al., In Press).
The continuous effects of ACE were explored in secondary analyses utilizing total ACE
score.

2.4 Assessment of mood
Mood was measured as a possible confound. Participants completed the Profile
of Mood States prior to TD procedure and again before fMRI. Total score and the
“Depression-Dejection” sub-score were used to assess changes in overall mood and
depressive symptoms, respectively. Difference in mood score (morning - afternoon)
served as the outcome variable in regression models used to assess the effects of TD
and ACE on mood.

2.5 Task paradigms
A letter version of the n-back task was used to probe working memory and
executive system function during fMRI scans. The task consisted of four conditions: 0back, 1-back, 2-back and 3-back. Stimuli were 4-letter non-words without vowels
presented for 500 ms, followed by an interstimulus interval of 2500 ms. During the 0back, participants responded to a target 4-letter stimulus with a button press. During
other conditions, participants responded to a stimulus “n” number of stimuli before it.
Each condition consisted of a 20-trial block (60s) and each class of blocks was repeated
three times. A target-foil ratio of 1:2 was maintained in all blocks. Visual instructions (9s)
preceded each block. The task began with a 48s baseline rest period. Additional 24s
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baseline rest periods occurred at the beginning, middle, and end of the acquisition. Total
task duration was 924s. Equivalent n-back tasks with unique stimuli were used for the
four sessions and version order was counter-balanced.
An emotional identification task was used to probe emotional bias and affective
processing. The task consisted of 60 faces displaying neutral, happy, sad, angry or
fearful expressions presented in a fast event-related design. Each face was displayed for
5.5 seconds followed by a variable inter-stimulus interval (0.5–18.5 seconds) during
which a complex crosshair (matched to the faces’ perceptual qualities) was displayed.
Participants were asked to select one of five labels (happy, sad, anger, fear, neutral) for
each face presented using a scroll wheel. Equivalent versions of the task with unique
stimuli were used for the four sessions and version order was counter-balanced. Total
task duration was 630s.

2.6 Image acquisition
Imaging data were acquired on 3T Siemens Trio scanner. A magnetizationprepared, rapid acquisition gradient echo T1-weighted image (TR = 1810 ms, TE = 3.51
ms, FOV = 180 x 241 mm, matrix = 192 x 256, 160 slices, effective voxel resolution of
0.94 x 0.94 x 1 mm) was acquired to aid spatial normalization to standard space.
Functional images were acquired using a whole-brain, single-shot gradient-echo (GE)
echoplanar sequence with the following parameters: TR/TE = 3000/32 ms, FOV= 192 ×
192 mm, matrix = 64 x 64, slice thickness/gap = 3/0 mm, 46 slices, effective voxel
resolution of 3 x 3 x 3 mm.

2.7 Network construction and visualization
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We examined the effects of ACE and TD on functional connectivity using a
system of functional networks described by Power et al. (Power et al., 2011). In this
system, networks are composed of spheres with a 5-mm radius (264 nodes) (Figure 41) and the connections between these nodes (34,716 unique edges). These nodes
compose 14 functional network modules that correspond to brain networks that are
present during both task performance and at rest (Power et al., 2011). This node system
provides good coverage of the whole brain (Power et al., 2011) and has been used to
examine functional connectivity between and within brain networks during cognitive
tasks and at rest (Dosenbach et al., 2010; Satterthwaite et al., 2013b).

Image registration
Subject-level functional and anatomical T1 images were co-registered using
boundary-based registration (Greve and Fischl, 2009). The anatomical image was
normalized to the MNI 152 T1 1mm template using the top-performing diffeomorphic
SyN registration in ANTs (Avants et al., 2011; Klein et al., 2009). Co-registration,
normalization, and

down-sampling

of network

nodes

to

subject space

were

concatenated so only one interpolation was performed.

2.8 Image Processing
BOLD time series data were skull stripped with BET (Smith, 2002), despiked with
AFNI’s 3dDespike (Cox, 1996), motion-corrected with MCFLIRT (Jenkinson et al., 2002),
high pass filtered (120 s), spatially smoothed (6 mm FWHM), and mean-based intensity
normalized. The event related emotion identification task time series were also slice-time
corrected. Subject-level time series analyses were carried out using FILM (FMRIB's
Improved Linear Model) with local autocorrelation correction (Woolrich et al., 2009).
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Task condition (0-back, 1-back, 2-back, and 3-back blocks for the n-back or happy, sad,
anger, fear, and neutral events for emotion identification) and their temporal derivatives
were modeled using a canonical (double-gamma) hemodynamic response function with
24 motion parameters (Friston et al., 1996; Yan et al., 2013a) included as nuisance
covariates. The rest condition (fixation point) served as the unmodeled baseline. Images
were assessed for excessive motion (mean relative displacement > 0.3 mm)
(Satterthwaite et al., 2013b). Time series were extracted from each of the 264 nodes in
subject space using the residuals of this subject-level analysis that modeled task and
motion. Task regression has been shown to aide test-retest reliability of connectivity
measurements obtained during tasks (Cao et al., 2014).

2.9 Graph construction and analyses of network topology
For each participant, pair-wise Pearson correlations were calculated using the
time series extracted from the 264 nodes. These values were then transformed using a
Fisher-Z transformation to construct a 264 x 264 symmetric connectivity matrix for each
participant. Our primary outcome of interest was within-network connectivity. Withinnetwork connectivity is the mean strength of edges between nodes within a network,
averaged across all networks. We also calculated total network strength to account for
potential motion artifact (Saad et al., 2013; Yan et al., 2013b). Total network strength is
the average strength of the connectivity matrix (Saad et al., 2013; Yan et al., 2013b).

2.9 Discovery and replication data sets
Prior studies have demonstrated that removing the effects of task from BOLD
data acquired during cognitive tasks produces “resting-state” timeseries that are
qualitatively similar to “true” resting-state data (Fair et al., 2007b). Several groups have
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used these residual timeseries to examine the effect of pathology on “resting-state”
functional connectivity (Fleisher et al., 2009; Weisberg et al., 2014). However, given that
differences between task-regressed residuals and “true” resting-state timeseries have
been noted (Fair et al., 2007b), we tested our hypotheses in both a discovery and
replication dataset. We obtained these two approximate resting-state timeseries by
regressing task effects during working memory and emotion identification tasks. Given
the differences in both task design (block vs event-related) and task demands,
consistency of results across timeseries would suggest differences due to intrinsic
functional network architecture rather than task performance.
We defined the timeseries obtained during the n-back as the discovery
timeseries for several reasons. First, the n-back task was longer and provided an
additional 98 volumes for calculation of correlations between network nodes. Second,
Cao et al. (2014) demonstrated that the test-retest reliability of graph-based connectivity
measures calculated from residual timeseries was higher for the n-back than for an
emotional face-processing task. Third, as described below in the results (section 3.1
Participants), a greater number of timeseries were available for the n-back than the
emotional identification task. Given these differences, we chose to first examine the
impact of ACE and TD in the residuals of the n-back timeseries, which may be more
consistent and a closer approximate to resting-state. The main effect of task on withinnetwork connectivity was evaluated using generalized estimating equations to assess
the validity of using residual timeseries from a separate task as the replication dataset.

2.9 Statistical analysis
Generalized estimating equations implemented using the geepack package
(HÃ¸jsgaard et al., 2006) in R (R Core Team, 2015) were employed to evaluate the
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effect of ACE, TD, and their interaction on within-network connectivity. This method
accommodates multiple assessments per participant and adjusts for non-independence
among these repeated measures. All models controlled for age, estradiol level, and time
since last menstrual period. As previous studies have demonstrated that the impact of
TD on brain function varies with estradiol level in menopausal women (Epperson et al.,
2012), we also controlled for this interaction in our analyses. Both mean relative
displacement (Power et al., 2015; Satterthwaite et al., 2013a) and mean network
strength (Saad et al., 2013; Yan et al., 2013a; Yan et al., 2013b) were included as
covariates to minimize the impact of motion. The effect of the number of ACEs
(continuous) on functional connectivity was evaluated in supplementary analyses that
examined interactions between TD and total ACE score. Statistical tests were two-sided
with p<=0.05 considered significant.

3. Results
3.1 Participants
Sixty participants completed screening and were enrolled in the present study. Of
these 60 participants, 2 withdrew from the study before the first test day, and 3 were lost
to follow up. Six participants did not complete the first test day due to inability to
complete the depletion procedure (n=1), claustrophobia (n=4), or lack of space (n=1)
inside the MRI scanner. Three participants withdrew prior to the second test day, and
one participant was excluded due to artifacts produced by dental fillings. Participants
were excluded from analyses for excessive motion (n-back n=1; emotion identification
n=2), having a percent change in tryptophan level approximately greater than 3 SD from
the average for the assigned depletion status (n=3), or missing data regarding ACE
(n=3), imaging (n-back n=1; emotion identification n=5), or tryptophan levels (n=4). The
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final sample included in the discovery dataset consisted of 24 low ACE participants (43
sessions) and 16 high ACE participants (30 sessions; see Table 4-1 and Table 4-S1).
Four of these participants did not complete the emotional identification task; the final
sample included in the replication dataset consisted of 24 low ACE participants (40
sessions) and 15 high ACE participants (28 sessions).

3.1 Tryptophan level and mood results
Blood was taken for free tryptophan analysis before consumption of the study
capsules (morning) and approximately 6 hours later (afternoon). The effect of active
depletion vs sham depletion was assessed using a generalized estimating equation with
percent change in free tryptophan concentration as the outcome. Active TD resulted in a
significant decrease in tryptophan level in comparison to sham TD (p<0.0001). There
was no significant difference in percent change in tryptophan levels between ACE
groups. There was no significant effect of ACE, TD, or ACE x TD on mood.

3.2 Validation of discovery and replication timeseries
As expected, nodes demonstrated greater connectivity with nodes of the same
network than with nodes of different networks in both the discovery (Figure 4-2a) and
replication (Figure 4-2b) data sets. The mean symmetric connectivity matricies from
these two timeseries qualitatively appeared very similar. However, prior to testing our
hypotheses regarding the impact of ACE and TD on functional connectivity, we
evaluated the main effect of cognitive task performed on within-network connectivity to
assess the validity of using residual timeseries from a separate task as the replication
dataset. There was no significant effect of task (n-back vs emotional identification) on
within-network connectivity. This effect remained non-significant when accounting for
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total network strength as well as motion and was not evaluated further. The lack of
significant task effect supported our use of these two sets of timeseries as discovery and
replication datasets.

3.3 Discovery timeseries results
To test our hypotheses that ACE would be associated with lower within-network
connectivity and that tryptophan depletion would selectively further lower connectivity
only in the high ACE group, we used a model that evaluated the impact of ACE group,
TD status, and ACE group x TD status on within-network connectivity. The effect of ACE
in this model was robust; as predicted, connectivity was significantly lower in the high
ACE group than in the low ACE group during sham depletion (p=0.002). In line with our
hypothesis that TD would selectively impair the high ACE group, TD had no effect on
connectivity in the low ACE group. Also as predicted, an interaction between ACE group
and depletion status on within-network connectivity was observed at a trend level
(p=0.1). However, contrary to our hypothesis that active TD would exacerbate the effect
of ACE observed during sham TD, active depletion actually increased connectivity in the
high ACE group (p=0.02; Figure 4-3a). This attenuated the effect of ACE during active
TD. As in the sham condition, the high ACE group also displayed lower within-network
connectivity during active TD, though this trend did not reach statistical significance
(p=0.1).
Previous studies using the ACE questionnaire to evaluate the impact of early life
adversity on mental health outcomes in adult life have used a threshold of ≥ 2 to define
the high ACE group (Epperson et al., In Press). As such, our primary analysis utilized
the same binary definitions of ACE. However, it is not clear whether such a threshold
applies to ACE effects on functional network connectivity. Therefore, we also examined
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the effect of the number of ACEs (continuous) using a model that evaluated the impact
of total ACE score, TD status, and ACE score x TD status. As hypothesized and in
agreement with our results using ACE group, there was a robust effect of ACE score as
ACE score was significantly negatively associated with within-network connectivity
during sham depletion (p=0.004; Figure 4-3b). Additionally, there was a significant ACE
score x TD status interaction on within-network connectivity (p=0.04). Consistent with
our TD x ACE group analysis, active TD diminished the impact of ACE score; there was
no association between total ACE score and within-network connectivity during active
TD (p=0.2).

3.3 Replication timeseries results
To probe the validity of our results, we tested our hypotheses regarding the
impact of ACE and TD on functional connectivity using a separate set of task-regressed
timeseries data acquired in a subsample of our participants. As in the discovery data set,
we used a model that evaluated the impact of ACE group, TD status, and ACE group x
TD status on within-network connectivity to test our hypotheses that ACE would be
associated with lower connectivity and that tryptophan depletion would selectively lower
connectivity only in the high ACE group. The effect of ACE group was robust and
consistent with discovery results. Within-network connectivity was significantly lower in
the high ACE group during both sham TD (p=0.002) and active TD (p=0.05; Figure 44a). The effect of TD in the low ACE group was also replicated and remained nonsignificant. However in contrast to discovery results, there was no significant ACE group
x TD status interaction and no effect of TD in the high ACE group.
We also attempted to replicate our findings regarding the continuous effects of
ACE using a model that evaluated the impact of total ACE score, TD status, and ACE
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score x TD status. Consistent with our hypothesis and analyses using ACE group, total
ACE score was significantly negatively associated with within-network connectivity
during sham TD (p=0.008; Figure 4-4b). As in the discovery dataset, this association did
not reach significance during active TD. However, it was present at a trend level (p=0.1),
and the interaction between ACE score and TD status was not significant.

4. Discussion
In this double-blind, placebo-controlled, cross-over study, we examined the
effects of ACE and TD on functional network connectivity in healthy menopausal women.
In our discovery dataset, high ACE women displayed lower within-network connectivity
than low ACE women regardless of depletion status. Similarly, total ACE score was
negatively associated with within-network connectivity. Additionally, active TD increased
within-network connectivity in women with high levels of early adversity but had no effect
in women with low levels of early adversity. While the robust effects of both ACE group
and ACE score were replicated, the more marginal ACE x TD interaction was not. These
results indicate early life adversity has lasting impacts on intrinsic large-scale functional
networks and provide preliminary evidence that serotonin’s effect on these networks
may be task-dependent.
As expected, we found a main effect of ACE on functional connectivity. High ACE
participants displayed lower within-network connectivity in both the discovery and
replication datasets. Connectivity within functional networks has been shown to underlie
multiple cognitive domains including working memory (Dosenbach et al., 2007; Fair et
al., 2007a; Power et al., 2010; Tsvetanov et al., 2016). Decrements in working memory
are associated with lower connectivity within default and cingulo-opercular networks
(Vaidya and Gordon, 2013). Decreases in within-network connectivity have been
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observed in psychiatric disorders exhibiting dysfunction in executive domains
(Satterthwaite and Baker, 2015; Shanmugan and Satterthwaite, 2016). While the impact
of ACE on similar measures of within-network connectivity has not been examined, our
findings are globally convergent with seed-based resting-state connectivity studies
examining the impact of early life stress on functional connectivity in healthy adults
(Philip et al., 2013) and adult women with posttraumatic stress disorder (Bluhm et al.,
2009). Although seed regions selected and networks examined vary, these studies
found that early adversity is associated with lower connectivity between regions within
the same network (Bluhm et al., 2009; Philip et al., 2013).
The mechanisms by which ACE imparts this negative impact on connectivity are
likely multifold. While we hypothesized that TD would selectively impair connectivity in
the high ACE group, we found that TD instead selectively improved connectivity in the
high ACE group. Though contrary to our hypothesis, this result is consistent with
previous findings demonstrating that tryptophan depletion attenuates ACE effects on
dorsolateral prefrontal cortex activation during the n-back in menopausal women
(Shanmugan et al., 2016). That TD attenuated the negative effects of ACE on
connectivity suggests that serotonergic differences may be contributing to baseline
differences in functional connectivity between ACE groups. However, we were not able
to replicate this ACE x TD interaction in our replication timeseries. This discordance may
be due to differences in task duration, task design, or variations in non-linear effects of
task remaining in the residual timeseries (Fair et al., 2007b). However, this lack of ACE x
TD interaction in our replication timeseries as well as the consistent effects of ACE
regardless of depletion status or cognitive task highlight the importance of considering
other mechanisms by which early adversity exerts enduring effects on functional
connectivity.
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Given that functional connections may be reflective of underlying structural
connections (Damoiseaux and Greicius, 2009), the effects of early adversity on neuronal
development during childhood and adolescence likely also play a role. During
development, within-network connectivity increases while between-network connectivity
decreases (Satterthwaite and Baker, 2015; Shanmugan and Satterthwaite, 2016).
Significant adversity during this developmental period may preclude this network
segregation (Vaidya and Gordon, 2013), possibly via structural changes. Early life stress
in mice has been shown to induce alterations in PFC dendritic architecture (Yang et al.,
2015). Female mice that experience peripubertal stress also display increases in PFC
myelin basic protein gene expression and proteolipid protein gene expression, both of
which are indicators of myelination (Morrison et al., 2016). Importantly, estradiol
supports the normal development and maintenance of serotonergic function (Epperson
et al., 2012), dendritic morphology (Shanmugan and Epperson, 2014), and neuronal
myelination (Luo et al., 2016).

4.1 Limitations
Certain limitations of the present study should be noted. First, we focused on
middle-aged females who were within 10 years of their final menstrual period, as women
are at risk of executive dysfunction during the menopause transition (Epperson et al.,
2015; Shanmugan and Epperson, 2014; Shanmugan et al., 2017). Given the impact of
estradiol on prefrontal cortex structure and function (Shanmugan and Epperson, 2014)
as well as evidence for sex differences in the effects of early adversity (Shanmugan and
Satterthwaite, 2016) on neural response, these data cannot be extrapolated to similaraged males or pre-menopausal females. Similarly, while results demonstrate that ACE is
associated with maladaptive connectivity patterns during menopause, it is not clear
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whether ACE has comparable effects prior to menopause. Longitudinal studies testing
women pre- and post-menopause would be necessary to determine whether the impacts
of ACE and menopause on functional connectivity are synergistic or additive. Second,
given the association between ACE and many adverse health-related outcomes (Felitti
et al., 1998), the resilient sample of highly educated, healthy hypogonadal women
without psychiatric disorders studied here reduces generalizability to the typical
menopausal population, particularly those with substantial early life adversity. However,
this sample allowed us to examine the impact of early adversity on functional network
connectivity while limiting the confounding effects of psychiatric symptomatology and
psychotropic medication use. Third, residuals from task-regressed timeseries, while
similar, are not identical to true resting state data (Fair et al., 2007b). However, that ACE
results were replicated in a separate set of residual timeseries lends confidence to our
results. Third, the sample size of 40 is relatively small. However, the double-blind,
placebo-controlled, cross-over study design using repeated-measures allowed for
decreased variance in estimates of condition effects and increased power to detect
between group differences.

4.2 Conclusions
In summary, these data suggest that early life adversity has lasting impacts on
functional network connectivity in healthy menopausal women. These results provide
preliminary evidence regarding the mechanisms by which early life adversity confers a
vulnerability for executive dysfunction during menopause. Further research in a larger
sample would be helpful in elucidating the impact of timing of early life adversity on brain
networks and whether sex-differences exist with regard to TD and ACE effects on
connectivity.
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Table 4-1. Participant characteristics
Low ACE

High ACE

Mean (SD) or number (%)
n

24

16

Age (years)

55.5 (3.3)

55.1 (3.1)

Months since last menstrual period

53.7 (33.0)

62.3 (30.9)

Follicle-stimulating hormone (IU/L)

93.5 (32.5)

74.0 (40.8)

Estradiol (pg/mL)

27.1 (17.7)

22.7 (11.3)

14 (58)

2 (13)

Some Graduate

1 (4)

3 (29)

College

4 (17)

6 (38)

Some College

2 (8)

5 (31)

Associates

1 (4)

0 (0)

High School

2 (8)

0 (0)

Caucasian

19 (79)

11 (69)

African American

3 (13)

4 (25)

Asian

1 (4)

1 (6)

Other

1 (4)

Education
Graduate

Race

Employment
Full time

16 (67)

10 (63)

Part time

2 (8)

5 (31)

Unemployed

1 (4)

0 (0)

Retired

2 (8)

0 (0)

Unknown or preferred not to disclose

0 (0)

1 (6)
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Figures

Figure 4-1. Power nodes. Nodes in the system of functional networks described by
Power et al. (Power et al., 2011). In this system, networks are composed of spheres with
a 5-mm radius (264 nodes) and the connections between these nodes (34,716 unique
edges). These nodes compose 14 functional network modules that correspond to brain
networks that are present during both task performance and at rest. This node system
provides good coverage of the whole brain and has been used to examine functional
connectivity between and within brain networks during cognitive tasks and at rest. Time
series were extracted from each of the 264 nodes in subject space using the residuals of
this subject-level analysis that modeled task and motion. Time series were extracted
from each of these nodes in subject space. Image is displayed using BrainNet Viewer.
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Figure 4-2. Mean symmetric connectivity matrices. The mean symmetric connectivity
matrix of discovery (a) and replication (b) timeseries confirmed nodes demonstrated
greater connectivity with nodes of the same network than with nodes of different
networks. The mean symmetric connectivity matrices from these two timeseries
qualitatively appeared very similar. We evaluated the main effect of cognitive task
performed on within-network connectivity to assess the validity of using residual
timeseries from a separate task as the replication dataset. There was no significant
effect of task (n-back vs emotional identification) on within-network connectivity. This
effect remained non-significant when accounting for total network strength as well as
motion. Values displayed are Fisher Z transformed pair-wise Pearson’s correlations.
Color bars to the left and bottom of connectivity matrices indicate community
membership.
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Figure 4-3. ACE and TD effects on within-network connectivity in discovery
timeseries. a. To test our hypotheses that ACE would be associated with lower withinnetwork connectivity and that tryptophan depletion would selectively further lower
connectivity only in the high ACE group, we used a model that evaluated the impact of
ACE group, TD status, and ACE group x TD status on within-network connectivity. The
effect of ACE in this model was robust; as predicted, connectivity was significantly lower
in the high ACE group than in the low ACE group during sham depletion (p=0.002). In
line with out hypothesis that TD would selectively impair the high ACE group, TD had no
effect on connectivity in the low ACE group. Also as predicted, an interaction between
ACE group and depletion status on within-network connectivity was observed at a trend
level (p=0.1). However, contrary to our hypothesis that TD would exacerbate the effect of
ACE observed during sham TD, active depletion actually increased connectivity in the
high ACE group (p=0.02). This attenuated the effect of ACE during active TD. As in the
sham condition, the high ACE group also displayed lower within-network connectivity
during active TD, though this trend did not reach statistical significance (p=0.1). Bars
represent least-square means adjusted for age, time since last menstrual period,
estradiol level, total network strength, and motion. Error bars represent standard error. b.
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We also examined the effect of the number of ACEs (continuous) using a model that
evaluated the impact of total ACE score, TD status, and ACE score x TD status. As
hypothesized and in agreement with our results using ACE group, there was a robust
effect of ACE score as ACE score was significantly negatively associated with withinnetwork connectivity during sham depletion (p=0.004). Additionally, there was a
significant ACE score x TD status interaction on within-network connectivity (p=0.04).
Consistent with our TD x ACE group analysis, active TD diminished the impact of ACE
score; there was no association between total ACE score and within-network
connectivity during active TD (p=0.2). The effect of all covariates included in analyses
have been regressed from the connectivity values depicted. ACE= adverse childhood
experiences; TD = tryptophan depletion; *p ≤ 0.1, **p ≤ 0.5, ***p ≤ 0.01
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Figure 4-4. ACE and TD effects on within-network connectivity in replication
timeseries. a. To probe the validity of our results, we tested our hypotheses regarding
the impact of ACE and TD on functional connectivity using a separate set of taskregressed timeseries data acquired in a subsample of our participants. As in the
discovery dataset, we used a model that evaluated the impact of ACE group, TD status,
and ACE group x TD status on within-network connectivity to test our hypotheses that
ACE would be associated with lower connectivity and that tryptophan depletion would
selectively lower connectivity only in the high ACE group. The effect of ACE group was
robust and consistent with discovery results. Within-network connectivity was
significantly lower in the high ACE group during both sham TD (p=0.002) and active TD
(p=0.05). The effect of TD in the low ACE group was also replicated and remained nonsignificant. However in contrast to discovery results, there was no significant ACE group
x TD status interaction and no effect of TD in the high ACE group. Bars represent leastsquare means adjusted for age, time since last menstrual period, estradiol level, global
connectivity, and motion. Error bars represent standard error. b. We also attempted to
replicate our findings regarding the continuous effects of ACE using a model that
evaluated the impact of total ACE score, TD status, and ACE score x TD status.
Consistent with our hypothesis and analyses using ACE group, total ACE score was
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significantly negatively associated with within-network connectivity during sham TD
(p=0.008). As in the discovery dataset, this association did not reach significance during
active TD. However, it was present at a trend level (p=0.1), and the interaction between
ACE score and TD status was not significant. The effect of all covariates included in
analyses have been regressed from the connectivity values depicted. ACE= adverse
childhood experiences; TD = tryptophan depletion; *p ≤ 0.1, **p ≤ 0.5, ***p ≤ 0.01
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Table 4-S1. Occurrence of Individual ACEs in Study Sample

Low ACE

High ACE

0.29 ± 0.46

3.75 ± 1.18

Emotional abuse

0

10

Physical abuse

0

5

Sexual abuse

1

5

Emotional neglect

0

9

Physical neglect

0

1

Parents divorced/separated

2

8

Witnessed domestic violence

0

8

Drug abuse in household

3

6

Mental illness in household

1

9

Incarceration of family member

0

0

Mean ACE
Abuse

Neglect

Household dysfunction
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Abstract
Many women with no history of executive dysfunction report difficulties in this
domain during the menopause transition. Lisdexamfetamine (LDX) has been suggested
to be a safe and effective treatment option for these women. However, the mechanisms
by which LDX improves executive functioning in these women is not known. Here we
investigated the effects of LDX on brain activation and neurochemistry, hypothesizing
that LDX would be associated with increased activation and decreased glutamate in
executive regions. Fourteen women underwent multi-modal neuroimaging at 7T at three
time points in this baseline-corrected, double-blind, placebo controlled, crossover study.
Effects of LDX on symptom severity, BOLD signal, and DLPFC glutamate + glutamine
(Glx) were measured using a clinician-administered questionnaire, fMRI during
performance of a fractal n-back task, and 1H-MRS, respectively. The effect of treatment
(LDX minus baseline vs. placebo minus baseline) on these behavioral and neural
markers of executive function was examined using repeated measures mixed-effects
models. LDX treatment was associated with decreased symptom severity, increased
activation in the insula and DLPFC, and decreased DLPFC Glx. Additionally, magnitude
of LDX-induced improvement in symptom severity predicted both direction and
magnitude of LDX-induced change in insular and DLPFC activation. Moreover, symptom
severity was positively correlated with Glx concentration in the left DLPFC at baseline.
These findings provide novel evidence that the neural mechanisms by which LDX acts to
improve self-reported executive functioning in healthy menopausal women with midlife
onset of executive difficulties include modulation of insular and DLPFC recruitment as
well as decrease in DLPFC Glx concentration.
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Introduction
During the menopause transition, many women with no history of executive
functioning deficits report cognitive difficulties in domains including working memory,
organization, focus, and attention (Epperson et al., 2011). This midlife onset of executive
difficulties may be a result of reduced estradiol modulation of the executive system
(Shanmugan and Epperson, 2014). Proper executive functioning depends on the
neurochemical environment of executive regions including the dorsolateral prefrontal
cortex (DLPFC), the region of the prefrontal cortex (PFC) critical for attention and
working memory (Arnsten and Jin, 2014). PFC function has been characterized as an
inverted U-shaped curve such that optimal executive function (EF) depends on a
balance of factors including baseline monoaminergic and glutamatergic function
(Arnsten and Jin, 2014) as well as hormonal status (Jacobs and D'Esposito, 2011). In
such a model, a decrease in estradiol levels during menopause could cause executive
difficulties in women whose genetics or previous life experiences make them susceptible
to such a cognitive decline (Kudielka et al., 2009; Shanmugan and Epperson, 2014;
Culpepper, 2015) (Figure 5-1).
Estradiol affects working memory through modulation of PFC dopamine activity.
In women who metabolize dopamine more quickly, low estradiol levels result in improper
PFC activation during working memory tasks (Jacobs and D'Esposito, 2011). Preclinical
models have suggested estradiol modulation of glutamatergic function may be an
additional mechanism by which estradiol loss induces changes in cognition. Estradiol
loss reduces the density of healthy dendritic spines in the DLPFC (Bailey et al., 2011)
that are necessary for communication between delay cells (Wang and Arnsten, 2015),
neurons capable of maintaining representations across a delay in the absence of
sensory input. Loss of this regulation could lead to disinhibition of neurons that fire in
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response to a stimulus, potentially resulting in higher DLPFC glutamate levels and worse
EF (Wang and Arnsten, 2015).
As such, interventions that increase dopamine and decrease glutamate may
improve executive difficulties induced by loss of estradiol input to the PFC during
menopause. We have shown lisdexamfetamine (LDX), a stimulant medication,
successfully improves subjective measures of EF in menopausal women with selfreported new onset executive difficulties (Epperson et al., 2015). In addition to
increasing extracellular dopamine and norepinephrine, stimulants also have direct and
indirect effects on striatal and cortical glutamate critical to optimal PFC function
(Paspalas and Goldman-Rakic, 2005).
Previous studies have shown that stimulant medications increase blood oxygen
level dependent (BOLD) signal in executive regions, including the insula (Rubia et al.,
2014) and DLPFC (Wong and Stevens, 2012) in subjects with ADHD. Additionally,
stimulants also decrease glutamate levels in the PFC of children with ADHD (Wiguna et
al., 2012). However, no neuroimaging studies examining the effect of LDX on brain
activation or neurochemistry have been performed. Additionally, whether stimulants
improve executive deficits in populations other than ADHD with similar cognitive
difficulties by analogous mechanisms is not known. Furthermore, while preclinical
studies suggest glutamatergic tone may mediate executive capabilities (Wang and
Arnsten, 2015), information regarding the role that DLPFC glutamate levels play in EF in
human subjects is limited. Thus, human subject studies evaluating the effect of
stimulants on neural markers of executive dysfunction in populations other than ADHD
are necessary to determine the mechanisms by which such medications improve
executive deficits in these populations.
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Accordingly, here we used multi-modal neuroimaging and a baseline corrected,
double-blind, placebo controlled, crossover design to examine the effects of LDX on
executive system recruitment and neurochemistry in 14 healthy menopausal women with
midlife onset executive dysfunction. We hypothesized LDX would increase executive
activation during a working memory task and decrease glutamate + glutamine (Glx)
levels in the DLPFC at rest. Furthermore, we predicted baseline DLPFC Glx levels would
be reflective of the degree of executive dysfunction.

Methods
Participants
Subjects in this study represent a subset of women who participated in a clinical
trial investigating the effects of LDX on EF (Epperson et al., 2015) and were recruited
from the parent trial to participate in this neuroimaging adjunct study. Women ages 45 to
60 with EF difficulty onset during menopause and were within 5 years of their last
menstrual period (LMP) were eligible to participate. Perimenopausal women had
irregular menstrual cycles for ≥12 months, no period for ≥ 3 months, and serum follicle
stimulating hormone (FSH) level of ≥ 20 IU/L. LMP of ≥12 months and serum FSH levels
≥35 IU/L indicated postmenopausal status. Subjective EF symptom severity was
assessed using the Brown Attention Deficit Disorder Scale (BADDS) (Brown, 1996).
BADDS score of ≥ 20 and onset of symptoms coinciding with the initiation of menstrual
cycle irregularity were required.
Women with a lifetime history of a DSM-IV psychotic disorder or psychostimulant
abuse, substance abuse disorder in the previous year, or present Axis I psychiatric
disorder were excluded. Psychotropic medication use, ET use within the previous 6
months, positive pregnancy test, Mini-mental Status Examination score < 26, IQ ≤ 90,
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history of seizures, cardiac disease, active hypertension, claustrophobia, abnormal
electrocardiogram at screening, left-handedness, and metallic implants were all
exclusionary. Subjects were excluded from ROI analyses for poor co-registration (n=2).
Excessive motion (mean relative displacement > 0.5 mm; n=1) was an additional
exclusionary criterion in whole-brain analyses.

Study Design
This study was a double-blind, placebo controlled, crossover study. After
screening, subjects underwent neuroimaging and cognitive assessment at three time
points. After baseline, subjects were randomized to one pill of study medication (LDX 20
mg or placebo) daily for the first week, two pills daily for the second week, and, if
tolerated, three pills daily for the final 2 weeks of each trial. Participants were allowed to
remain in the study if they could tolerate at least 1 pill per day throughout the study.
Upon completion of the first 4-week trial, participants underwent a 2-week washout and
were crossed over to the other treatment condition. Testing and imaging were conducted
approximately 2 – 6 hours after last LDX dose.

Assessment of Executive Function
Assessment of subjective EF was as previously reported (Epperson et al., 2015).
Briefly, subjects completed the BADDS, a validated subjective measure of EFs (Sandra
Kooij et al., 2008). The BADDS is a clinician-administered questionnaire that assesses
the frequency and severity of five clusters of executive dysfunction: (1) organization and
activating for work, (2) sustaining attention and concentration, (3) sustaining alertness,
effort, and processing speed, (4) managing affective interference, and (5) using working
memory and accessing recall. Subjects rate symptoms on a scale from 0 to 3, with 0
120

meaning the problem described does not relate to them and 3 indicating the problem
occurs almost daily. Subjects also completed an out-of-scanner cognitive battery
consisting of a letter n-back task, NYU paragraph recall task, and Penn Continuous
Performance Task to assess working memory, verbal memory, and sustained attention,
respectively (See Epperson et al, 2015 for further detail).

fMRI Task paradigm
Subjects completed a fractal n-back task (Ragland et al., 2002) with 3 conditions
(0-, 2-, and 3-back) during each scan to probe working memory. Subject performance
was monitored to ensure adequate task engagement. See Supplementary Methods for
further detail.

Image Processing
Imaging data were acquired on 7T Siemens Trio scanner (Supplementary
Methods). In comparison to 3T, the higher signal to noise ratio and greater sensitivity to
BOLD signal at 7T allows for increased ability to distinguish differences between
conditions, though 7T is more sensitive to distortion and artifacts.
Timeseries

were

analyzed

with

FEAT

(fMRI

Expert

Analysis

Tool)

(Supplementary Methods). To determine the effect of treatment (active-baseline vs.
placebo-baseline), mean signal change for the 3-back contrast was extracted from
functionally defined ROIs in the right and left DLPFC, medial frontal/cingulate gyrus
(MF/CG), right and left insula, right and left parietal cortex, and posterior cingulate
cortex. ROI masks for these regions were functionally defined using the parametric
contrast of the group mean of all sessions (baseline, active, and placebo). The activation
map of the group mean of the parametric contrast was cluster corrected at a voxel
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threshold of z>4.5 and cluster probability of p <0.001 (Woolrich et al., 2009). ROI masks
were transformed into subject space using FLIRT. An exploratory whole brain analysis
using a two sample paired t-test in FSL was also performed on the 3-back contrast to
characterize the effect of treatment (active vs. placebo). Type I error control was
provided by cluster correction using Gaussian Random Field Theory (voxel height of z
>1.6; cluster probability of p <0.05).

MRS and Quantification of Glutamate
Water reference single voxel spectroscopy (SVS) and water suppressed SVS
scans were obtained on a voxel placed in the left DLPFC (15x30x20 mm3)
(Supplementary Figure 5-1a). Voxels were placed approximately 1 cm from the skull to
avoid lipid contamination. Automated shimming of the B0 field was performed on the
voxel to obtain localized water line width of ~20 Hz or less using FASTMAP. Variable
power RF pulses with optimized relaxation delays (Tkac et al., 1999) were used to obtain
water suppression spectra (Cai et al., 2012). SVS for Glx were obtained using short TE
SVS with modified Point-Resolved Spectroscopy sequence (PRESS) having the
following parameters: spectral width=4kHz, number of points=2048, averages=16 (water
reference) or 64 (water suppressed), TE=20 ms, TR=3000 ms. Chemical shift artifact for
Glx was minimized by setting water acquisition spectrum excitation and refocusing
pulses in resonance with the water peak at 4.7ppm, and also setting water suppressed
spectrum excitation and refocusing pulses in resonance with the Glx peak at 2.35ppm.
Water reference data were used to obtain channel wise time dependent phase
shifts due to eddy current and amplitude scale factors. Using a fitting method validated
by Cai et al. (Cai et al., 2012) metabolite peaks from water suppressed spectrum were
fitted as Lorentzian functions with non-linear least squares fitting using lsqcurvefit in
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MATLAB. This procedure accounted for amplitudes, line widths and peak positions for 8
macromolecular and 14 metabolite peaks. Normalization by water reference signal
allowed for quantification of Glx (Supplementary Figure 5-1b). See Supplementary
Information for goodness of fit assessment.

Statistical Analysis
Mixed effects models were employed to compare the BADDS scores, cognitive
task performance, BOLD in ROIs, and glutamate levels measured at the end of the
active trial minus baseline vs. those measured at the end of the placebo minus baseline
for each participant to account for repeated measures. While the parametric activation
map used to identify ROIs was corrected for multiple comparisons using Gaussian
Random Field Theory (Woolrich et al., 2009), we did not further correct for the number of
ROIs examined and p-values reported are uncorrected.

BMI was included as a

covariate in models examining the effect of LDX on BOLD and glutamate to ensure LDXinduced change in BMI did not affect results. Age and the proportion of grey matter in
the spectroscopy voxel were included as covariates in a model examining the drug effect
on glutamate (Supplementary Results).
Spearman rank-order correlations were used to compare 1) BADDS scores to
glutamate levels at baseline and 2) change in BADDS scores between active and
baseline to change in BOLD between active and baseline. Association between
glutamate and BOLD was evaluated with linear regression. Measures of anxiety,
depression, sleep, and overlap between BOLD and spectroscopy voxels were controlled
for in supplementary analyses (Supplementary Methods). The effect of LDX on n-back
performance was evaluated using mixed effects models with condition as a 3-level
predictor variable to minimize the effect of missing data.
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Results
Participants
Eighteen subjects from the parent clinical trial were enrolled in this neuroimaging
adjunct study. Of these 18 subjects, 14 subjects completed all 3 imaging session. One
subject was unable to see the screen during the fMRI task and did not complete the
baseline session, two subjects withdrew after the baseline session, and one subject was
unable to tolerate being in the scanner during her final scan due to nasal congestion.
Baseline characteristics for the 14 women who completed both active LDX and placebo
conditions are depicted in Table 5-1. The order of active and placebo visits across these
14 women was counterbalanced: 7 received active first and 7 received placebo first. The
14 subjects who completed imaging had higher total BADDS scores at baseline than
subjects from the parent clinical trial who did not participate in this imaging adjunct study
(imaging: 44.7 ± 17.8; other: 28.6 ± 12.3; t=-3.01, DF=30, p=0.005) but were similar in
terms of age, race, education (See Supplementary Information for Methods). All but two
participants finished each trial taking three pills per day. One participant experienced
jitteriness and increased heart rate after increasing from one to two pills and remained
on one pill for the remainder of the trial (Active LDX).

The other experienced an

increase in blood pressure upon increasing from two to three pills and remained on two
pills for the remainder of that trial (Placebo).

Behavioral Results
LDX significantly decreased total BADDS (F=26.6, DF=13, p<0.0002) (Figure 52a, Supplementary Figure 5-2a) and each BADDS subscale (organization/activation for
work, F=14.3, DF=13, p=0.002; attention/concentration, F=31.7, DF=13, p<0.0001;
alertness/effort/processing speed, F=12.3, DF=13, p=0.004; managing affective
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interference, F=4.8, DF=13, p=0.05; working memory/accessing recall, F=14.4, DF=13,
p=0.002) (Figure 5-2b, Supplementary Figure 5-2b). While there was a trend towards
an effect of LDX in decreasing out-of-scanner 2-back true positive reaction time (F=3.2,
DF=10, p=0.1), no significant effect of LDX was observed on delayed paragraph recall,
continuous

performance

task,

or

in-scanner

n-back

performance

(p>0.05)

(Supplementary Figure 5-3).

BOLD Results
As expected, the n-back task robustly activated executive network regions and
deactivated non-executive regions (Figure 5-3a). ROI analyses demonstrated LDX
increased activation in the right Insula/IFG (F=20.7, DF=11, p=0.0008) and left DLPFC
(F=2.9, DF=11, p=0.12) (Figure 5-3b, Supplementary Table 5-1) during the 3-back.
This robust insular finding remained significant in an exploratory whole-brain analysis
(MNI coordinates: x=48, y=52, z=18; k=1416) (Figure 5-3c).
LDX-induced change in right insula activation was positively associated with
LDX-induced decrease in total BADDS score (r=0.95, p=<0.0001, t=9.88, DF=11),
BADDS subscale 1 (r=0.86, p=0.0004, t=5.22, DF=11), and BADDS subscale 3 (r=0.83,
p=0.0008, t=4.70, DF=11). Similar results were obtained for correlation between LDXinduced change in activation in the left DLPFC and total BADDS score (r=0.78, p=0.003,
t=3.90, DF=11), BADDS subscale 1 (r=0.78, p=0.0028, t=3.93, DF=11), and BADDS
subscale 3 (r=0.81, p=0.0014, t=4.38, DF=11) (Figure 5-3d). Correlations remained
significant

when

controlling

for

measures

(Supplementary Results).

Spectroscopy Results
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of

anxiety,

depression,

and

sleep

LDX was associated with decreased Glx concentration in left DLPFC (F=4.6,
DF=13, p=0.052) (Figure 5-4a, Supplementary Figure 5-4). Glx values (mean mM ±
SD) at baseline, active, and placebo were 9.14 ± 0.81, 8.4 ± 1.03, and 8.91 ± 0.86,
respectively. At baseline, left DLPFC Glx concentration was positively correlated with
total BADDS (r=0.64, p=0.01, t=2.90, DF=13), BADDS subscale 1 (r=0.70, p=0.005,
t=3.43, DF=13), and BADDS subscale 3 (r=0.58, p=0.03, t=2.47, DF=13) (Figure 5-4b).
There were no other significant correlations between Glx and BADDS or between Glx
and DLPFC BOLD (p>0.05).

Discussion
In this double-blind, placebo controlled, cross-over study, we examined the effect
of LDX on behavioral and neural markers of EF at 7T. To account for the inherent
variability in the BOLD signal, a repeated measures, baseline corrected study design
was used. LDX treatment was associated with improved self-reported EF in comparison
to placebo, as shown by a significant reduction in BADDS scores. Furthermore, LDX
treatment significantly increased recruitment of executive regions during performance of
a working memory task. Additionally, LDX treatment decreased Glx concentrations in the
left DLPFC at rest. Taken together, these data provide novel evidence for the neural
mechanisms by which this drug acts to improve self-reported EF in previously healthy
menopausal women with midlife onset of executive difficulties.

Evidence for psychostimulant effects on EF
As in the parent clinical trial (Epperson et al., 2015), we found that LDX
improved EF in this subset of women as measured by self-reported symptom severity.
We did not, however, find an effect of LDX on working memory task performance. While
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the task used in this study was validated in a large sample of healthy volunteers (Gur et
al., 2010), education level has been shown to be correlated with performance on
executive tasks, particularly the n-back (Gur et al., 2010). Given the large portion of our
sample that had at least a college degree (79%) and graduate degree (35%), ceiling
effects from the high performance at baseline likely rendered these tests unable to
detect any objective improvements in EF.

Evidence for psychostimulant effects on executive activation
The most robust finding in the present study is evidence of LDX’s effect of
increasing activation in the insula/IFG region. This was observed in both an ROI analysis
at all levels of the n-back task performed as well as in a whole-brain analysis. These
results accord with a copious literature of neuroimaging studies of stimulant effects in
individuals with ADHD (Rubia et al., 2014), and moreover highlight the mechanism of
this drug’s action in a population that exhibits similar executive deficits but who do not
meet criteria for ADHD.
A meta-analysis of 14 fMRI data sets found stimulants relative to placebo/offmedication most consistently increase activation in the insula/IFC (Rubia et al., 2014).
This finding is present during tasks probing executive domains of interference inhibition
(Rubia et al., 2014), time discrimination (Rubia et al., 2014) and working memory
(Spencer et al., 2013). The insula is part of the cinglo-opercular control network critical
for cognitive control, and is particularly important in the maintenance of task sets and
error monitoring (Power et al., 2011).
While the DLPFC is a part of the frontoparietal network supporting goal-directed
executive processes (Cortese et al., 2012) and is an area implicated in the pathogenesis
of executive deficits seen in ADHD (Cortese et al., 2012), the effect of stimulants on the
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DLPFC is inconsistent. Studies have found stimulants increase (Wong and Stevens,
2012), decrease (Cubillo et al., 2014), or have no effect (Kobel et al., 2009; Rubia et al.,
2014) on DLPFC activation. Such inconsistency may be due in part to the type or
dosage of medication used and level of working memory load probed (Cubillo et al.,
2014).
We also found the magnitude of LDX-induced improvement in symptom severity
predicted both the direction and magnitude of LDX-induced change in both insular and
DLPFC activation. While subjects with the greatest improvements in BADDS scores
demonstrated less task-induced activation, subjects with the least improvements in
BADDS scores demonstrated greater task-induced activation, suggesting that other
factors such as genetics, adverse childhood experiences, baseline activation and
symptom severity, and time since last menstrual period impact the relationship between
LDX treatment and brain and behavioral response. Our observation that LDX treatment
resulted in an overall increase in DLPFC and insular cortex BOLD (Figures 5-3b – 5-3c)
was likely driven by the greater proportion of individuals who experienced an increase
rather than a decrease in activation from baseline (Figure 5-3d). One study found no
correlation between activation during a stop-signal task and symptom severity after
controlling for psychostimulant use in adults with ADHD (Congdon et al., 2014).
However, no studies have looked at the correlation between stimulant-induced changes
in brain activation during working memory and stimulant-induced changes in symptom
severity in adults. Thus, our findings make an important step towards understanding
factors that impact stimulant effects on brain activation and may in part explain the
contradictory findings (Kobel et al., 2009; Wong and Stevens, 2012; Cubillo et al., 2014;
Rubia et al., 2014) of stimulants on brain activation in the literature.
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Evidence for psychostimulant effects on neurochemistry
A third important finding in this study was that LDX significantly decreases Glx
concentrations in the DLPFC from baseline in comparison to placebo. Results of the few
studies that have examined the effect of stimulants on left PFC glutamate levels are
inconsistent and have shown that stimulants either decrease (Wiguna et al., 2012) or
have no effect (Carrey et al., 2002; Husarova et al., 2014b) on glutamate concentrations.
Differential effects of stimulants on glutamate levels have been attributed to differences
in medication formulation, treatment duration, or a combination of both (Husarova et al.,
2014b).
Importantly, we found that left DLPFC Glx levels at baseline positively correlated
with self-reported executive function symptom severity. Only one other study has
examined the relationship between DLPFC glutamate concentration and subjective
executive dysfunction symptom severity (Husarova et al., 2014a). While this study found
no correlation between left DLPFC glutamate and parent-reported symptom severity,
associations between executive symptom severity and other neurometabolites including
N-acetylaspartate/creatine, glutamate + glutamine/creatine, and choline/creatine in the
DLPFC or white matter behind the DLPFC were observed. However, it is important to
note that subjects in that study were children who met criteria for ADHD combined
subtype and almost one-third of subjects also had comorbid oppositional defiant
disorder.
Interestingly, we did not find an association between treatment-induced change
in Glx and treatment-induced change in symptom severity. This would seem to indicate
that LDX disrupts the relationship between Glx and symptom severity seen at baseline.
The implications of the lack of association between these variables with placebo
treatment is less clear, but could indicate that either placebo also causes a change in
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neurochemistry, prior LDX treatment alters the relationship between Glx and symptom
severity, or that the washout period was not of sufficient duration to return the
relationship between these variables to baseline. Glutamate antagonists have been
shown to improve symptoms of anxiety and depression in preclinical models (Gerhard et
al., 2016), suggesting the moderating effect of glutamate on mood symptoms could be a
confounding factor when evaluating the relationship between glutamate and executive
symptom severity. However, we found that correlations between Glx and total BADDS
score remained significant even when controlling for measures of depression and sleep,
indicating that this relationship is not simply a reflection of the effect of LDX on mood.
No other studies have directly examined the correlation between stimulant-induced
changes in left DLPFC Glx and stimulant induced changes in symptom severity.
We did not find an association between Glx concentration and BOLD signal in
the left DLPFC. Interestingly, both of these measures were correlated with the same
measures of symptom severity: total BADDS, Subscale 1, and Subscale 3. There was
not, however, an association between neural outcome measures and other BADDS
subscales even though LDX significantly improved symptoms in all domains, suggesting
certain subscales may be more sensitive to neural markers of EF in this population. The
relationship between glutamate concentration and BOLD signal is not well established.
One study found a positive correlation between dorsal anterior cingulate cortex (ACC)
glutamate and BOLD during a cognitive control task in several regions including the
retrosplenial cortex, orbitofrontal cortex, inferior parietal lobule, and basal ganglia
(Falkenberg et al., 2012). Another study found a positive correlation between
dorsomedial PFC glutamate and pregenual ACC BOLD during emotional processing
(Stan et al., 2014). In contrast, another study found no correlation between glutamate
and BOLD in the ACC or inferior frontal gyrus before, during, or after performance of an
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interference inhibition task (Kuhn et al., 2015) even though voxel placement was guided
by individual’s BOLD activity. However, no studies have examined the relationship
between DLPFC glutamate concentration and activation during a working memory task
at baseline or with psychostimulant treatment.

Limitations
Certain limitations of the present study should be noted. First, the sample size is
relatively small. However, the repeated-measures design allowed for decreased
variance in estimates of treatment effects and increased power to detect between group
differences. Additionally, while the BOLD signal is inherently variable, this study included
a baseline session allowing comparisons between active and placebo to be baseline
corrected. Doing so contrasted the minimal differences in behavior, executive activation,
and Glx concentrations between placebo and baseline with the significant differences
between active and baseline. Furthermore, the high signal to noise ratio at 7T allows for
increased ability to distinguish differences between conditions.
A second limitation of this study is that 1H-MRS does not distinguish between
intra- and extracellular glutamate levels. Preclinical studies show the extracellular pool of
glutamate is between 1-4 micromoles (Lerma et al., 1986). Glutamate measured using
1

H-MRS is between 8-12 millimoles, suggesting our findings are based primarily on the

intracellular pool of glutamate. Another limitation is the inability to resolve glutamate from
glutamine, even at 7T, due to spin-spin coupling. However, the small values in Glx fit
uncertainty (<0.1) and strong intraclass correlation (0.6) between Glx values at baseline
and placebo suggest robust goodness of fit and test-retest reliability, respectively.
Third, current substance abuse could affect both behavioral and imaging
outcomes and subjects were not required to undergo a drug screen on each test day.
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However, a clear urine toxicology during screening was required for inclusion in the
study. Additionally, because these subjects did not have any history of substance abuse,
substance abuse during the study was unlikely. Fourth, we did not formally assess
whether participants could accurately guess when they were on active LDX or placebo.
However, we did examine carry-over effects in the larger clinical trial and did not find any
order effects on behavioral outcome measures (Epperson et al, 2015) suggesting that if
participants accurately identified the active LDX from placebo trials, this knowledge did
not unduly impact our outcomes.

Conclusions
In summary, these data provide novel evidence regarding the neural
mechanisms by which stimulants act to improve executive functioning in healthy
menopausal women with midlife onset of executive difficulties. Further research is
needed to determine if other factors such as genetics or adverse childhood experiences
modulate the effect of LDX on glutamate and executive system recruitment. Such
information could serve as markers of women who may experience cognitive difficulties
upon entering menopause and of women who would benefit from early intervention.
Furthermore, the mechanisms by which loss of estradiol and healthy dendritic spines as
well as higher cortical glutamate concentrations contribute to worse executive
functioning in human subjects are yet to be elucidated, and future research should
consider the role of such factors in promoting neuroinflammation and oxidative stress
(Kitamura et al., 2009). Additional research in a larger sample would be helpful in
ascertaining whether there is a three-way interaction between symptom severity, BOLD,
and Glx. A larger sample may also reveal an effect of menopause stage on these
measures. Executive function has been shown to decline between early and late post132

menopause (Elsabagh et al., 2007), though declines observed in other cognitive
domains such as verbal memory (Epperson et al., 2013) suggest executive dysfunction
may begin earlier. Moreover, it would be important to confirm whether LDX acts by
similar mechanisms after surgery- or chemotherapy-induced menopause.
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Table 5-1. Participant Characteristics
Mean (SD) or number (%)
Age (years)

53.1 (3.0)

Time since last menstrual period (months)

31.8 (18.1)

IQ

115.9 (11.3)

Mini-mental status exam

28.8 (1.1)

Marital status
Single

2 (14.3)

Married

9 (64.3)

Divorced/separated

2 (14.3)

Widowed

0 (0)

Did not disclose

1 (7.1)

Menopause status
Perimenopause

2 (14.3)

Postmenopause

12 (85.7)

Race
Caucasian

9 (64.3)

African American

3 (21.4)

American Indian/Alaska native

1 (7.1)

Others

1 (7.1)

Ethnicity
Hispanic

0 (0)

Non-Hispanic

14 (100)

Education
High school

1 (7.1)

Some college/vocational

2 (14.3)

College graduate/some graduate school

6 (42.9)

Graduate/professional degree

5 (35.7)

Household income
Unknown or did not disclose

4 (28.6)

< $50,000

2 (14.3)

$50,000 to $100,000

3 (21.4)

$100,000 to $200,000

4 (28.6)

> $200,000

0 (0)

Employed
Full time

14 (100)
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Figure 5-1. Model for effects of estradiol and LDX on executive function. Executive
functioning capacity depends on the neurochemical environment in the PFC. Within the
optimum

range

of

neurotransmitter

concentrations,

represented

by

the

grey

crosshatching in the figure, normal executive functioning is maintained by a balance of
factors including dopamine, norepinephrine, and glutamate concentrations as well as
estradiol level. Where a woman falls on this curve depends on her genetics for
catecholaminergic and glutamatergic metabolism and signaling as well as hormonal
status and stress level. Response to stress is modified by numerous factors such as
age, hormonal and reproductive status, current or previous use of medications such as
glucocorticoids or psychoactive drugs, smoking, coffee and alcohol consumption, caloric
intake, genetics, exposure to prenatal stress, birth weight, gestational age, level of early
family adversity, and position in social hierarchy indicating individual lifestyle choices
and adverse childhood experiences may impact an individual’s executive functioning
capacity before and during menopause [reviewed by Kudielka et al., 2009]. Additionally,
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factors such as depressive symptoms (Culpepper, 2015), substance use, and
medication side effects (Kudielka et al, 2009) may also contribute to an individual’s
executive functioning capacity. During menopause, women whose combination of such
factors place them toward the left of the optimal range may experience executive
functioning difficulties due to loss of estradiol modulation of prefrontal systems. LDX may
improve executive functioning in these women by increasing dopamine and
norepinephrine as well as decreasing glutamate in the PFC, though response to LDX
should be considered in the context of underlying genetic variability in catecholaminergic
and glutamatergic neurotransmission.
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Figure 5-2. LDX improves subjective measures of executive function. The decrease
in BADDS scores from baseline was significantly greater with LDX versus placebo for
both (a) total BADDS (F=26.6, DF=13, p<0.0002) as well as (b) each BADDS subscale
(organization/activation for work, F=14.3, DF=13, p=0.002; attention/concentration,
F=31.7, DF=13, p<0.0001; alertness/effort/processing speed, =12.3, DF=13, p=0.004;
managing affective interference, F=4.8, DF=13, p=0.05; working memory/accessing
recall, F=14.4, DF=13, p=0.002). Error bars represent standard error.
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Figure 5-3. LDX increases executive activation during working memory. (a) The nback task robustly activated executive network regions and deactivated non-executive
regions, as depicted by the parametric contrast (z>4.5, p<0.001). (b) Recruitment of the
right insula, and left DLPFC increased with increasing levels of working memory load.
Values plotted represent mean difference in activation from baseline at each task level.
Error bars represent standard deviations. (c) Whole-brain analysis using a paired t-test
(z>1.6, p <0.05) of the 3-back contrast demonstrated that activation in the right insula
(MNI coordinates: x=48, y=52, z=18; k=1416) was significantly greater than placebo. (d)
LDX-induced increase in both right insula and left DLPFC BOLD signal from baseline
during the 3-back was positively correlated with LDX-induced decrease in total BADDS
Scores as well as BADDS subscales measuring organization/activation for work and
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alertness/effort/processing speed. Subjects with the greatest improvements in BADDS
scores demonstrated less task-induced activation with LDX while subjects with the least
improvements in BADDS scores demonstrated greater task-induced activation with LDX.
Right insula: total BADDS (r=0.95, p=<0.0001, t=9.88, DF=11); organization/activation
for work (r=0.86, p=0.0004, t=5.22, DF=11); alertness/effort/processing speed (r=0.83,
p=0.0008, t=4.70, DF=11). Left DLPFC: total BADDS (r=0.78, p=0.003, t=3.90, DF=11);
organization/activation

for

work

(r=0.78,

p=0.0028,

alertness/effort/processing speed (r=0.81, p=0.0014, t=4.38, DF=11).
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t=3.93,

DF=11);

Figure 5-4. Left DLPFC Glx concentrations. (a) Decrease in left DLPFC Glx
concentration from baseline was greater with LDX vs placebo (F=4.5, DF=12, p=0.056).
Error bars represent standard error. (b) At baseline, left DLPFC Glx concentration was
positively correlated with total BADDS (r=0.64, p=0.01, t=2.90, DF=13) as well as
BADDS subscales measuring organization/activation for work (r=0.70, p=0.005, t=3.43,
DF=13) and alertness/effort/processing speed (r=0.58, p=0.03, t=2.47, DF=13).
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Supplementary Information
Supplementary Methods
fMRI Task Paradigm
Subjects completed a fractal version of the n-back task during each fMRI scan.
During the task, a fractal was presented for 500 ms followed by a 2500 ms interstimulus
interval. This task was used to probe working memory and had 3 conditions: 0-, 2-, and
3-back. Each condition consisted of three 20-trial blocks, each preceded by a 9s
instruction period, with a target to foil ratio of 1:3. The task included a total of 45 targets
and 135 foils, as well as three 24 s blocks of rest during which a fixation crosshair was
displayed. Analyses on in-scanner n-back performance focused on true positives, false
positives, and reaction time.

Image Acquisition
Structural and functional images were acquired on 7T Siemens Trio scanner.
Structural image acquisition sequence consisted of a gradient echo localizer, a 3D
Magnetization Prepared Rapid Gradient Echo (MPRAGE) whole brain acquisition (TR,
2110 ms; TE, 3.17 ms; TI, 1500 ms; FOV, 240×180 mm; matrix, 256×192; 160 slices;
slice thickness, 1 mm; flip angle, 10°; effective voxel resolution, 0.9×0.9×1 mm), and 3D
reformatting of the MPRAGE data. Functional images were obtained using a wholebrain, single-shot, multislice, gradient-echo echoplanar sequence (239 volumes; TR,
3000; TE, 27 ms; flip angle, 70°; FOV, 220×220 mm; matrix 110×110; 37 slices; slice
thickness 2.2 mm; effective voxel resolution, 2×2×2.2 mm).

Image Processing
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BOLD timeseries data were analyzed with FEAT (fMRI Expert Analysis Tool) in
FSL, using skull removal with BET (Smith, 2002), motion-correction with MCFLIRT
(Jenkinson et al., 2002), high pass filtering, spatial smoothing (6 mm FWHM), and meanbased intensity normalization. Subject-level timeseries analyses were carried out using
FILM (FMRIB's Improved Linear Model) with local autocorrelation correction (Woolrich et
al., 2009). The three condition blocks (0-back, 2-back, and 3-back) were modeled using
a canonical (double-gamma) hemodynamic response function with standard plus
extended motion parameters included as nuisance covariates. The rest condition
(crosshair) served as the unmodeled baseline. The median functional and anatomical
volumes were co-registered using boundary-based registration (Greve and Fischl, 2009).
The anatomical image was normalized to the MNI 152 T1 2 mm template using linear
registration with 12 degrees of freedom. Statistical maps for the contrasts of interest (3back) were used in group-level analyses.

MRS and Quantification of Glutamate
Goodness of fit for the fitting method used to quantify Glx was evaluated on all
scans for all subjects. Using residuals and the Jacobian matrix

(dYi/dPj) where Yi

represents the fitted result at point i and Pj represents the parameter j, 90% confidence
limits were determined for all parameters. Upper and lower integral limits and
concentrations for Glx were calculated using the amplitude and width limits for these two
metabolites. Goodness of fit was estimated from these integral limits. Fit uncertainty was
conservatively represented by the higher of these values. Additionally, test-retest
reliability of acquisition and fitting methods were evaluated using intraclass correlation,
which assessed agreement between Glx concentrations at baseline and placebo. An Ftest was used to test whether intraclass correlation is different from zero.
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Statistical Analysis
We examined how representative subjects who completed this neuroimaging
adjunct study were of subjects who participated in the parent clinical trial in terms of age,
race, education, and baseline BADDS scores. Age and BADDS were assessed using
pooled t-tests while race and education were assessed using Fisher’s Exact Test.
Modulation of glutamate has been shown to effectively reduce symptoms of
depression and anxiety (Gerhard et al., 2016). Primary analyses also included
Spearman rank-order correlations to compare 1) BADDS scores to Glx levels at baseline
and 2) change in BADDS scores between active and baseline to change in BOLD signal
between active and baseline. Therefore, we also included measures of anxiety,
depression, and sleep in models examining the change in BADDS scores between
active and baseline to change in BOLD signal between active and baseline in subsets of
subjects for whom data were available. Anxiety, depression, and sleep were assessed
using the Beck Anxiety Inventory, Beck Depression Inventory, and Pittsburgh Sleep
Quality Index, respectively. Baseline scores for these indices were used as covariates in
the model examining correlations between BADDS scores to Glx levels at baseline.
BMI was included as a covariate in models examining the effect of LDX on BOLD
and Glx to ensure LDX-induced change in BMI did not affect results.
Separate linear regression models were used to test for association between Glx
and BOLD signal at each condition (baseline, active, placebo). These models were
repeated with distance between peak of the BOLD signal and the center of the
spectroscopy voxel was included as a covariate to account for variations in overlap
between the functionally defined DLPFC ROI and DLPFC spectroscopy voxel. The
functionally defined left DLPFC ROI is superficial with respect to cortical tissue making
voxel placement for spectroscopy somewhat of a challenge, as any overlap of the voxel
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with skull would introduce lipid contamination and partial voluming, obscuring results.
While we measured Glx before individuals performed the n-back in order to avoid any
potential impact of task activation effecting Glx levels, we could not ensure the voxel
used for MRS of Glx always completely overlapped with the functionally defined ROI
used for BOLD analyses. However, distance between peak of the BOLD signal and the
center of the spectroscopy voxel was included as a covariate to account for variations in
overlap between the functionally defined DLPFC ROI and DLPFC spectroscopy voxel.
This metric was calculated as follows. The group level DLPFC ROI was transformed into
subject space using FLIRT and binarized with fslmaths. This mask was multiplied by the
subject’s zstat image to isolate the subject’s BOLD signal within the DLPFC voxel. This
image was then transformed to the same T1 space as the subject’s spectroscopy voxel.
Fslstats was then used to obtain the coordinates of the peak of the bold signal and the
center of the spectroscopy voxel.
The volume of grey matter in the spectroscopy voxel relative to the total volume
of grey matter, white matter, and CSF was determined as follows. FAST was used to
segment each skull-stripped T1 image into grey matter, white matter, and CSF. Each
segmented image was then multiplied by a mask of the subject’s spectroscopy voxel to
obtain the number of volumes of grey matter, white matter, and CSF in this voxel. Age
and proportion of grey matter volume in the spectroscopy voxel were included as
covariates in a model examining the effect of LDX on Glx.

Supplementary Results
BOLD Results
In the right insula, results were similar to the unadjusted model (F=20.7, DF=11,
p=0.0008) when controlling for the effects of BMI (F=17.6, DF=9, p=0.0023), anxiety
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(F=9.1, DF=7, p=0.019), depression (F=24.0, DF=9, p=0.0009), and sleep (F=14.1,
DF=9, p=0.0046). In the left DLPFC, results were similar to the unadjusted model
(F=2.9, DF=11, p=0.12) when controlling for the effects of BMI (F=2.2, DF=9, p=0.17),
anxiety (F=2.1, DF=7, p=0.19), depression (F=4.8, DF=9, p=0.06), and sleep (F=2.5,
DF=9, p=0.15).
As stated in the primary manuscript, significant correlations were observed
between LDX-induced change in activation in the right insula and total BADDS score,
BADDS subscale 1, and BADDS subscale 3. The correlation between LDX-induced
change in activation and LDX-induced change in total BADDS score remained significant
when controlling for measures of anxiety (p<0.0004, t=7.07, DF=8), depression
(p<0.0001, t=7.04, DF=10), and sleep (p<0.0001, t=9.05, DF=10). Correlations also
remained significant for BADDS subscale 1 (anxiety p<0.008, t=3.99, DF=8; depression
p<0.005, t=3.09, DF=10; sleep p<0.002, t=4.71, DF=10) and BADDS subscale 3 (anxiety
p<0.02, t=3.58, DF=8; depression p<0.02, t=3.13, DF=10; sleep p<0.003, t=4.41,
DF=10). Likewise, the correlation between LDX-induced change in left DLPFC activation
and LDX-induced change in total BADDS score remained significant when controlling for
measures of anxiety (p=0.0007, t=6.42, DF=8), depression (p<0.03, t=2.64, DF=10), and
sleep (p<0.007, t=3.65 DF=10). Results were similar for BADDS subscale 1 (anxiety
p<0.005, t=3.99, DF=8; depression p<0.03, t=2.81, DF=10; sleep p<0.006, t=3.72,
DF=10) and BADDS subscale 3 (anxiety p<0.002, t=5.31, DF=8; depression p<0.007,
t=3.66, DF=10; sleep p<0.003, t=4.22, DF=10).

Spectroscopy Results
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The SNR for NAA, Glx, Cho, and Cr is ~110, ~20, 60, and 90, respectively.
fWHM for NAA and Cr are ~18 Hz (We used line broadening of 6Hz when processing
raw data). Glx fit uncertainty (mean ± SD) was 0.096 ± 0.082, 0.095 ± 0.068, and 0.093
± 0.087 at baseline, placebo and active conditions, respectively. The intraclass
correlation between baseline and placebo was 0.63 (F(6,7)=4.35, p=0.038).
As stated in the main manuscript, significant correlations were observed between
baseline Glx concentration in the left DLPFC and total BADDS score, BADDS subscale
1, and BADDS subscale 3. The correlation between Glx and total BADDS score
remained significant when controlling for measures of sleep (p<0.04, t=2.49, DF=10) but
not measures of anxiety or depression (p>0.05). Correlations also remained significant
for BADDS subscale 1 when measures of sleep (p<0.01, t=3.05, DF=13) and depression
(p<0.03, t=2.60, DF=13) were included, though correlations between Glx and BADDS
subscale 3 were no longer significant.
To examine whether variations in voxel placement in relation to the BOLD peak
could be affecting results, we calculated a distance metric that was a measure of the
distance between the peak of the BOLD signal and the center of the spectroscopy voxel.
However, including this distance metric as a covariate did not alter results and
correlations between Glx and BOLD did not reach significance.
To ensure LDX-induced decreases in Glx were not due to changes in the amount
of grey matter in the spectroscopy voxel, we examined the proportion of grey matter in
the voxel at each time point. A mixed model was used to determine whether the
proportion of grey matter within this voxel differed by condition. There was no significant
difference in this ratio across conditions (F=0.27, Numerator DF=2, Denom DF = 26;
p=0.77) (Supplementary Figure 5). This proportion (mean ± SD) was 0.17 ± 0.06, 0.17 ±
0.07, and 0.16 ± 0.05 at baseline, active, and placebo, respectively. Results were
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consistent with the original model examining the effect of LDX on Glx concentration
when the change in this proportion between baseline and condition was included as a
covariate (F=4.72, Num DF=1, Denom Df=12, p=0.051).
Effects of LDX on Glx concentration were similar when BMI (p=0.058, t=-2.10,
DF=12) and age (p=0.056, t=-2.10, DF=13) were included as covariates.
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Supplementary Tables

Region

k

Peak z

x

y

z

Activation
Frontal Pole, Right DLPFC

1935

6.55

36

40

18

Precentral Gyrus, Left DLPFC

1360

6.03

-34

-6

42

MF/CG

897

6.14

2

8

54

Right Parietal lobe

473

5.89

42

-48

46

Right Insular Cortex

379

6.49

30

22

6

Left Insular Cortex

356

5.96

-28

22

4

Left Parietal lobe

320

6.31

-50

-48

40

5243

5.6

-18

-94

26

Deactivation
Occipital Pole, PCC

Supplementary Table 5-1. Effect of n-back task on executive and non-executive
regions. Performance of the n-back task robustly activated executive regions (z>4.5,
p<0.001) and deactivated non-executive regions (z>1.9, p<0.05). Values displayed for
mean of parametric contrast for all sessions.
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Supplementary Figures

Supplementary Figure 5-1.

1

H-MRS of left DLPFC voxel. (a) Localization of

spectroscopy voxel in the left DLPFC. (b) Representative water suppressed raw
spectrum, fitted spectrum, and difference spectrum from one scan session.
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Supplementary Figure 5-2. BADDS scores across the study. BADDS scores
measured across the study for total BADDS (a) and BADDS subscales (b) Error bars
represent standard error.

Supplementary Figure 5-3. In-scanner n-back performance across the study.
Accuracy (% correct) (a) and true positive reaction time (b) measured across the study.
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Supplementary Figure 5-4. Glx measurements across the study. Left DLPFC Glx
concentrations measured across the study. Error bars represent standard error.

Supplementary Figure 5-5. Proportion of grey matter volume in Left DLPFC
spectroscopy voxel across the study. The proportion of grey matter in the
spectroscopy voxel did not significantly differ at any time point. This value (mean ± SD)
was 0.17 ± 0.06, 0.17 ± 0.07, and 0.16 ± 0.05 at baseline, active, and placebo,
respectively. Error bars represent standard error.
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CHAPTER 6
Early Adversity as a Moderator of
Lisdexamfetamine’s Effects on
Executive Function in Menopausal
Women: An Addendum to Chapter 5
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Rodent studies have indicated that early life stress may increase sensitivity to
amphetamine (Zimmerberg and Shartrand, 1992; Rentesi et al., 2013). Therefore, in this
addendum to chapter 5, we examined whether adverse childhood experiences (ACE)
altered brain and behavioral response to lisdexamfetamine (LDX) in menopausal women
with subjective cognitive complaints. We hypothesized that women with high levels of
early life adversity would demonstrate greater response to LDX vs placebo in
comparison to women with low levels of early life adversity. Specifically, we predicted
that high ACE women would report greater symptom improvement with LDX than low
ACE women. We also predicted that high ACE women would show a greater increase in
insula activation and a greater decrease in dorsolateral prefrontal cortex (DLPFC)
glutamate concentration from baseline with LDX than low ACE women.

Methods
Inclusion and exclusion criteria, study design, assessment of executive function,
image acquisition and processing, and quantification of glutamate were as described in
chapter 5 (Shanmugan et al., 2017) but are reproduced below for completeness.

Participants
Subjects in this addendum represent a subset of women who participated in a
clinical trial investigating the effects of LDX on executive function (Epperson et al.,
2015). Women ages 45 to 60 with EF difficulty onset during menopause and were within
5 years of their last menstrual period (LMP) were eligible to participate. Perimenopausal
women had irregular menstrual cycles for ≥12 months, no period for ≥ 3 months, and
serum follicle stimulating hormone (FSH) level of ≥ 20 IU/L. LMP of ≥12 months and
serum FSH levels ≥35 IU/L indicated postmenopausal status. Subjective EF symptom
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severity was assessed using the Brown Attention Deficit Disorder Scale (BADDS)
(Brown, 1996). BADDS score of ≥ 20 and onset of symptoms coinciding with the
initiation of menstrual cycle irregularity were required.
Women with a lifetime history of a DSM-IV psychotic disorder or psychostimulant
abuse, substance abuse disorder in the previous year, or present Axis I psychiatric
disorder were excluded. Psychotropic medication use, ET use within the previous 6
months, positive pregnancy test, Mini-mental Status Examination score < 26, IQ ≤ 90,
history

of

seizures,

cardiac

disease,

active

hypertension,

and

abnormal

electrocardiogram at screening were all exclusionary. Left-handedness, metallic
implants, and claustrophobia were additional exclusion criteria for subjects who
underwent neuroimaging. Subjects were excluded from ROI analyses for poor
coregistration (n = 2).

Study Design
This study was a double-blind, placebo-controlled, crossover study. After
screening, subjects underwent neuroimaging and cognitive assessment at three time
points. After baseline, subjects were randomized to one pill of study medication (LDX 20
mg or placebo) daily for the first week, two pills daily for the second week, and, if
tolerated, three pills daily for the final 2 weeks of each trial. Participants were allowed to
remain in the study if they could tolerate at least 1 pill per day throughout the study.
Upon completion of the first 4-week trial, participants underwent a 2-week washout and
were crossed over to the other treatment condition. Testing and imaging were conducted
∼ 2–6 h after last LDX dose.
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Assessment of Executive Function
Assessment of subjective EF was as previously reported (Epperson et al., 2015).
Briefly, subjects completed the BADDS, a validated subjective measure of EFs (Sandra
Kooij et al., 2008). The BADDS is a clinician-administered questionnaire that assesses
the frequency and severity of five clusters of executive dysfunction: (1) organization and
activating for work, (2) sustaining attention and concentration, (3) sustaining alertness,
effort, and processing speed, (4) managing affective interference, and (5) using working
memory and accessing recall. Subjects rate symptoms on a scale from 0 to 3, with 0
meaning the problem described does not relate to them and 3 indicating the problem
occurs almost daily.

Assessment of early life adversity
The Adverse Childhood Experiences Questionnaire (Felitti et al., 1998) was used
to assess history of emotional, physical, or sexual abuse, childhood neglect, and
household dysfunction. Number of exposures was summed to create the ACE score
(range: 0–10). Subjects with an ACE score ≥ 2 were considered “high ACE” while
subjects with ACE score of < 2 were considered “low ACE”. A threshold of 2 was used to
define the high ACE group based on studies of depression prevalence in later life that
demonstrate increased susceptibility at this level of exposure (Chapman et al., 2004;
Epperson et al., In Press).

fMRI Task Paradigm
Subjects completed a fractal version of the n-back task during each fMRI scan.
During the task, a fractal was presented for 500 ms followed by a 2500 ms interstimulus
interval. This task was used to probe working memory and had 3 conditions: 0-, 2-, and
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3-back. Each condition consisted of three 20-trial blocks, each preceded by a 9s
instruction period, with a target to foil ratio of 1:3. The task included a total of 45 targets
and 135 foils, as well as three 24 s blocks of rest during which a fixation crosshair was
displayed. Analyses on in-scanner n-back performance focused on true positives, false
positives, and reaction time.

Image Acquisition
Structural and functional images were acquired on 7T Siemens Trio scanner.
Structural image acquisition sequence consisted of a gradient echo localizer, a 3D
Magnetization Prepared Rapid Gradient Echo (MPRAGE) whole brain acquisition (TR,
2110 ms; TE, 3.17 ms; TI, 1500 ms; FOV, 240×180 mm; matrix, 256×192; 160 slices;
slice thickness, 1 mm; flip angle, 10°; effective voxel resolution, 0.9×0.9×1 mm), and 3D
reformatting of the MPRAGE data. Functional images were obtained using a wholebrain, single-shot, multislice, gradient-echo echoplanar sequence (239 volumes; TR,
3000; TE, 27 ms; flip angle, 70°; FOV, 220×220 mm; matrix 110×110; 37 slices; slice
thickness 2.2 mm; effective voxel resolution, 2×2×2.2 mm).

Image Processing
BOLD timeseries data were analyzed with FEAT (fMRI Expert Analysis Tool) in
FSL, using skull removal with BET (Smith, 2002), motion-correction with MCFLIRT
(Jenkinson et al., 2002), high pass filtering, spatial smoothing (6 mm FWHM), and meanbased intensity normalization. Subject-level timeseries analyses were carried out using
FILM (FMRIB's Improved Linear Model) with local autocorrelation correction (Woolrich et
al., 2009). The three condition blocks (0-back, 2-back, and 3-back) were modeled using
a canonical (double-gamma) hemodynamic response function with standard plus
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extended motion parameters included as nuisance covariates. The rest condition
(crosshair) served as the unmodeled baseline. The median functional and anatomical
volumes were co-registered using boundary-based registration (Greve and Fischl, 2009).
The anatomical image was normalized to the MNI 152 T1 2 mm template using linear
registration with 12 degrees of freedom.

Functional ROI analysis
Functional ROIs were defined using the parametric contrast of the group mean of
all sessions (baseline, active, and placebo) for subjects who completed the
neuroimaging adjunct study (Shanmugan et al., 2017). The activation map of the group
mean of the parametric contrast was cluster corrected at a voxel threshold of z > 4.5 and
cluster probability of p<0.001 (Woolrich et al., 2009). While this analysis identified 8
functionally defined regions, we limited our analysis of ACE x LDX effects specifically to
outcomes where the effect of LDX was significant in chapter 5. However, in chapter 5,
we examined the effect of LDX on BOLD in 8 regions and therefore restricted statistical
tests on BOLD to the 3-back condition to limit multiple comparisons. Because we focus
only on the right insula in this chapter, we evaluated the effect of ACE x LDX at each
condition of working memory load. Therefore, mean signal change for the 0-back, 2back, and 3-back contrast was extracted from this functionally defined right insula ROI.
The ROI mask was transformed into subject space using FLIRT.

MRS and Quantification of Glutamate
Water-reference single voxel spectroscopy (SVS) and water- suppressed SVS
scans were obtained on a voxel placed in the left DLPFC (15×30×20mm3). Voxels were
placed ~1cm from the skull to avoid lipid contamination. Automated shimming of the B0
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field was performed on the voxel to obtain localized water line width of ~ 20 Hz or less
using FASTMAP. Variable power RF pulses with optimized relaxation delays (Tkac et
al., 1999) were used to obtain water suppression spectra (Cai et al., 2012). SVS for
glutamate + glutamine (Glx) was obtained using short TE SVS with modified pointresolved spectroscopy sequence (PRESS) having the following parameters: spectral
width = 4 kHz, number of points = 2048, averages = 16 (water reference) or 64 (water
suppressed), TE = 20 ms, TR = 3000 ms. Chemical shift artifact for Glx was minimized
by setting water acquisition spectrum excitation and refocusing pulses in resonance with
the water peak at 4.7 p.p.m., and also setting water-suppressed spectrum excitation and
refocusing pulses in resonance with the Glx peak at 2.35 p.p.m.
Water-reference data were used to obtain channel-wise time-dependent phase
shifts due to eddy current and amplitude scale factors. Using a fitting method validated
by Cai et al (2012), metabolite peaks from water-suppressed spectrum were fitted as
Lorentzian functions with nonlinear least squares fitting using lsqcurvefit in MATLAB.
This procedure accounted for amplitudes, line widths, and peak positions for 8
macromolecular and 14 metabolite peaks. Normalization by water-reference signal
allowed for quantification of Glx.

Statistical analysis
In chapter 5, we demonstrated that, relative to baseline, LDX (vs placebo)
decreased scores on the Brown Attention Deficit Disorder Scale (BADDS), increased
activation in the insula, and decreased glutamate in the DLPFC. Here we examined the
impact of ACE as a moderator of the effect of LDX specifically on these outcomes where
the effect of LDX was significant. Linear mixed effects models implemented using the
nlme (Pinheiro et al, 2016) in R (R Core Team, 2015) were employed to test the effect of
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ACE, LDX, and ACE x LDX on BADDS scores, insula BOLD, and DLPFC glutamate
measured at the end of the active trial minus baseline vs those measured at the end of
the placebo trial minus baseline for each participant to account for repeated measures.
Spearman’s rank-order correlations were used to compare (1) change in BOLD between
active and baseline to ACE scores, (2) glutamate concentration at baseline to ACE
score, and (3) change in glutamate concentration between active and baseline to ACE
score. Statistical tests were two-sided with p<=0.05 considered significant.

Results
Participants
The effect of ACE on BADDS scores was evaluated using the sample of
participants who completed the clinical trial examining the effect of LDX on executive
function (Epperson et al., 2015). Of the 32 participants who completed this clinical trial, 3
subjects did not complete the ACE questionnaire and were excluded from analyses. The
final sample included in analyses of ACE x LDX effects on BADDS (n=29) consisted of
18 low ACE participants and 11 high ACE participants. The mean +/- SD ACE score in
the high ACE group was 3.8 +/- 1.6. The effect of ACE on BOLD and glutamate was
evaluated using the sample of participants who completed the neuroimaging adjunct
study described in chapter 5 (Shanmugan et al., 2017). One subject in that sample did
not complete the ACE questionnaire and was excluded from analyses. The final sample
included in analyses of ACE x LDX effect on BOLD (n=12) consisted of 8 low ACE
subjects and 4 high ACE subjects. The mean +/- SD ACE score in the high ACE group
was 3.3 +/- 1.3. The final sample included in analyses of ACE x LDX effect on glutamate
(n=13) consisted of 8 low ACE subjects and 5 high ACE subjects. The mean +/- SD ACE
score in the high ACE group was 3.8 +/- 1.6.
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Behavioral results
Linear mixed-effects models were used to test the hypothesis that the high ACE
group would show a greater reduction in symptom severity with LDX vs placebo than the
low ACE group. A significant ACE x LDX interaction was detected on BADDS scores
relating to organization and activation for work (p=0.01). Post-hoc comparisons revealed
that low ACE subjects demonstrated a greater response to placebo than high ACE
subjects (p=0.03). While there was no significant difference between LDX vs placebo
treatment in the low ACE group, the high ACE group showed a significantly greater
reduction in symptoms with LDX treatment in comparison to placebo (p=0.0002; Figure
6-1). There was no significant effect of ACE or ACE x LDX on total BADDS or other
BADDS subscales. There was an effect of LDX vs placebo in decreasing total BADDS
score (low ACE p=0.004; high ACE p=0.02) as well as BADDS subscales assessing
attention and concentration (low ACE p=0.01; high ACE p=0.09) and alertness, effort,
and processing speed (low ACE p=0.008; high ACE p=0.07). At a trend level, LDX
decreased symptoms related to managing affective interference in the high ACE group
(p=0.09), but had no effect in the low ACE group (p=0.16). In contrast, LDX decrease
symptoms related to working memory/accessing recall in the low ACE group (p=0.002)
but had no effect in the high ACE group (p=0.15). These differences in LDX effects
between ACE groups where the interaction was not significant are likely due to
insufficient power to detect the drug effect in the small sub-samples.

BOLD results
In chapter 5, we saw that LDX resulted in an increase in activation in the right
insula during the 3-back condition (Shanmugan et al., 2017). Given that previous
literature has indicated that early life stress may increase sensitivity to amphetamine
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(Zimmerberg and Shartrand, 1992; Rentesi et al., 2013), we tested the hypothesis that
higher ACE would be associated with a greater increase in BOLD in this ROI with LDX.
As predicted, an ACE x LDX interaction was present at a trend level in the 0-back
condition (p=0.06). In the high ACE group, the difference in BOLD between LDX and
baseline was significantly higher than the difference in BOLD between placebo and
baseline (p=0.01). In contrast, in the low ACE group, LDX did not significantly change
BOLD from baseline in comparison to placebo. There was no significant ACE x LDX
interaction at either 2-back or 3-back. The increase in BOLD signal from baseline was
significantly greater with LDX than with placebo during both 2-back (low ACE p= 0.006,
high ACE=0.02) and 3-back (low ACE p=0.009, high ACE p=0.01). The high ACE group
exhibited greater change in BOLD from baseline with LDX in comparison to the low ACE
group during the 2-back (p=0.08) and 3-back (p=0.09). While a similar ACE effect was
present with LDX during the 3-back (p=0.09), there was no difference between ACE
groups during placebo (p=0.02) (Figure 6-2).
The above analyses demonstrated that LDX-induced change in BOLD from
baseline was higher in the high ACE group than in the low ACE group at the higher
levels of working memory load. To further probe this finding, we examined the
association between the number of ACEs (continuous) and LDX-induced change in
BOLD signal. At each level of working memory load, change in BOLD signal was
correlated with total ACE score, though this correlation only reached significance during
the 2-back (0-back r=0.47, p=0.1; 2-back r=0.58, p=0.05; 3-back r=0.51, p=0.09; Figure
6-3).

Spectroscopy results
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There is preliminary evidence that individuals with a history of early adversity
may have higher PFC glutamate levels (Duncan et al., 2015), though it is unclear
whether adversity would moderate the effect of stimulant medications on prefrontal
glutamate concentration. Based on evidence from rodent studies suggesting increased
sensitivity to amphetamines with early life stress (Zimmerberg and Shartrand, 1992;
Rentesi et al., 2013), we hypothesized the difference in LDX-induced change from
baseline vs placebo-associated change from baseline would be greater in the high ACE
group compared to the low ACE group. Contrary to this hypothesis, we did not find an
effect of ACE or an ACE x LDX interaction on DLPFC glutamate concentration. The
effect of LDX was present at a trend level in this subsample of subjects who completed
the ACE questionnaire (p=0.1). There was also no significant correlation between total
ACE score and either baseline glutamate concentration or change in glutamate between
baseline and active.

Conclusions
In this double-blind, placebo-controlled, crossover study, we examined whether
ACE moderates the effect of LDX on behavioral and neural markers of executive
function. In the high ACE group, LDX (vs placebo) reduced symptoms related to difficulty
with organization and activation for work. However, response to LDX was not
significantly different from placebo in the low ACE group. Additionally, the extent to
which LDX increased activation in the insula increased linearly with total ACE score.
These findings are in agreement with animal studies indicating that early adversity may
increase sensitivity to amphetamine. In contrast, there was no effect of ACE or ACE x
LDX on glutamate concentration in the left DLPFC. Given the literature suggesting that
early adversity has multiple, complex effects on PFC glutamate systems including
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increases in glutamate concentration (Duncan et al., 2015), alterations in NMDA
receptor subunit composition (Kinnunen et al., 2003), and decreases in glutamatergic
dendritic spine density in the PFC (Michelsen et al., 2007), this finding is likely due to
insufficient power in this small sample. Behavioral and BOLD results provide preliminary
evidence that early adversity may also have lasting effects on catecholaminergic
neurotransmission. Furthermore, they emphasize the importance of considering ACE
when treating executive difficulties with stimulant medications during menopause.
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Figures

Figure 6-1. ACE x LDX effect on BADDS. Linear mixed-effects models were used to
test the hypothesis that the high ACE group would show a greater reduction in symptom
severity with LDX vs placebo than the low ACE group. A significant ACE x LDX
interaction was detected on BADDS scores relating to organization and activation for
work (p=0.01). Post-hoc comparisons revealed that low ACE subjects demonstrated a
greater response to placebo than high ACE subjects (p=0.03). While there was no
significant difference between LDX vs placebo treatment in the low ACE group, the high
ACE group showed a significantly greater reduction in symptoms with LDX treatment in
comparison to placebo (p=0.0002). There was no significant effect of ACE or ACE x LDX
on total BADDS or other BADDS subscales. There was an effect of LDX vs placebo in
decreasing total BADDS score (low ACE p=0.004; high ACE p=0.02) as well as BADDS
subscales assessing attention and concentration (low ACE p=0.01; high ACE p=0.09)
and alertness, effort, and processing speed (low ACE p=0.008; high ACE p=0.07). At a
trend level, LDX decreased symptoms related to managing affective interference in the
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high ACE group (p=0.09), but had no effect in the low ACE group (p=0.16). In contrast,
LDX decrease symptoms related to working memory/accessing recall in the low ACE
group (p=0.002) but had no effect in the high ACE group (p=0.15). These differences in
LDX effects between ACE groups where the interaction was not significant are likely due
to insufficient power to detect the drug effect in the small sub-samples.
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Figure 6-2. ACE x LDX effect on insular activation. We tested the hypothesis that
higher ACE would be associated with a greater increase in BOLD in the right insula with
LDX. As predicted, an ACE x LDX interaction was present at a trend level in the 0-back
condition (p=0.06). In the high ACE group, the difference in BOLD between LDX and
baseline was significantly higher than the difference in BOLD between placebo and
baseline (p=0.01). In contrast, in the low ACE group, LDX did not significantly change
BOLD from baseline in comparison to placebo. There was no significant ACE x LDX
interaction at either 2-back or 3-back. The increase in BOLD signal from baseline was
significantly greater with LDX than with placebo during both 2-back (low ACE p= 0.006,
high ACE=0.02) and 3-back (low ACE p=0.009, high ACE p=0.01). The high ACE group
exhibited greater change in BOLD from baseline with LDX in comparison to the low ACE
group during the 2-back (p=0.08). While a similar ACE effect was present with LDX
during the 3-back (p=0.09), there was no difference between ACE groups during
placebo (p=0.2).
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Figure 6-3. LDX-induced change in activation correlates with ACE score. Figure 2
demonstrated that LDX-induced change in BOLD from baseline was higher in the high
ACE group than in the low ACE group at the higher levels of working memory load. To
further probe this finding, we examined the association between the number of ACEs
(continuous) and LDX-induced change in BOLD signal. At each level of working memory
load, change in BOLD signal was correlated with total ACE score, though this correlation
only reached significance during the 2-back (0-back r=0.47, p=0.1; 2-back r=0.58,
p=0.05; 3-back r=0.51, p=0.09).
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CHAPTER 7
Overall Discussion and Future
Directions
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Synthesis of results and overall discussion
During the menopause transition, many healthy women with no history of
cognitive dysfunction experience subjective difficulties with sustained attention,
motivation for work, organization and working memory (Epperson et al., 2011;
Shanmugan and Epperson, 2014; Epperson et al., 2015; Shanmugan et al., 2017).
Indicators of risk for cognitive decline during menopause are lacking, as is an
understanding of the mechanisms contributing to this vulnerability with waning estradiol.
Results of this dissertation support the hypothesis that adverse childhood experiences
(ACE) is a risk factor for this cognitive decline and that ACE increases the risk of
executive

dysfunction

during

menopause

via

alterations

in

monoaminergic

neurotransmission.
In chapter 2, we examined the impact of ACE on subjective and objective
measures of executive function in a large sample of women who underwent surgical
menopause. We found that high ACE women reported more subjective symptoms of
executive dysfunction and performed worse on neuropsychological tasks probing
working memory and sustained attention. To account for the fact that early adversity is
associated with increased risk of mood disorders with loss of estradiol (Epperson et al.,
In Press), we conducted mediation analyses to determine the extent to which ACE
effects on executive function result from concurrent mood (anxiety and depressive
symptoms) changes. We determined that mood symptoms were a partial mediator of
ACE effects on subjective symptoms of executive dysfunction and sustained attention.
However, mood did not mediate ACE effects on working memory. Moreover, ACE
effects on working memory remained significant when accounting for the effects of mood
symptoms, age, chemotherapy use, time since oophorectomy, hormone therapy use,
and education. Together, results of chapter 2 suggest that mood symptoms are one
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component of the mechanism underlying new onset cognitive dysfunction with loss of
estradiol but that at least a portion of ACE-associated risk for executive difficulties is
independent of the association between ACE and anxiety and depressive symptoms.
We next pursued these mood-independent mechanisms in chapters 3 through 6.
Given the strong associations between ACE and mood symptoms in chapter 2,
we hypothesized that an additional mechanism by which ACE exerts a negative impact
on executive function during periods of low estradiol may be via effects on serotonin. In
chapter 3, the effects of tryptophan depletion (TD), ACE, and TD x ACE were evaluated
using a voxelwise, whole-brain analysis. In the absence of exogenous estradiol, a
significant TD by ACE interaction was observed on BOLD signal in the right DLPFC such
that TD increased activation in high ACE subjects but decreased activation in low ACE
subjects. While a similar interaction was observed with placebo treatment, treatment with
estradiol attenuated the effects of ACE and TD such that no between or within group
differences were observed. In chapter 4, we observed a similar ACE x TD interaction on
within-network connectivity in the absence of exogenous estradiol. While ACE was
robustly associated with lower within-network connectivity regardless of depletion
condition, TD increased connectivity in the high ACE group but had no effect on
connectivity in the low ACE group.
Overall, results from chapters 3 and 4 suggest that early life adversity has lasting
impacts on serotonergic circuits underlying executive function that are unmasked by loss
of estradiol during menopause. These results also emphasize serotonin’s role in
executive function and highlight that the moderating effects of early adversity must be
accounted for when manipulating serotonin levels. Further research targeting specific
components of the serotonin system would be necessary to pinpoint the molecular
targets of ACE. In animal models, early life stress is associated with lower tryptophan
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hydroxylase type 2 gene expression (Shively et al., 2003), higher monoamine oxidase-A
expression (Wong et al., 2015), and attenuated 5-HT1A function (Matsuzaki et al.,
2009), indicating that future research in human participants should focus on
understanding how ACE affects serotonin synthesis, metabolism, and signaling during
menopause.
While the TD x ACE interactions on DLPFC activation and functional connectivity
seen in chapters 3 and 4 provided evidence for ACE effects on serotonergic function, the
robust effects of ACE on functional connectivity that were significant regardless of
depletion status highlight that ACE effects on serotonin are only part of the story. Given
the preclinical literature suggesting that ACE negatively impacts other monoaminergic
systems (Shively, 1998; Matthews et al., 2001; Rentesi et al., 2013), we next examined
the impact of ACE on dopaminergic and noradrenergic function in menopausal women
with subjective cognitive complaints.
We probed catecholaminergic function in women with high and low levels of early
adversity using lisdexamfetamine (LDX), a stimulant medication that has been shown to
improve subjective measures of executive function in menopausal women with selfreported new-onset executive difficulties (Epperson et al., 2015). Because no previous
imaging studies had utilized LDX, before examining whether ACE altered response to
this drug, we first characterized the impact of LDX on executive activation and
neurochemistry in chapter 5. We found that relative to baseline, LDX (vs placebo)
decreased scores on the Brown Attention Deficit Disorder Scale (BADDS), increased
activation in the insula, and decreased glutamate in the DLPFC. In chapter 6, we
examined whether ACE moderated the effect of LDX on these outcomes. A significant
ACE x LDX interaction was observed on subjective report of executive difficulties related
to organization and activation for work. In the high ACE group, LDX (vs placebo)
178

reduced these symptoms from baseline while response to LDX was not significantly
different from placebo in the low ACE group. Additionally, LDX-induced change in insular
activation correlated with ACE score across varying levels of working memory load.
These findings are in agreement with animal studies indicating that early adversity may
increase sensitivity to amphetamine (Zimmerberg and Shartrand, 1992; Rentesi et al.,
2013). Given that stimulants increase dopamine and norepinephrine levels in the PFC
(Arnsten, 2009, 2011), lower baseline concentrations of catecholamines in the high ACE
group may play a role in the differential treatment response to LDX. Animal studies
demonstrating that early adversity is associated with increased dopamine transporter
(DAT) expression (Novick et al., 2015), increased catechol-o-methyl transferase (COMT)
expression (Grissom et al., 2015), and increased D2 autoreceptor expression (Lovic et
al., 2013) and activity (Watt et al., 2014) support this hypothesis.
In sum, chapters 5 and 6 suggest that early adversity may have lasting effects on
catecholaminergic neurotransmission. Furthermore, they emphasize the importance of
considering ACE when treating executive difficulties with stimulant medications during
menopause.
In contrast to our findings regarding ACE x LDX effects on subjective symptoms
of executive dysfunction and brain activation in the insula, there was no effect of ACE x
LDX effect on glutamate concentration in the left DLPFC. The lack of ACE x LDX
interaction was surprising given that prior studies have demonstrated that individuals
with high levels of early adversity have higher PFC glutamate concentrations (Duncan et
al., 2015). Evidence from rodent studies indicates that early life stress alters the
composition of N-methyl-D-aspartic acid (NMDA) receptor subunits in the prefrontal
cortex (Kinnunen et al., 2003), which are important for the persistent firing of
glutamatergic neurons during working memory and sustained attention (Arnsten and
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Wang, 2016). Early stress in mice has also been shown to decrease mGluR2 and
mGluR3 mRNA and protein levels in the frontal cortex (Matrisciano et al., 2012), which
are important for anxiolytic and anti-psychotic drug response (Marek, 2010). Additionally,
chronic postnatal stress has been shown to decrease dendritic spine density in the PFC
of rats (Michelsen et al., 2007). This negative impact of early life stress on dendritic
spine density is particularly intriguing given that executive functioning is dependent on
the number of prefrontal small spines (Hara et al., 2012) and the substantial literature
demonstrating negative effects of ovariectomy and positive effects of estradiol on
dendritic spine morphology (Shanmugan and Epperson, 2014). Estrogen treatment has
been shown to reverse both the decreases in PFC dendritic spine density and number
as well as the impairments in PFC dependent functions caused by ovariectomy in both
rodents and nonhuman primates (Rapp et al., 2003; Tang et al., 2004; Hao et al., 2007;
Chen et al., 2009). In particular, long-term 17b-estradiol administration following
ovariectomy increases apical and basal dendritic spine density and the number of
smaller, more motile spines thought to be important for synaptic plasticity (Hao et al.,
2007). Enhanced performance on working memory tasks in ovariectomized nonhuman
primates receiving estradiol is thought to be at least in part due to these changes in
spine density (Rapp et al., 2003; Hao et al., 2007). This literature suggests that our lack
of ACE x LDX effect on glutamate levels may be due to insufficient power in the small
sample of n=13. It is also possible that ACE predominantly impacts other aspects of
glutamate system function (per above) which cannot be assessed with magnetic
resonance spectroscopy. Clearly, the impact of ACE and the interaction between ACE
and LDX on glutamatergic function in hypogondal women warrant further study in a
larger sample.
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Future directions
In the preceding chapters, we provided evidence that ACE confers a vulnerability
for executive dysfunction during menopause via alterations in monoaminergic
neurotransmission. However, there are likely several other mechanisms by which ACE
impacts executive function that merit further investigation.
In chapter 4, we found that ACE was robustly associated with lower withinnetwork connectivity. Given that functional connectivity may be reflective of underlying
structural connections, impairments in neuronal development during childhood and
adolescence may be one mechanism by which ACE predisposes individuals to executive
dysfunction. As discussed above, early life stress in mice has been shown to induce
alterations in PFC dendritic architecture (Yang et al., 2015). Female mice that
experience peripubertal stress also display increases in PFC myelin basic protein gene
expression and proteolipid protein gene expression, both of which are indicators of
myelination (Morrison et al., 2016). Importantly, estradiol supports the normal
development and maintenance dendritic morphology (Shanmugan and Epperson, 2014)
and neuronal myelination (Luo et al., 2016). Future neuroimaging studies utilizing
diffusion tensor imaging would be helpful in determining whether ACE effects on white
matter integrity mediate the relationship between ACE and executive function during
menopause.
Immune markers may also mediate the effects of early adversity on later life
cognitive function. In healthy adults, early life stress has been associated with increases
in pro-inflammatory cytokines such as IL-6, IL1-beta, and TNF-alpha (Hartwell et al.,
2013). Elevated inflammatory markers have been implicated in the associations between
early adversity and increased risk of major depressive disorder (Miller and Cole, 2012;
Grosse et al., 2016), schizophrenia (Khandaker and Dantzer, 2016), and posttraumatic
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stress disorder (Eraly et al., 2014). There is preliminary evidence that such chronic
inflammation and oxidative stress may play a role in the pathogenesis of executive
dysfunction seen in ADHD (Buske-Kirschbaum et al., 2013; Verlaet et al., 2014). As
such, whether immune dysregulation contributes to the increased vulnerability for
executive dysfunction seen with ACE should be investigated.
This work has also generated several hypotheses with implications for clinical
practice. In chapter 2, we have provided evidence that ACE is a risk factor for executive
dysfunction after surgical menopause. However, the majority of our sample completed
cognitive testing shortly after oophorectomy. This limited our ability to separate the
effects of current age from those of age at oophorectomy. Future studies should
examine whether the impact of ACE is moderated by age at oophorectomy. Given that
estradiol attenuates the effects of ACE on working memory (as seen in chapter 3) and
greater duration of endogenous estrogen exposure may be beneficial for PFC
dependent cognitive functions (Shanmugan and Epperson, 2014), one could
hypothesize that the negative effects of ACE on executive function may be magnified by
earlier age at oophorectomy. If future research in a sample with greater variability in the
relationship between age and age at oophorectomy supported this hypothesis,
physicians may be more informed when counseling patients who are high ACE as to the
risks and benefits of undergoing vs postponing oophorectomy as a way to mitigate the
negative effects of ACE on cognitive function.
In chapter 3, we demonstrated that neural response to estradiol treatment varies
depending on levels of early adversity. This finding supports the hypothesis that
individual biological and environmental differences contribute to risk vs resilience for
executive dysfunction with waning estradiol. Failure to account for this moderating effect
of ACE is likely a major factor contributing to the inconclusive literature regarding
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estradiol’s effects on executive function in human participants. Future studies examining
the efficacy of estradiol in alleviating menopause-associated cognitive dysfunction
should account for history of early adversity. Validation of ACE as a moderator of
estradiol’s impact on executive functions would support the use of ACE as a potential
indicator of a patient’s response to estrogen therapy.
However, many perimenopausal and postmenopausal women are not candidates
for estrogen therapy due to medical contraindications or family history (Shifren and
Schiff, 2010). Our results regarding ACE x monomanine interactions provide preliminary
evidence for the use of serotonergic and catecholaminergic medications to treat
menopause-associated executive dysfunction. In addition to psychotherapy, selective
serotonin reuptake inhibitors (SSRIs) may be an appropriate treatment for the ACEassociated anxiety and depressive symptoms contributing to executive dysfunction.
Because decreases in serotonin concentration may be one mechanism by which ACE
confers a vulnerability for executive difficulties in healthy women without associated
mood symptoms, future clinical trials should examine whether SSRIs could also
ameliorate cognitive dysfunction in this population. Previous studies have indicated that
serotonin-norepinephrine reuptake inhibitors (Epperson et al., 2011) and stimulants
(Epperson et al., 2015; Shanmugan et al., 2017) are successful in reducing subjective
symptoms of executive dysfunction in women who have undergone natural menopause.
Here we provided preliminary evidence that ACE moderates treatment response to LDX.
Given that this research into catecholaminergic agents as an alternative to hormone
therapy for the alleviation of executive dysfunction is particularly relevant to women who
are BRCA1/BRCA2 positive, future studies in a larger sample would be helpful in
determining whether ACE moderates both brain and behavioral response to
catecholaminergic medications after surgery- or chemotherapy-induced menopause.
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Conclusions
In summary, this body of work supports the hypothesis that ACE is a risk factor
for executive function difficulties during menopause and that ACE increases the risk of
executive dysfunction with loss of estradiol via alterations in monoaminergic
neurotransmission. Our results highlight that addressing concurrent mood changes is a
critical step in treating menopause-induced executive difficulties. They also suggest that
early life adversity has latent effects on serotonergic circuits underlying executive
function that are unmasked by loss of estradiol during menopause. Additionally, our
findings indicate that early adversity may have lasting effects on catecholaminergic
neurotransmission and may alter treatment response to stimulant medications. Together,
they emphasize the importance of considering ACE in neuroimaging studies utilizing
neurotransmitter manipulations and when treating executive function difficulties during
menopause.
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Common and Dissociable Mechanisms of Executive System Dysfunction
Across Psychiatric Disorders in Youth
This section has been published:
Shanmugan S, Wolf DH, Calkins ME, Moore TM, Ruparel K, Hopson RD, Vandekar SN,
Roalf DR, Elliott MA, Jackson C, Gennatas ED, Leibenluft E, Pine DS, Shinohara RT,
Hakonarson H, Gur RC, Gur RE, Satterthwaite TD (2016) Common and Dissociable
Mechanisms of Executive System Dysfunction Across Psychiatric Disorders in Youth.
The American journal of psychiatry 173:517-526.
ABSTRACT
Objective: Disruption of executive function is present in many neuropsychiatric
disorders. However, determining the specificity of executive dysfunction within these
disorders is challenging given high comorbidity of conditions. Here we investigated
executive system deficits in association with dimensions of psychiatric symptoms in
youth using a working memory paradigm, hypothesizing that common and dissociable
patterns of dysfunction would be present.
Methods: We studied 1,129 youths who completed a fractal n-back task during fMRI at
3T as part of the Philadelphia Neurodevelopmental Cohort. Factor scores of clinical
psychopathology were calculated using an itemwise confirmatory bifactor model,
describing overall psychopathology as well as four orthogonal dimensions of symptoms
including anxious-misery (mood / anxiety), behavioral disturbance (ADHD / conduct),
psychosis-spectrum symptoms, and fear (phobias). The impact of psychopathology
dimensions on behavioral performance and executive system recruitment (2-back > 0back) were examined using both multivariate (matrix regression) and mass-univariate
(linear regression) analyses.
Results: Overall psychopathology was associated with both abnormal multivariate
patterns of activation and a failure to activate executive regions within the cingulo190

opercular control network including the frontal pole, cingulate cortex, and anterior insula.
Additionally, psychosis-spectrum symptoms were associated with hypo-activation of left
dorsolateral prefrontal cortex, whereas behavioral symptoms were associated with hypoactivation of fronto-parietal cortex and cerebellum. In contrast, anxious-misery symptoms
were associated with widespread hyper-activation of the executive network.
Conclusions: These findings provide novel evidence that common and dissociable
deficits within the brain’s executive system are present in association with dimensions of
psychopathology in youth.

INTRODUCTION
Deficits of executive function are present in a wide range of psychiatric disorders
including attention deficit hyperactivity disorder (ADHD) (1), conduct disorder (2), and
psychotic disorders such as schizophrenia (3,4). Executive deficits negatively impact
everyday functioning (5), and contribute to diminished quality of life in many clinical
populations (6,7). Consequences of executive deficits may be particularly acute in
childhood and adolescence, and include increased interpersonal conflict, decreased
academic achievement, and risk-taking behavior (7,8).
Many studies have investigated the neural basis of executive impairments in
individual psychiatric disorders. Working memory is one of the most commonly studied
components of executive function. For example, meta-analyses in patients with ADHD
demonstrate hypoactivation within a network of regions including the dorsolateral
prefrontal cortex, anterior cingulate cortex, thalamus, superior parietal lobule, and
precuneus (9,10). Patients with schizophrenia also fail to recruit portions of the executive
network including the dorsolateral prefrontal cortex (11-13). Likewise, conduct disorder is
associated with a failure to activate a similar network of regions (14). Taken together,
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these studies suggest there are likely overlapping effects across disorders, with
hypoactivation of the executive system being a common underlying brain phenotype.
However, evidence exists for dissociable abnormalities among psychiatric disorders.
For example, hyperactivation of executive regions have been reported in major
depressive disorder and anxiety disorders (15-17). Nonetheless, some heterogeneity in
results exists, and such hyperactivation has also frequently been reported in
schizophrenia (18).
A case-control design in a single disorder is the predominant approach in the
studies reviewed above, and thus most studies are unable to directly evaluate whether
common executive deficits exist across disorders. Furthermore, while the incidence of
psychiatric co-morbidity is quite high, studies typically do not explicitly evaluate its
impact. In epidemiological studies, approximately 40% of individuals meeting criteria for
one diagnosis met criteria for at least one additional disorder in a different class (19).
Thus, studies that use subjects with “pure” single diagnoses may not be representative.
More recently, the neural basis of executive deficits across disorders have been
investigated in an attempt to isolate regions of dysfunction specific to each diagnosis
(20). However, studies comparing multiple clinical groups are typically hampered by
small sample size, and few prior studies compared more than two disorders at a time.
Furthermore, as psychiatric symptomatology exists on a continuum of normal to
abnormal, dimensional analyses that cut across categorical clinical diagnoses may both
enhance power and improve biological interpretability (21). Thus, studies in large
samples evaluating the impact of multiple dimensions of psychopathology on executive
functioning are necessary.
Accordingly, here we used a dimensional approach to examine executive
dysfunction with a working memory fMRI task in a sample of 1,129 youth imaged as part
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of the Philadelphia Neurodevelopmental Cohort (22,23). Notably, the ascertainment
strategy used in the Philadelphia Neurodevelopmental Cohort differs substantially from
studies using clinical help-seeking samples, instead employing a population-based
approach that examines symptoms in non-help seeking youth. While such a design will
likely have lower symptom severity than clinical samples, a population-based approach
may nonetheless be valuable for investigating dimensions of psychopathology. We
hypothesized that there would be both common and dissociable deficits in executive
recruitment associated with different dimensions of psychopathology. Specifically, we
predicted that general psychopathology would be associated with executive hypoactivation regardless of clinical diagnosis. Furthermore, we predicted that specific
dimensions of psychopathology would be linked to dissociable regional patterns of
impairment within the executive network.

METHODS
Participants
As previously described, the Philadelphia Neurodevelopmental Cohort is a
collaboration between the Center for Applied Genomics at the Children’s Hospital of
Philadelphia and the Brain Behavior Laboratory at the University of Pennsylvania
(22,23). The current report considers the entire cross-sectional sample of 1,601 subjects
imaged as part of the Philadelphia Neurodevelopmental Cohort; of these, 1,462
completed the n-back task described below. Following subject exclusions including
medical co-morbidity, task non-performance, and image quality assurance (see
Supplementary Methods), the final sample included in analyses was n=1,129 (mean age
= 15.5 years; SD = 3.4 years; 520 males). This sample thus constitutes a super-set of
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subjects previously included in reports that focused on effects of working memory
performance (24) and psychosis-spectrum symptoms (25).

Clinical assessment
As previously detailed (26,27), psychopathology symptoms were evaluated using
a structured screening interview (GOASSESS).

Computerized algorithms used

endorsement of symptoms, their frequency and duration, and the presence of distress or
impairment to determine whether DSM-IV criteria were met (see Supplementary
Methods). The frequency and relevant demographic data for each screening diagnosis
considered are detailed in Table 1. As in large-scale epidemiologic datasets (19), comorbidity was quite common, with more subjects meeting criteria for more than one
category (n=529) than a single category (n=249).

Psychopathology factor analysis
In

order

to

parse

this

co-morbidity

into

orthogonal

dimensions

of

psychopathology, we performed factor analyses of item-level data from GOASSESS. To
produce stable factor scores, analyses utilized all subjects for whom clinical data were
available (n=9,498) rather than only the subset who completed neuroimaging (26,27). As
initial exploratory factor analyses indicated correlated traits of psychopathology, we used
a bifactor confirmatory model, which can produce orthogonal scores from correlated
traits (28).
Methods regarding estimation of the bifactor model will be presented in detail
elsewhere (also see Supplementary Methods). Briefly, the confirmatory bifactor model
(Figure 1A) was estimated using a Bayesian estimator in Mplus. As predicted by theory
and supported by initial exploratory models, the four factors primarily represent anxious194

misery (mood & anxiety) symptoms, psychosis-spectrum symptoms, behavioral
symptoms (conduct and ADHD), and fear symptoms (phobias). Additionally, the bifactor
model estimated a general psychopathology factor, representing the overall burden of
psychopathology while controlling for the presence of specific symptom dimensions.
Importantly, all five factors (including general psychopathology) from the bifactor model
are orthogonal and can be considered jointly in analysis of imaging data. Factors scores
within each of the categorical screening categories were as expected given item-level
loading (Figure 1B).

Task paradigm, image acquisition and image processing
Task paradigm, image acquisition, and pre-processing methods were as
previously reported (24). Briefly, a fractal version of the n-back task (29) was used to
probe executive system function across three levels of working memory load (Figure
2A). The primary behavioral measure was d’, a signal detection metric that limits the
influence of response bias. Task performance (d’) across all levels of working memory
load was related to categorical diagnosis from GOASSESS and dimensional factor
scores using linear models while controlling for age and sex. Testing five dimensions of
psychopathology were accounted for using Bonferroni correction.
fMRI, T1, and B0 images were acquired on the same scanner (Siemens 3T Tim
Trio) for all subjects (see Supplementary Methods). Timeseries analysis of subject-level
imaging data used FSL (30) to model three condition blocks (0-back, 1-back, and 2back); the primary contrast was 2-back > 0-back, which robustly recruits the executive
network (24). Subject-level statistical maps were distortion corrected, co-registered to
the T1 image using boundary-based registration, and normalized to the MNI 152 1mm

195

template using ANTs (31) and then downsampled to 2mm. All transformations were
concatenated so only one interpolation was performed.

Multivariate group-level analysis: Global associations with psychopathology
As a first step, we evaluated the degree to which dimensions of psychopathology
from the factor analysis impacted overall multivariate patterns of activation (see Figure
S1). To do this, we used multivariate distance-based matrix regression, a statistical
technique developed originally for large-scale ecologic datasets that has recently been
used in image analysis (32); this was implemented using the vegan package in R (33).
Subject-level activation maps are compared on a pairwise basis (Euclidean distance) to
yield a distance matrix. Matrix regression is then used to test whether each phenotypic
variable explains the distances among each participant’s activation patterns. In contrast
to other multivariate methods, this approach allowed us to examine the influence of
multiple dimensions of psychopathology simultaneously while also controlling for
covariates (age, sex, and in-scanner motion). Multiple tests were accounted for using
Bonferroni correction as above.

Mass-univariate group-level analysis: Regional associations with psychopathology
While the multivariate analysis detailed above provided an estimate of the degree
to which dimensions of psychopathology impacted the global pattern of activation, this
analysis does not evaluate regional effects. Accordingly, we next conducted a standard
mass-univariate analysis using a general linear model implemented in FSL (30). We
evaluated the effect of each dimension of psychopathology within this linear model, with
covariates

as

above.

Additionally,

we

investigated

whether

dimensions

of

psychopathology that showed a significant effect were significantly different from each
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other using an F-test across dimensions. Type I error control was provided by cluster
correction using 10,000 Monte-Carlo simulations (voxel height of z > 3.09; cluster
probability of p < 0.001; minimum cluster size of k=67) (34). All analyses described
below used unmasked, whole-brain voxelwise data. Images were displayed using Caret.

Supplementary analyses
In order to evaluate whether potentially confounding factors influenced observed
results, we conducted a series of supplementary analyses. This included a) removing
the minority (11.4%) of subjects who were taking psychoactive medication; b) including
task performance (d’ ) as a covariate; c) excluding subjects with poor performance (>7
non-responses) on the 2-back condition; and d) including mean accuracy on an out-ofscanner computerized neuropsychological battery, race, assessment-scan interval,
maternal education, and in-scanner performance (d') together as covariates in one
model.

RESULTS

Multiple dimensions of psychopathology impact task performance
As expected, increasing working memory load was associated with fewer correct
responses to targets and increased false positive responses to foils (Figure 2B & C).
These measures were integrated using the signal detection measure d’. As expected, d’
varied considerably by screening categorical diagnosis (see Table 1). When
summarized as psychopathology dimensions, several factors significantly impacted
working memory task performance (Figure 2D). Higher levels of both overall
psychopathology (t[1124]=2.58, p=0.001) and behavioral symptoms (t[1124]=3.82,
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p=0.0001) were associated with lower working memory performance. In contrast, higher
levels of anxious-misery symptoms were associated with a trend towards better working
memory performance (t[1124]=2.45, p=0.015). There was not a significant relationship
between fear or psychosis and working memory performance.

Overall psychopathology alters global patterns of executive system recruitment
As expected, the 2-back > 0-back contrast robustly recruited the entire executive
network, and resulted in de-activation of non-executive regions (Figure 2E). We next
evaluated whether dimensional psychopathology was associated with changes in this
multivariate pattern of activation and de-activation using multivariate distance-based
matrix regression. This procedure revealed that overall psychopathology was associated
with a significant disturbance in the global pattern of executive system recruitment
(p=0.009). Other symptom dimensions did not have a significant relationship; nonsignificant trends were observed for behavioral (p=0.044) and anxious-misery (p=0.092)
symptoms.

Dimensions of psychopathology differentially impact regional executive activation
Multivariate distance-based matrix regression evaluates the presence of global
multivariate effects, but is not sensitive to regional changes. Accordingly, we used massunivariate generalized linear models to examine the relationship between dimensions of
psychopathology and executive system activation (Figure 3, Table S1). As suggested
by multivariate results, overall psychopathology had the most robust impact on executive
activation. Higher levels of overall psychopathology were associated with diminished
activation of bilateral frontal pole, anterior cingulate cortex, anterior insula, thalamus, and
precuneus. Behavioral symptoms were associated with diminished activation of
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frontoparietal cortex as well as thalamus and cerebellum. Psychosis-spectrum
symptoms were associated with diminished activation of the left dorsolateral prefrontal
cortex. Fear (phobia symptoms) was associated with diminished activation of a
marginally significant cluster of medial frontal cortex, but this effect did not survive
supplementary analyses (see below) and was not evaluated further. Finally, in contrast
to the hypo-activation described above, anxious-misery symptoms were associated with
a marked hyper-activation of multiple executive regions including anterior cingulate
cortex, dorsolateral prefrontal cortex, parietal cortex, and thalamus. Notably, a small
area of overlapping significant effects across dimensions was seen in the left
dorsolateral prefrontal cortex (MNI coordinates: x=-28, y=-6, z=58; k=10). Significant
differential effects of each dimension were present in multiple executive regions (Figure
4, Table S2). This was driven by the divergent impact of global psychopathology (hypoactivation) and anxious misery (hyper-activation). We did not find any differences in
default mode regions where task-induced deactivation was present.

Supplementary analyses
Overall, convergent results were obtained from supplementary analyses where
participants taking psychoactive medications were excluded (Table S3), when working
memory performance was included as a covariate (Table S4), and when multiple
additional covariates were included (Table S5). When participants with poor
performance on the 2-back condition were excluded, psychosis-spectrum symptoms
were associated with a marginally significant cluster of hyperactivation in the cingulate
gyrus; otherwise results were similar (Table S6). As noted above, fear did not have a
significant association with activation in any of the supplementary analyses.
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DISCUSSION

In this large study of psychopathology in youth, we examined associations
between diverse psychopathology and activation of the brain’s executive system during
a working memory task. To account for the fact that psychiatric disorders are highly comorbid, factor analysis of the psychopathology data using a bifactor model allowed us to
examine both general psychopathology and orthogonal dimensions of psychopathology.
Overall psychopathology was associated with a significant alteration of the global
multivariate pattern of activation. Furthermore, dimensions of psychopathology
significantly influenced regional patterns of activation in different ways. In contrast to the
hypo-activation seen in association with overall psychopathology, anxious misery
symptoms were associated with hyper-activation of the same network. Taken together,
these data emphasize that dimensions of psychiatric symptomatology are associated
with both common and distinct deficits within the executive system.

Evidence for common executive deficits across psychiatric syndromes in youth
The most robust finding in the present study is evidence of common executive
deficits attributable to overall psychopathology present across categorical clinical
diagnoses. This was observed on both a global and local scale: overall psychopathology
was associated with an alteration of the global multivariate pattern of activation, driven
by regional hypoactivation in a network of executive regions including the frontal pole,
anterior cingulate, anterior insula, and precuneus. These results accord with a copious
literature of case-control studies from multiple individual disorders, and moreover
highlight the centrality of executive dysfunction across major psychiatric syndromes.
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We were able to estimate the influence of overall psychopathology across
disorders through the use of a bifactor analysis of the item-level responses from the
psychopathology screening interview. This approach obviates several major obstacles to
estimating common deficits across traditional categorical diagnoses. First, when comorbidity is represented in standard models as shared variance, it is controlled for but
cannot be estimated. Estimating overall psychopathology may be particularly important
in youth where the pattern of psychopathology may not fit standard diagnostic criteria in
context of ongoing development. Second, strongly non-random patterns of comorbidity
exist between different disorders (19). For example, mood and anxiety disorders have a
high rate of comorbidity, as do ADHD and conduct disorders. Third, the frequency of
each diagnosis varies considerably; thus the statistical power to estimate the impact of
each individual diagnosis is not equal. Fourth, categorical diagnoses are by definition
dichotomous, and important dimensional effects cannot be examined.
Crucially, each of these problems can be overcome through modeling of latent
dimensions of psychopathology. Here we used confirmatory factor analysis to estimate a
bifactor model, which provides orthogonal scores for every subject in each
psychopathology domain, as well as a score for general psychopathology. These
orthogonal scores can thus be included in a single model that can estimate dissociable
dimensions of psychopathology with equal power, as well as the impact of overall
psychopathology through the general score. The regions implicated by overall
psychopathology include the frontal pole, anterior cingulate cortex, and anterior insula.
Notably, all these regions are part of the cingulo-opercular control network (also called
the salience or ventral attention network), which is consistently identified as among the
most reproducible large-scale functional brain networks both at rest and during task
performance (35). This network is critical for cognitive control, and is particularly
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implicated in maintenance of task sets and error monitoring (36). These regions are
among the most commonly impaired in case-control studies of schizophrenia, ADHD,
and conduct disorder, suggesting that dysfunction of this network is not associated with
one specific domain of psychopathology (4,10,37). Further support is provided from a
large-scale meta-analysis by Goodkind et al., who found that gray matter loss in these
cingulo-opercular regions was present across psychiatric disorders and associated with
impaired executive function (38).

Orthogonal dimensions of psychopathology are associated with dissociable deficits
In addition to robust effects of overall psychopathology, we also identified both
regionally

and

directionally

dissociable

effects

of

specific

dimensions

of

psychopathology. Behavioral symptoms were associated with diminished activation of a
network of regions including fronto-parietal cortex, thalamus, and cerebellum, whereas
psychosis-spectrum symptoms were associated with hypo-activation of the left
dorsolateral prefrontal cortex. The behavioral dimension loaded most prominently onto
items assessing externalizing disorders such as ADHD, conduct disorder, and
oppositional defiant disorder. Results are consistent with case-control studies in each of
these disorders, which have demonstrated hypo-function of executive regions including
most commonly fronto-parietal regions (10,20). Similarly, dysfunction of the dorsolateral
prefrontal cortex is considered one of the cardinal impairments of psychosis (39).
However, it should be noted that the effects of the psychosis spectrum observed here
are more circumscribed than those typically reported; this may be due to the use of a
population rather than a clinical sampling strategy, a focus on sub-threshold psychosis
symptoms, and accounting for overall psychopathology through the bifactor model.
However, consistent with the current results, in our previous report on psychosis202

spectrum symptoms in this sample we observed that hypo-activation of executive
regions was linked to cognitive performance but not to severity of positive psychotic
symptoms, suggesting a substantial effect of overall impairment rather than psychosis
per se (25).
In contrast to the diminished recruitment seen in other symptom domains,
anxious-misery symptoms were associated with widespread hyper-activation of the
executive network.

Indeed, after accounting for overall psychopathology, anxious-

misery symptoms were associated with a trend towards better working memory
performance. However, executive hyper-activation is unlikely to be simply an
epiphenomenon associated with working memory performance, as hyper-activation was
still seen in sensitivity analyses that controlled for both in-scanner and out-of-scanner
cognitive performance. This result is consistent with several studies of executive function
in major depression and anxiety disorders that have found over-activation of executive
regions (15-17). In contrast to the deficient ability to recruit the executive network seen in
association with other symptom dimensions, these data suggest that mood and anxiety
symptoms are associated with an inefficient executive system, where higher levels of
executive network activation occur. It should be noted that participants in our sample
who screened positive for mood and anxiety disorders frequently also had high levels of
overall psychopathology. As these dimensions have directionally opposite associations
with executive recruitment, the relative presence of co-morbidity in a given sample could
conceivably result in divergent results.

Limitations
Certain limitations of the present work should be noted. First, the young
community-based sample studied here had diminished symptom severity compared to
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that found in typically older help-seeking samples drawn from clinical practices. Drawing
from a different distribution of symptoms may result in reduced generalizability to clinical
populations. However, the approach used here allowed us to accrue a larger, mainly
unmedicated sample at a single site and scanner, and is well suited to investigating
broad dimensions of psychopathology. A second important limitation is that this crosssectional report does not include longitudinal data. As our prior work in this dataset has
demonstrated that between-subject cross-sectional age effects are relatively subtle (24),
within-subject longitudinal data will be particularly informative regarding whether specific
symptom domains are associated with development of executive deficits over time.
Third, certain important classes of psychopathology such as substance use that have
been shown to impact executive function were not considered in the current analysis
(40). Fourth, despite prior research showing abnormalities of the default mode network
in multiple psychiatric disorders, we did not find significant effects in the default mode
network; this may be due to the task paradigm employed. Finally, as previously noted
(26,27), the highly-structured screening format of GOASSESS may have resulted in high
sensitivity but relatively diminished specificity, leading to over-estimation of the
frequency of several disorders. Alternatively, high rates of endorsed symptoms may
accurately reflect this particular sample. Although factor-analytic results of the
GOASSESS appear consistent with prior findings and lend support to the validity of the
measure, ongoing longitudinal follow-up with semi-structured assessments applying
DSM disorder criteria will allow further evaluation of the clinical relevance and stability of
the current findings.

Conclusions
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These data provide novel evidence regarding common and dissociable executive
system deficits across multiple dimensions of psychopathology in young people. Results
emphasize

that

executive

dysfunction

is

present

in

association

with

overall

psychopathology across traditional categorical psychiatric diagnoses, underscoring this
system’s central relevance for circuit-based conceptualizations of neuropsychiatric
disorders such as the NIMH Research Domain Criteria (RDoC) (21). These results may
suggest that interventions seeking to enhance executive function may not fit well within
the existing categorical diagnostic framework, and may be beneficial to individuals
across diverse clinical syndromes where executive deficits are present. Future research
employing longitudinal designs may motivate targeted early interventions that seek to
mitigate executive dysfunction in youth before negative outcomes accrue.
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TABLES

Table 1. Demographic information by screening diagnostic category. Individual
subjects may be present in multiple categories due to co-morbidity.
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FIGURE LEGENDS

Figure

1.

Bifactor

model

of

common

and

divergent

dimensions

of

psychopathology across categorical screening diagnoses. The input data to the
bifactor model were 112 items from the GOASSESS screening diagnostic interview,
resulting in orthogonal dimensions of psychopathology (A). Mean (SD) factor scores of
each dimension for each screening diagnosis (with at least n=20) is displayed in (B).
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Figure 2. Working memory task paradigm, behavioral performance and contrast
of interest. A fractal version of the n-back task was used to probe working memory
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function where working memory load was varied parametrically across three levels (A).
Higher working memory load was associated with fewer correct responses to targets (B)
and more false positive responses to foils (C). Correct responses and false positives
were summarized across all levels of working memory load using the signal detection
metric d’ to provide an integrated measure of working memory performance. Task
performance was reduced in association with both overall psychopathology and
behavioral symptoms; anxious-misery was conversely associated with a trend towards
improved task performance (D).

The contrast of interest (2-back > 0-back) robustly

activated the entire executive system and de-activated non-executive regions (E).
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Figure 3. Relationship of orthogonal dimensions of psychopathology with
executive

network

recruitment.

The

association

of

each

dimension

of

psychopathology with executive network activation (2-back > 0-back) was examined
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using linear regression. The most robust effects were seen for overall psychopathology,
where greater symptom severity was associated with diminished activation of the frontal
pole, anterior cingulate, anterior insula, thalamus, and precuneus.

Behavioral

symptoms were associated with fronto-parietal, thalamic, and cerebellar hypoactivation;
psychosis-spectrum symptoms were associated with diminished activation of the left
dorsolateral prefrontal cortex.

In contrast to the observed hypo-activation for all other

dimensions of psychopathology, anxious misery was associated with hyper-activation of
regions within the executive network, including the dorsolateral prefrontal cortex and
anterior cingulate cortex.

All analyses included age, sex, and in-scanner motion as

covariates; images thresholded at z>3.09, corrected p<0.001. Scatter plots were drawn
from significant clusters identified by red circles. Activation is plotted in arbitrary BOLD
units. For detailed results see Tables S1.
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Figure 4. Differential effects of psychopathology on executive system activation.
A linear model comparing the differential impact of each dimension of psychopathology
revealed significant differences in multiple executive regions including the anterior
cingulate cortex, frontal pole, and dorsolateral prefrontal cortex.

Differential effects

were driven by the divergent impact of anxious misery (hyper-activation) and overall
psychopathology (hypo-activation).

Activation is plotted in arbitrary BOLD units.

Shaded area represents 95% confidence intervals. For detailed results see Table S2.
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SUPPLEMENTARY METHODS
Participants: Exclusion Criteria
The Philadelphia Neurodevelopmental Cohort is a collaboration between the
Center for Applied Genomics at CHOP and the Brain Behavior Laboratory at the
University of Pennsylvania (Penn). Children, adolescents, and young adults between the
ages of 8 and 21 who presented to the Children’s Hospital of Philadelphia (CHOP) or a
CHOP-affiliated clinic for a pediatric visit and volunteered to participate in genomic
studies of complex pediatric disorders were eligible for inclusion in the Philadelphia
Neurodevelopmental Cohort (1-3). Participants and/or their parents signed an informed
consent form approved by the Institutional Review Boards at CHOP and Penn. After
stratification by age and sex, a subsample of 1,601 randomly selected participants
underwent multi-modal neuroimaging. Of these participants, 1,462 completed the n-back
task described below. Subject exclusion criteria included medical conditions that might
impact brain function (n=151), incidentally encountered structural brain abnormalities
(n=20), and inadequate task performance (>7 nonresponses on the 0-back condition;
n=65). As part of image quality assurance, subjects were also excluded for excessive
motion (mean relative displacement > 0.5mm or maximum displacement > 6 mm; n=94)
or poor image coverage (n=73). Many of the subjects excluded met multiple exclusion
criteria. The final sample included in analyses was 1,129. This sample thus constitutes a
super-set of subjects previously included in reports which focused on normative
development (4) and psychosis-spectrum symptoms (5).

Clinical Assessment
Psychopathology was assessed using a structured screening instrument
(GOASSESS) administered by trained assessors (1). Participants age 11-21 were
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interviewed individually; collateral information was obtained independently from a
caregiver for children age 8-17. To allow rapid training and standardization across a
large number of assessors, GOASSESS was designed to be highly structured, with
screen-level symptom and episode information. The instrument is abbreviated and
modified from the epidemiologic version of the NIMH Genetic Epidemiology Research
Branch Kiddie-SADS (6). Assessors underwent a common training protocol developed
and implemented by MEC that included didactic sessions, assigned readings, and
supervised pair-wise practice. They were certified for independent assessments through
a standardized procedure requiring observation by a certified clinical observer who rated
the proficiency of the assessor on a 60-item checklist of interview procedures.
The

psychopathology

screen

in

GOASSESS

assessed

psychiatric

and

psychological treatment history, as well as lifetime occurrence of major domains of
psychopathology

including

mood

(major

depressive

episode,

mania),

anxiety

(agoraphobia, generalized anxiety, panic, specific phobia, social phobia, separation
anxiety), behavioral (oppositional defiant, attention deficit/hyperactivity, conduct), eating
disorders (anorexia, bulimia), and suicidal thinking and behavior. Substance use
disorders were assessed with a different instrument for a subset of participants and are
not evaluated here.

Each section included a screen for relevant symptoms and

additional DSM-IV criteria such as symptom frequency, duration, onset, and offset.
Associated distress and impairment were each rated on 11-point scales ranging from 0
to 10. To establish screening diagnostic criteria for each domain of psychopathology, a
computerized algorithm integrated information regarding symptom frequency and
duration approximating each DSM-IV disorder or episode criteria, accompanied by
significant distress or impairment rated>=5 on the 11-point scale.
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Assessment of Psychosis Spectrum Symptoms
As described in detail in our prior articles focused on psychosis-spectrum
symptoms (5,7,8), GOASSESS provided three measures of psychosis-spectrum
symptoms. First, sub-threshold positive symptoms in the past year were assessed with
the 12-item assessor administered PRIME Screen-Revised (PS-R)(9). Items were read
aloud by the assessor and self-rated on a 7-point scale (0 = Definitely Disagree; 6 =
Definitely Agree). Second, lifetime threshold hallucinations and delusions were
evaluated with the K-SADS (6) psychosis questions and structured follow-up probes.
Third, negative and disorganized symptoms were evaluated using six assessor rated
items from the Scale of Prodromal Symptoms (SOPS) in the Structured Interview for
Prodromal Syndromes (SIPS)(10), including: N2 Avolition; N3 Expression of Emotion;
N4 Experience of Emotions and Self; N6 Occupational Functioning; D3 Trouble with
Focus and Attention; and P5 Disorganized Communication. We identified subjects as
psychosis-spectrum if they: 1) had an age-deviant PRIME total score >= 2SD above age
matched peers or had >= one PRIME item rated 6 or >= three items rated 5 (Somewhat
Agree); 2) endorsed definite or possible hallucinations or delusions on the K-SADS
psychosis screen; or 3) had an age deviant total negative/disorganized SOPS score
>=2SD above age-matched peers.

Factor Analysis Methods
Factor analysis methods and results have been previously presented (11) and
will be detailed in a separate manuscript (Calkins et al., In Preparation). Briefly, factor
analyses proceeded in several phases. First, we performed exploratory factor analyses
in order to determine which items loaded on which factors, with the ultimate goal of
estimating a confirmatory factor analysis model from which to calculate scores. Because
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there are multiple exploratory factor analyses extraction methods (and an even greater
number of factor rotations), we decided to estimate several exploratory factor analyses
for thoroughness. Methods provided convergent results, supporting a four-factor model.
Because

all

exploratory

factor

analyses

indicated

correlated

traits

of

psychopathology, and because a goal of the item-wise confirmatory analysis was to
generate orthogonal scores, we opted to use the only type of confirmatory model
capable of accommodating such a combination, which is the bifactor model (12-14).
Bifactor modeling is a way to estimate the contribution of an item to an overall dimension
(psychopathology in this case) after controlling for its specific factor, and vice versa.
Bifactor models are similar to higher-order models, except in a bifactor model there are
direct effects of the general factor on the individual items.
The confirmatory bifactor model was estimated using the Bayesian estimator in
Mplus (15).

The Bayesian estimator comes with the drawback of not producing

conventional fit indices, but was chosen because the computation time of other
estimators (e.g. wlsmv) was anticipated to be much longer. The model was later
estimated using the other estimators (wlsmv and MLR), and the minimum correlation
between scores calculated using the different methods was 0.93 (mean = 0.98). The fit
indices provided by the wlsmv-estimated model suggest acceptable fit, with a
Comparative Fit Index (CFI) of 0.91 and Root Mean-Square Error of Approximation
(RMSEA) of 0.027 ± 0.0005.

Task Paradigm
Subjects completed a fractal version of the n-back task (16) during their fMRI
scan. During the task, a fractal was presented for 500 ms followed by a 2500 ms
interstimulus interval. This task was used to probe working memory and had 3
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conditions: 0-, 1-, and 2-back. During the 0-back, subjects responded by pressing a
button when the fractal presented matched a predefined fractal. During the 1-back,
subjects responded when the fractal presented was the same as the one preceding it.
During the 2-back, subjects responded when the fractal was identical to the one two
before it. Each condition consisted of three 20-trial blocks, each preceded by a 9s
instruction period, with a target to foil ratio of 1:3. The task included a total of 45 targets
and 135 foils, as well as three 24 s blocks of rest during which a fixation crosshair was
displayed.

Image Acquisition
Imaging data were acquired on 3T Siemens TIM Trio whole-body scanner using
a 32-channel head coil. A magnetization-prepared rapid acquisition gradient echo T1weighted (MPRAGE) image (TR, 1810 ms; TE, 3.51 ms; TI, 1100 ms; FOV, 180 × 240
mm; matrix, 192 × 256; 160 slices; slice thickness/gap, 1/0 mm; flip angle, 9°; effective
voxel resolution, 0.9 × 0.9 × 1 mm) and B0 field map (TR, 1000 ms; TE1, 2.69 ms; TE2,
5.27 ms; 44 slices; slice thickness/gap, 4/0 mm; FOV, 240 mm; effective voxel
resolution, 3.8 × 3.8 × 4 mm) were acquired to aid spatial normalization to standard
space and application of distortion correction procedures, respectively. Functional
images were then obtained using a whole-brain, single-shot, multislice, gradient-echo
echoplanar sequence (231 volumes; TR, 3000; TE, 32 ms; flip angle, 90°; FOV, 192 ×
192 mm; matrix 64 × 64; 46 slices; slice thickness/gap 3/0 mm; effective voxel
resolution, 3.0 × 3.0 × 3.0 mm).

Image Processing
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As previously described (4), fMRI data was pre-processed with FSL (17),
including skull removal with BET (18), slice time correction, motion-correction with
MCFLIRT (19), spatial smoothing (6 mm FWHM), and mean-based intensity
normalization. Subject-level timeseries analyses were carried out using FILM (FMRIB's
Improved Linear Model) with local autocorrelation correction (20). The three condition
blocks (0-back, 1-back, and 2-back) were modeled using a canonical (double-gamma)
hemodynamic response function with six motion parameters and the instruction period
included as nuisance covariates. The rest condition served as the unmodeled baseline.
The median functional and anatomical volumes were co-registered using boundarybased registration (21) with integrated distortion correction using FUGUE. The
anatomical image was normalized to the Montreal Neurologic Institute 152 1 mm
template using the top-performing diffeomorphic SyN registration of ANTS (22,23). All
transformations (distortion correction, co-registration, normalization, and down-sampling
to 2mm3) were concatenated so only one interpolation was performed. The statistical
maps for the contrast of interest (2-back > 0-back) were then used in the group-level
analyses. Statistical maps were downsampled further to 4mm3 for the multivariate
distance-based matrix regression analysis (see below) for computational feasibility;
generalized linear model analyses used 2mm3 resolution data.

Matrix Regression
Multivariate distance-based matrix regression operates in two steps. In the first
step, the overall multivariate pattern of activation and de-activation in down-sampled
data (4mm isotropic voxels) was compared among subjects using a distance metric
(Euclidean distance). This produces a matrix (size 1,129 x 1,129) representing how
similar the overall pattern of activation is between each combination of subject pairs.
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Second, matrix regression is used to test how well each phenotypic variable explains the
distances between each participant’s pattern of activation created in step 1. This
provides a measure of how the overall pattern of activation is impacted by each group
level variable entered into the design matrix in standard regression format. Our grouplevel design matrix included symptom dimensions (from the factor analysis), age, sex,
and in-scanner motion. As in our prior work, motion was summarized for each subject as
the mean relative displacement of realignment parameters across the time series (2426). This multivariate distance-based matrix regression procedure yields a pseudo-F
statistic, the significance of which was tested using 1,000 permutations.
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Figure S1
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Table S1. Main effect of psychopathology dimensions in complete sample (n=1129)
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Table S1 continued.

Table S2. Differential effects of psychopathology dimensions in complete sample
(n=1129)
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Table S3. Main effect of psychopathology dimensions in sub-sample of participants not
taking psychotropic medication (n=1007)
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Table S4. Main effect of psychopathology dimensions with working memory
performance (d' ) as a covariate (n=1129)
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Table S5. Main effect of psychopathology dimensions while including additional
covariates (n=1112 due to missing covariate data in 17 subjects). Covariates included:
age, sex, race, in-scanner motion, maternal education, time between assessment and
imaging, out-of-scanner cognitive performance, and in-scanner working memory
performance.
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Table S6. Main effect of psychopathology dimensions after excluding for poor 2-back
performance (n=963)
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Neural Markers of the Development of Executive Function: Relevance for
Education
This section has been published:
Shanmugan S, Satterthwaite TD (2016) Neural Markers of the Development of
Executive Function: Relevance for Education. Current opinion in behavioral sciences
10:7-13.
ABSTRACT
Executive functions are involved in the development of academic skills and are
critical for functioning in school settings. The relevance of executive functions to
education begins early and continues throughout development, with clear impact on
achievement. Diverse efforts increasingly suggest ways in which facilitating development
of executive function may be used to improve academic performance. Such
interventions seek to alter the trajectory of executive development, which exhibits a
protracted course of maturation that stretches into young adulthood. As such, it may be
useful to understand how the executive system develops normally and abnormally in
order to tailor interventions within educational settings. Here we review recent work
investigating the neural basis for executive development during childhood and
adolescence.

Introduction
Executive function (EF) is a broad category of cognition, including cognitive
control, sustained attention, inhibition, error monitoring, and working memory. Unlike
other cognitive domains, the executive system undergoes a protracted period of
development that extends into young adulthood. Behavioral studies have suggested that
different domains of EF may develop at different rates during this time [1]. These
processes are necessary for the normal development of nearly all academic areas
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including math [2,3] and language [3] skills. The importance of early EF capacity to
academic achievement begins as early as preschool [4] and continues throughout
adolescence [5]. As such, there has been much interest in methods to facilitate the
development of EFs in school settings in an effort to improve academic performance.
Accordingly, an understanding of the neural basis of the executive system’s
development could help target interventions to facilitate the development of executive
function.
Here we review the existing literature regarding brain systems implicated in the
development of the executive system and its significance for academic achievement. We
first describe recent behavioral and neuroimaging studies regarding the maturation of
the executive system from childhood through adolescence. Second, we describe
moderating factors that have been shown to affect the course of executive development.
Third, we review studies documenting executive dysfunction in neuropsychiatric
disorders, which often begin in adolescence and are associated with poor educational
outcomes [6]. Finally, we present examples of educational interventions that have been
proposed as ways of facilitating EF development.

Normative development of executive function: behavioral studies
Childhood and adolescence are periods of rapid development of EF. Dajani and
Uddin [7] note that different domains of EF develop at various times during development:
inhibition and attentional control emerge and develop in early childhood, information
processing abilities improve in mid childhood, while cognitive flexibility and goal setting
continue to develop into adolescence. For instance, a longitudinal study of young
children charting trajectories of inhibitory control and cognitive flexibility found that these
processes developed most rapidly during 3-4 years of age [1]. Though cognitive
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flexibility develops more slowly than inhibitory control [1], age-related improvements in
inhibition have been observed through mid-childhood [8]. Attention and working memory
(WM) are additional domains of EF that continue to mature throughout adolescence,
while other cognitive domains such as spatial memory and verbal memory do not [9].

Normative development of executive function: neuroimaging studies
Though it is clear from behavioral studies that EF matures during childhood and
adolescence,

neuroimaging

studies

provide

information

regarding

how

neurodevelopmental processes may underlie the improvement in performance. Studies
of brain structure, function, and connectivity provide complementary evidence regarding
maturation of the executive system. Structural brain imaging studies indicate that grey
matter

volume

increases

during

childhood

and

subsequently

declines

during

adolescence, whereas white matter volumes increase throughout development [10].
However, the trajectory of development may be more important in predicting intelligence
and EF than cross-sectional measurements [11]. For example, the correlation between
prefrontal cortical thickness and IQ is negative in early childhood but becomes positive in
late childhood through early adulthood. Additionally, the trajectory of these changes in
cortical thickness are more reflective of IQ than cortical thickness itself [11].
More recent studies have examined how changes in cortical thickness of specific
brain regions correlate with EF. For example, in healthy older children, cortical grey
matter thinning in the inferior frontal gyrus and anterior cingulate cortex is associated
with age-related improvements in cognitive control, while thinning in the superior parietal
cortex is associated with improvements in working memory [12]. In contrast, a
longitudinal study showed that increased rate of cortical thinning in medial cortical
regions during development is associated with more executive deficits in adulthood [13].
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While age is strongly related to changes in brain structure, this relationship is
less robust for functional measures of executive function. In young children, age was
found to be correlated with increased lateral PFC recruitment during a working memory
task [14]. In addition, cognitive control studies have shown that children with good task
performance recruit different prefrontal regions than adults [15]. However, age effects on
task-induced activation of executive regions during sustained attention and inhibition are
not completely consistent [16-18]. Cognitive control studies have shown that there is a
shift from diffuse to focal patterns of activation during development, with increased
activation in regions necessary for effective task performance [19,20].
More recently, a large study of 951 youths showed that increased activation of
executive regions and reciprocal deactivation of default mode network (DMN) regions
underlie the improvements in WM seen during adolescence (see Figure 1). Executive
activation and DMN de-activation was more strongly correlated with WM performance
than chronological age [21], suggesting that executive development may be understood
as a process of functional (rather than chronologic) maturation. Notably, multivariate
pattern regression demonstrated that while both executive activation and DMN deactivation could be used to predict performance, maximum accuracy required integration
of features from both networks.
Studies of resting-state functional connectivity provide evidence regarding the
development of interacting functional networks, which support EF. Both cross-sectional
[22] and longitudinal studies [23] demonstrate that correlations among regions within the
DMN are weak in childhood but become stronger with age. Furthermore, a recent study
in a large cohort of youth found that the DMN’s role as a “cohesive connector” system
within the functional connectome increased with age, and was correlated with cognitive
performance [24]. This finding contrasts with a longitudinal study in young adolescents,
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which found weaker between network correlations between the central executive
network and the DMN with age [23]. The divergence of these findings may be due to the
different edge measures used for the network analyses of the two studies: wavelet
coherence was used as an edge measure in Gu et al., 2015, which quantifies highly
related, but out-of-phase (anti-correlated) signals as strongly connected, and all values
range from 0-1. This contrasts with the commonly-used Pearson’s correlation (as in
[23]), where out-of-phase signals will be represented with negative values.
Such developmental changes in resting state connectivity have been associated
with EF capacity. Hyper-connectivity within the DMN and cingulo-opercular network are
seen in children with executive deficits [25]. Greater anti-correlation between the DMN
and lateral frontal cortex is associated with better inhibitory performance in children [25],
but the relationship between inhibition and strength of anti-correlation between the taskpositive executive system and DMN is also stronger in adults than in children [26]. These
studies support the idea that the development of functional network topology contributes
to the maturation of EF during this critical period.

Moderating factors
Development of EF is influenced by several factors including sex and
socioeconomic status (SES). Females demonstrate better working memory and attention
from childhood through adolescence [9], though males show more improvement in these
domains during adolescence [27]. In contrast, males show better processing speed at
the beginning of adolescence but improve less [27]. SES also affects multiple domains
of EF, including sustained attention and inhibition [27]. Inhibitory control and cognitive
flexibility develop more slowly in preschool-aged children with less access to learning
resources [1]. In contrast to findings from behavioral studies, a longitudinal neuroimaging
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study found an interactive effect of SES and sex on both behavior and brain function, but
no effect of SES or sex alone [28]. Sex differences in EF that are present before puberty
have been attributed to organizational effects of exposure to gonadal hormones in early
development on emerging neural circuits, whereas sex differences that first appear
during puberty may be due to activational effects of differences in gonadal steroid levels
associated with puberty [29].

Relevance for psychopathology
Executive deficits are present in a wide range psychiatric disorders affecting
children and adolescents including attention deficit hyperactivity disorder (ADHD) [30],
conduct disorder [31], substance use disorders [32], and psychotic disorders [33,34].
Consequences of executive deficits during childhood and adolescence include
decreased academic achievement, social isolation, low self-esteem, and risk-taking
behavior [35]. Individuals with these disorders are thus most likely to benefit from
educational interventions aimed at improving EF. Therefore, understanding how
psychopathology is related to failures of executive development is critical.
Recent behavioral studies in neuropsychiatric disorders have examined how
executive dysfunction impacts academic and social aspects of school performance, with
most evidence accumulating in ADHD and substance use disorders. Developmental
trajectories in adolescents with ADHD compared to healthy individuals are delayed for
inhibition and shifting but similar for WM and planning [36]. In youths with ADHD, those
with worse EF have more problems with academic performance and peer interactions
[37]. Additionally, poor EF in adolescence is associated with early and greater use of
alcohol and other substances [32].

239

Many neuroimaging studies have examined the relationship between executive
system dysfunction and neuropsychiatric disorders during development. Case-control
studies often attribute dysfunction of executive regions such as the dorsolateral
prefrontal cortex, anterior cingulate, and anterior insula to disorders such as ADHD [38],
schizophrenia [39], and conduct disorder [40]. However, a recent study of 1,129 youths
with diverse psychopathology found that overall psychopathology (as measured using a
bi-factor model, Figure 2A) is associated with reduced recruitment of the executive
network (Figure 2B) [41]. Such functional data is convergent with recent evidence
demonstrating grey matter loss in similar regions across several disorders that exhibit
executive deficits [42]. In contrast, anxious-misery symptoms are associated with
widespread hyper-activation of the executive network (Figure 2C) [41], suggesting that
there are both common and dissociable deficits in executive system recruitment among
neuropsychiatric disorders. Taken together, these studies emphasize the degree to
which failures of executive function are a central feature of diverse psychopathology that
often emerge in school-age children and adolescents, and frequently present as
difficulties within educational environments.

Educational interventions
Understanding executive development and the factors that moderate it are
important for developing interventions to improve it. Cognitive remediation has been
shown to significantly improve multiple executive domains in patients with schizophrenia
[43] and ADHD [44]. These improvements in EF are correlated with changes in brain
activation such that cognitive remediation diminishes the degree of hypoactivation
observed in psychosis [45]. However, the majority of recent studies proposing
educational interventions that would improve EF, such as music and physical education
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classes, do not include a neuroimaging component, and thus brain-based data are
limited. Two recent exceptions include one study that demonstrated improved EF and
increased task-induced prefrontal activation in healthy young adults following exercise
[46]. Another recent study suggested that musically trained children exhibit better verbal
fluency and processing speed as well as increased activation of executive regions [47].
While cognitive training [48], neurofeedback training [49], and mindfulness training [50]
are additional methods that have shown early positive results in improving executive
deficits, the impact of these interventions on brain function has not yet been evaluated.
Given the paucity of studies in this area, it is clear that more work is needed to
understand how proposed educational interventions may impact EF at a neural level.

Limitations of current research
While much progress has been made regarding our understanding of executive
system development, there are several limitations that should be noted. First, many of
the studies investigating EF in development are cross-sectional, and thus are unable to
delineate the longitudinal developmental trajectory of EF. While cross-sectional studies
are often the basis of longitudinal inferences regarding development, factors such as the
selection of time points, trajectory of developmental process, and test-retest reliability of
methods employed affect the extent to which cross-sectional findings accurately
represent longitudinal processes [51]. Many of the few longitudinal neuroimaging studies
suffer from relatively small sample sizes or relatively brief longitudinal follow-up.
Furthermore, existing work has used a variety of tasks to probe EF, and results may not
be generalizable across tasks or executive domains. Additionally, task difficulty likely
decreases with age, and the strategies used to perform such tasks evolve during
development [7], limiting the ability to similarly probe EF across age groups.
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Similarly, few studies evaluate the impact of educational interventions on brain
measures of EF. As such, it is not known how such interventions lead to improvements
in EF or whether they produce lasting neural changes that affect the course of executive
system development. Additionally, methods of assessing EF and task paradigms vary
across studies, limiting replication of existing results.

Future directions
Studies reviewed here emphasize that EF undergoes an extended maturational
period throughout childhood and young adulthood. It is clear from both behavioral and
neuroimaging studies that different domains of EF exhibit different developmental
trajectories. However, charting these trajectories remains incomplete. Large longitudinal
neuroimaging studies that consistently account for factors that would affect the course of
development are necessary in determining how the executive system develops normally
and abnormally in association with performance deficits. Determining the normal
developmental trajectory of the executive system is a necessary step in identifying both
abnormal development in youth at risk for poor outcomes as well as critical periods
where interventions might be most effective. Notably, the Adolescent Brain Cognitive
Development (ABCD) initiative will provide detailed cognitive and clinical phenotyping in
concert with longitudinal multi-modal neuroimaging on a large cohort of 10,000 youth
followed over 10 years. This landmark study has the potential to provide data that may
transform our understanding regarding how the executive system develops during youth.
Additionally, it is evident that there are several factors that moderate the
development of EFs. Preliminary studies indicate cognitive remediation [43,44], cognitive
training [48], music classes [47], and physical education [46] may be ways to improve EF
during development. However, more information regarding their impact and mode of
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action are needed before these factors can be used to inform the implementation of
educational strategies that can facilitate EF development. For example, while several
studies have identified factors that correlate with better or worse EF, the optimal time
periods for implementation remain unclear. Similarly, the mechanisms by which
educational interventions exert their effects are yet to be determined. Incorporating
brain-based measurements within such studies may be an important step in
understanding the mechanisms of interventions that have the potential to produce longterm benefits for academic achievement.
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FIGURE LEGENDS

Figure 1. Brain response to WM load is more significantly related to WM performance
than subject age. In a sample of 951 youths ages 8-22 imaged as part of the
Philadelphia Neurodevelopmental Cohort using a fractal version of the n-back working
memory task, working memory load was associated with executive activation and
reciprocal de-activation of non-executive regions including the default mode network
(DMN). This pattern of activation was weakly associated with chronological age (A), but
strongly associated with WM performance (B). The complex multivariate pattern of brain
response could be used to predict WM performance with a relatively high degree of
accuracy using a cross-validated multivariate pattern regression (C), which included
features from both the executive and default mode system (D). Notably, while both
executive and non-executive regions could predict WM performance, maximally accurate
predictions required the combined feature set which spanned both networks (E). All
data from Satterthwaite et al., 2013.
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Figure 2.

Psychopathology is associated with common and dissociable patterns of

executive dysfunction. In a sample of 1,129 youths imaged as part of the Philadelphia
Neurodevelopmental Cohort, a bifactor factor analysis identified common and divergent
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dimensions of psychopathology across categorical screening diagnoses (A). When
these dimensions of psychopathology were related to activation during a fractal version
of the n-back working memory task, overall psychopathology across categorical
screening diagnoses was associated with hypo-activation of the executive system (B),
whereas anxious-misery symptoms (depression, anxiety) were associated with elevated
activation of the executive system (C). All data from Shanmugan et al., 2016.
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